{
  "success": true,
  "stage": 12,
  "stage_name": "QEB Builder",
  "duration_seconds": 584.1921029090881,
  "qeb_output": {
    "protocolId": "NCT00481091",
    "version": "1.0",
    "generatedAt": "2026-02-13T14:35:56.430628",
    "therapeuticArea": "Oncology",
    "summary": {
      "totalQEBs": 50,
      "inclusionQEBs": 20,
      "exclusionQEBs": 30,
      "fullyQueryable": 6,
      "llmExtractable": 17,
      "hybridQueryable": 3,
      "screeningOnly": 0,
      "notApplicable": 0,
      "partiallyQueryable": 17,
      "requiresManualReview": 7,
      "totalAtomicsConsolidated": 204,
      "uniqueOmopConcepts": 21,
      "deduplicationRate": 0.8970588235294118,
      "killerCriteriaCount": 2,
      "funnelStagesCount": 7,
      "eligibilitySectionPages": {
        "start": 28,
        "end": 30
      }
    },
    "funnelStages": [
      {
        "stageId": "FS_1",
        "stageName": "CLL Diagnosis and Treatment Need",
        "stageOrder": 1,
        "qebIds": [
          "QEB_INC_5.2.1.2",
          "QEB_INC_5.2.3.2"
        ],
        "combinedEliminationRate": 99.99,
        "stageDescription": "Confirms the primary diagnosis of relapsed/refractory Chronic Lymphocytic Leukemia (CLL) and the investigator's opinion that treatment is required."
      },
      {
        "stageId": "FS_2",
        "stageName": "Demographics and Performance Status",
        "stageOrder": 2,
        "qebIds": [
          "QEB_INC_5.2.1.1",
          "QEB_INC_5.2.3.1",
          "QEB_INC_5.2.1.3",
          "QEB_INC_5.2.3.4"
        ],
        "combinedEliminationRate": 15.0,
        "stageDescription": "Verifies fundamental patient characteristics including age and overall functional health (ECOG score)."
      },
      {
        "stageId": "FS_3",
        "stageName": "Prior Anti-Cancer Therapy Review",
        "stageOrder": 3,
        "qebIds": [
          "QEB_INC_5.2.3.3",
          "QEB_EXC_5.2.2.2",
          "QEB_EXC_5.2.4.3",
          "QEB_EXC_5.2.2.8",
          "QEB_EXC_5.2.4.7",
          "QEB_EXC_5.2.2.9",
          "QEB_EXC_5.2.4.9",
          "QEB_EXC_5.2.2.10",
          "QEB_EXC_5.2.4.10"
        ],
        "combinedEliminationRate": 40.0,
        "stageDescription": "Assesses the patient's treatment history, including number of prior regimens, specific therapies like stem cell transplant, and required washout periods from previous treatments."
      },
      {
        "stageId": "FS_4",
        "stageName": "Significant Medical History and Comorbidities",
        "stageOrder": 4,
        "qebIds": [
          "QEB_EXC_5.2.2.1",
          "QEB_EXC_5.2.4.1",
          "QEB_EXC_5.2.2.12",
          "QEB_EXC_5.2.4.12",
          "QEB_EXC_5.2.4.15",
          "QEB_EXC_5.2.4.16",
          "QEB_EXC_5.2.4.14"
        ],
        "combinedEliminationRate": 25.0,
        "stageDescription": "Reviews for major medical conditions that would exclude a patient, such as CNS malignancy, other active cancers, uncontrolled infections, or significant organ system diseases."
      },
      {
        "stageId": "FS_5",
        "stageName": "Bleeding Risk and Prohibited Medications",
        "stageOrder": 5,
        "qebIds": [
          "QEB_EXC_5.2.2.3",
          "QEB_EXC_5.2.4.2",
          "QEB_EXC_5.2.2.4",
          "QEB_EXC_5.2.4.4",
          "QEB_EXC_5.2.2.5",
          "QEB_EXC_5.2.4.5",
          "QEB_EXC_5.2.2.6",
          "QEB_EXC_5.2.4.8",
          "QEB_EXC_5.2.2.7",
          "QEB_EXC_5.2.4.6",
          "QEB_EXC_5.2.4.17",
          "QEB_INC_5.2.1.4",
          "QEB_INC_5.2.3.5",
          "QEB_EXC_5.2.2.11",
          "QEB_EXC_5.2.4.11"
        ],
        "combinedEliminationRate": 30.0,
        "stageDescription": "Focuses on specific conditions and medications that increase bleeding risk, including history of bleeding, peptic ulcers, and use of anticoagulants, platelet inhibitors, or certain supplements."
      },
      {
        "stageId": "FS_6",
        "stageName": "Screening Laboratory and Organ Function",
        "stageOrder": 6,
        "qebIds": [
          "QEB_INC_5.2.1.5",
          "QEB_INC_5.2.3.6"
        ],
        "combinedEliminationRate": 10.0,
        "stageDescription": "Requires screening procedures to confirm adequate bone marrow, renal, and hepatic function based on specific laboratory values."
      },
      {
        "stageId": "FS_7",
        "stageName": "Informed Consent and Reproductive Safety",
        "stageOrder": 7,
        "qebIds": [
          "QEB_INC_5.2.1.8",
          "QEB_INC_5.2.3.9",
          "QEB_INC_5.2.1.6",
          "QEB_INC_5.2.3.7",
          "QEB_EXC_5.2.2.13",
          "QEB_EXC_5.2.4.13",
          "QEB_INC_5.2.1.7",
          "QEB_INC_5.2.3.8"
        ],
        "combinedEliminationRate": 5.0,
        "stageDescription": "Finalizes eligibility with the formal signing of the informed consent form and confirms reproductive status, including negative pregnancy tests and agreement to contraception."
      }
    ],
    "queryableBlocks": [
      {
        "qebId": "QEB_INC_5.2.1.1",
        "originalCriterionId": "INC_5.2.1.1",
        "criterionType": "inclusion",
        "clinicalName": "Minimum Age of 18 Years",
        "clinicalDescription": "Patients must be 18 years of age or older to participate.",
        "clinicalCategory": "Demographics",
        "funnelStage": "Demographics and Performance Status",
        "funnelStageOrder": 2,
        "combinedSql": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
        "sqlLogicExplanation": "A0001",
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0001"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [
          {
            "conceptId": 4265453,
            "conceptName": "Age",
            "domain": "Observation",
            "vocabularyId": "SNOMED",
            "conceptCode": "397669002"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|30525-0"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Age",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:397669002 (domain: Observation)",
            "sourceOmopConceptId": 4265453
          }
        ],
        "protocolText": "The subject must be \u2265 18 years of age.",
        "provenance": {
          "pageNumber": 28,
          "sectionId": null,
          "textSnippet": "5.2.1 Phase 1 Inclusion Criteria\nA subject will be eligible for study participation if he/she meets the following criteria:\n1. The subject must be \u2265 18 years of age."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Age >= 18 years",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0001"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Age >= 18 years"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Age >= 18 years"
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.2",
        "originalCriterionId": "INC_5.2.1.2",
        "criterionType": "inclusion",
        "clinicalName": "Diagnosis of Relapsed or Refractory CLL",
        "clinicalDescription": "Patient must have Chronic Lymphocytic Leukemia that has returned or stopped responding to prior treatment and requires therapy.",
        "clinicalCategory": "Disease Indication",
        "funnelStage": "CLL Diagnosis and Treatment Need",
        "funnelStageOrder": 1,
        "combinedSql": "((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824))) INTERSECT (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)",
        "sqlLogicExplanation": "(A0002 OR A0003) AND A0004",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "The concepts of 'relapsed,' 'refractory,' and especially 'require treatment in the opinion of the investigator' are not standard structured data and require clinical interpretation and chart review.",
        "estimatedEliminationRate": 99.99,
        "isKillerCriterion": true,
        "epidemiologicalEvidence": "Incidence of CLL is ~4.9 per 100,000 per year. (SEER Cancer Stat Facts: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. National Cancer Institute. Bethesda, MD).",
        "atomicIds": [
          "A0002",
          "A0003",
          "A0004"
        ],
        "atomicCount": 3,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 4173824,
            "conceptName": "B-cell chronic lymphocytic leukemia variant",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "277474005"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|277474005,C91.1"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "B-cell chronic lymphocytic leukemia variant",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:277474005 (domain: Condition)",
            "sourceOmopConceptId": 4173824
          }
        ],
        "protocolText": "The subject must have relapsed or refractory CLL and require treatment in the opinion of the investigator.",
        "provenance": {
          "pageNumber": 28,
          "sectionId": null,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Cll Relapsed Refractory Status",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0002",
                "A0003"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Relapsed Chronic Lymphocytic Leukemia (CLL) OR Refractory Chronic Lymphocytic Leukemia (CLL)"
            },
            {
              "groupName": "Requires treatment in the opinion of the investiga...",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0004"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Requires treatment in the opinion of the investigator"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Cll Relapsed Refractory Status, Requires treatment in the opinion of the investiga..."
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.3",
        "originalCriterionId": "INC_5.2.1.3",
        "criterionType": "inclusion",
        "clinicalName": "Good Performance Status (ECOG \u2264 1)",
        "clinicalDescription": "Patient must be generally well and able to perform light activities with minimal symptoms.",
        "clinicalCategory": "Functional Status",
        "funnelStage": "Demographics and Performance Status",
        "funnelStageOrder": 2,
        "combinedSql": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlLogicExplanation": "A0005",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "ECOG scores are not consistently captured in structured data, are subjective, and must be assessed at the time of screening. Historical values are not sufficient.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0005"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has an Eastern Cooperative Oncology Group performance score of \u2264 1.",
        "provenance": {
          "pageNumber": 28,
          "sectionId": null,
          "textSnippet": "opinion of the investigator.\n3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Eastern Cooperative Oncology Group performance sco...",
              "clinicalCategory": "performance_status",
              "atomicIds": [
                "A0005"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Eastern Cooperative Oncology Group performance score of <= 1"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Eastern Cooperative Oncology Group performance sco..."
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.4",
        "originalCriterionId": "INC_5.2.1.4",
        "criterionType": "inclusion",
        "clinicalName": "Stable Dose of SSRI Antidepressants",
        "clinicalDescription": "Patients taking certain antidepressants must be on a stable dose for at least 21 days before starting the study drug.",
        "clinicalCategory": "Concomitant Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '21 days'))",
        "sqlLogicExplanation": "IF (A0006) THEN (A0007)",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Verifying dose 'stability' over a specific period (21 days) is challenging with structured data alone and often requires reviewing medication administration records, prescription history, and clinical notes.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0006",
          "A0007"
        ],
        "atomicCount": 2,
        "internalLogic": "IMPLICATION",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants (e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 28,
          "sectionId": null,
          "textSnippet": "3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n4. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Receiving Selective Serotonin Reuptake Inhibitor (...",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0006"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants"
            },
            {
              "groupName": "Receiving a stable dose of SSRI anti-depressant",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0007"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Receiving a stable dose of SSRI anti-depressant"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Receiving Selective Serotonin Reuptake Inhibitor (... AND Receiving a stable dose of SSRI anti-depressant"
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.5",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "clinicalName": "Adequate Organ and Bone Marrow Function",
        "clinicalDescription": "Patient must have acceptable blood counts, kidney function, and liver function based on screening lab tests.",
        "clinicalCategory": "Organ Function",
        "funnelStage": "Screening Laboratory and Organ Function",
        "funnelStageOrder": 6,
        "combinedSql": "(((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1000) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 75000) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)))) UNION ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number < 1000) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 2.0) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number >= 50)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 3.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 3.0) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value_as_number <= 1.2) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value_as_number <= 1.2)",
        "sqlLogicExplanation": "(A0008 AND A0009 AND NOT (A0010) AND A0011 AND NOT (A0012) OR A0013 AND A0014) AND (A0015 OR A0016) AND A0017 AND A0018 AND (A0019 OR A0020) AND A0021 AND A0022",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "While lab values are structured, confirming they are 'independent of growth factor support' or 'independent of transfusion within 14 days' requires querying other data domains with precise timing. The bone marrow infiltration exception requires pathology report review.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0008",
          "A0009",
          "A0010",
          "A0011",
          "A0012",
          "A0013",
          "A0014",
          "A0015",
          "A0016",
          "A0017",
          "A0018",
          "A0019",
          "A0020",
          "A0021",
          "A0022"
        ],
        "atomicCount": 15,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 3017732,
            "conceptName": "Neutrophils [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26499-4"
          },
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          },
          {
            "conceptId": 3000963,
            "conceptName": "Hemoglobin [Mass/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "718-7"
          },
          {
            "conceptId": 3016723,
            "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "2160-0"
          },
          {
            "conceptId": 3013721,
            "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1920-8"
          },
          {
            "conceptId": 3006923,
            "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1742-6"
          },
          {
            "conceptId": 3024128,
            "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1975-2"
          },
          {
            "conceptId": 4099740,
            "conceptName": "Gilbert's syndrome",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "27503000"
          },
          {
            "conceptId": 3013466,
            "conceptName": "aPTT in Blood by Coagulation assay",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "3173-2"
          },
          {
            "conceptId": 3034426,
            "conceptName": "Prothrombin time (PT)",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "5902-2"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26499-4"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|718-7"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|2160-0"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1920-8"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1742-6"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1975-2"
            },
            "description": null
          },
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|27503000,E80.4"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|3173-2"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|5902-2"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Neutrophils [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26499-4 (domain: Measurement)",
            "sourceOmopConceptId": 3017732
          },
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          },
          {
            "conceptName": "Hemoglobin [Mass/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:718-7 (domain: Measurement)",
            "sourceOmopConceptId": 3000963
          },
          {
            "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:2160-0 (domain: Measurement)",
            "sourceOmopConceptId": 3016723
          },
          {
            "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1920-8 (domain: Measurement)",
            "sourceOmopConceptId": 3013721
          },
          {
            "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1742-6 (domain: Measurement)",
            "sourceOmopConceptId": 3006923
          },
          {
            "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1975-2 (domain: Measurement)",
            "sourceOmopConceptId": 3024128
          },
          {
            "conceptName": "Gilbert's syndrome",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:27503000 (domain: Condition)",
            "sourceOmopConceptId": 4099740
          },
          {
            "conceptName": "aPTT in Blood by Coagulation assay",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:3173-2 (domain: Measurement)",
            "sourceOmopConceptId": 3013466
          },
          {
            "conceptName": "Prothrombin time (PT)",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:5902-2 (domain: Measurement)",
            "sourceOmopConceptId": 3034426
          }
        ],
        "protocolText": "The subject must have adequate bone marrow independent of growth factor support (with the exception of subjects with ANC < 1000/\u03bcL and bone marrow heavily infiltrated with underlying disease [80% or more]), renal and hepatic function, per local laboratory reference range at Screening as follows:\n\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\u03bcL; Platelets \u2265 75,000/mm3 (entry platelet count must be independent of transfusion within 14 days of Screening), Hemoglobin \u2265 9.0 g/dL;\n\u25cf Renal function: Serum creatinine \u2264 2.0 mg/dL or calculated creatinine clearance \u2265 50 mL/min;\n\u25cf Hepatic function and enzymes: AST and ALT \u2264 3.0 \u00d7 the upper normal limit (ULN) of institution's normal range; Bilirubin \u2264 1.5 \u00d7 ULN. Subjects with Gilbert's Syndrome may have a Bilirubin > 1.5 \u00d7 ULN;\n\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \u00d7 ULN.",
        "provenance": {
          "pageNumber": 28,
          "sectionId": null,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),..."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0008"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL"
            },
            {
              "groupName": "Platelets >= 75,000/mm3",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0009"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Platelets >= 75,000/mm3"
            },
            {
              "groupName": "Received platelet transfusion",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0010"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received platelet transfusion"
            },
            {
              "groupName": "Hemoglobin >= 9.0 g/dL",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0011"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Hemoglobin >= 9.0 g/dL"
            },
            {
              "groupName": "Received growth factor support",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0012"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received growth factor support"
            },
            {
              "groupName": "Absolute Neutrophil count (ANC) < 1000/\u03bcL",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0013"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Absolute Neutrophil count (ANC) < 1000/\u03bcL"
            },
            {
              "groupName": "Bone marrow heavily infiltrated with underlying di...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0014"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Bone marrow heavily infiltrated with underlying disease (80% or more)"
            },
            {
              "groupName": "Serum creatinine <= 2.0 mg/dL",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0015"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Serum creatinine <= 2.0 mg/dL"
            },
            {
              "groupName": "Calculated creatinine clearance >= 50 mL/min",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0016"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Calculated creatinine clearance >= 50 mL/min"
            },
            {
              "groupName": "AST <= 3.0 x the upper normal limit (ULN)",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0017"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "AST <= 3.0 x the upper normal limit (ULN)"
            },
            {
              "groupName": "ALT <= 3.0 x the upper normal limit (ULN)",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0018"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "ALT <= 3.0 x the upper normal limit (ULN)"
            },
            {
              "groupName": "Total Bilirubin <= 1.5 x ULN",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0019"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Total Bilirubin <= 1.5 x ULN"
            },
            {
              "groupName": "Subject has Gilbert's Syndrome",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0020"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject has Gilbert's Syndrome"
            },
            {
              "groupName": "aPTT not to exceed 1.2 x ULN",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0021"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "aPTT not to exceed 1.2 x ULN"
            },
            {
              "groupName": "PT not to exceed 1.2 x ULN",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0022"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "PT not to exceed 1.2 x ULN"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Absolute Neutrophil count (ANC) >= 1000/\u03bcL, Platelets >= 75,000/mm3, Received platelet transfusion, and 12 more requirements"
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.6",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "clinicalName": "Negative Pregnancy Status for Female Patients",
        "clinicalDescription": "Female patients of childbearing potential must not be pregnant, confirmed by testing.",
        "clinicalCategory": "Reproductive Status",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "(-- Unknown table: person\n-- Atomic text: Subject is female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) UNION (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive result for serum hCG test.)) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957)) UNION ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive result for urine hCG test.))))))",
        "sqlLogicExplanation": "A0023 AND (A0024 OR A0025 OR NOT (A0026) AND IF (A0027) THEN (NOT (A0028)))",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "The criterion requires a pregnancy test to be performed at the time of screening, which is a prospective action, not a query of existing data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0023",
          "A0024",
          "A0025",
          "A0026",
          "A0027",
          "A0028"
        ],
        "atomicCount": 6,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 42528957,
            "conceptName": "Pregnancy status",
            "domain": "Observation",
            "vocabularyId": "LOINC",
            "conceptCode": "82810-3"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|82810-3,77386006"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Pregnancy status",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
            "sourceOmopConceptId": 42528957
          }
        ],
        "protocolText": "Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or have negative results for a pregnancy test performed as follows:\n\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study drug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Cycle 1 Day 1 or Lead-in Day 1 (lead-in period) if it has been > 7 days since obtaining the serum pregnancy test results.",
        "provenance": {
          "pageNumber": 28,
          "sectionId": null,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and"
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Subject is female",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0023"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject is female"
            },
            {
              "groupName": "Surgically sterile",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0024"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Surgically sterile"
            },
            {
              "groupName": "Postmenopausal for at least 1 year",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0025"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Postmenopausal for at least 1 year"
            }
          ],
          "screeningOnlyRequirements": [
            {
              "atomicId": "A0026",
              "description": "Positive serum pregnancy test result at Screening",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0027",
              "description": "More than 7 days between obtaining serum pregnancy test and initial study drug administration",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0028",
              "description": "Positive urine pregnancy test on Cycle 1 Day 1 or Lead-in Day 1",
              "note": "Site/documentation requirement, not patient filter"
            }
          ],
          "clinicalLogicSummary": "Patient must meet: Subject is female, Surgically sterile, Postmenopausal for at least 1 year"
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.7",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "clinicalName": "Contraception Requirement for Fertile Patients",
        "clinicalDescription": "Patients who can have children must agree to use an effective method of birth control during the study.",
        "clinicalCategory": "Reproductive Status",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (((-- Unknown table: person\n-- Atomic text: Gender is Female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)))) UNION ((-- Unknown table: person\n-- Atomic text: Gender is Male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)))))) UNION ((((-- Unknown table: person\n-- Atomic text: Gender is Female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)))) UNION ((-- Unknown table: person\n-- Atomic text: Gender is Male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */))))) INTERSECT ((SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))))",
        "sqlLogicExplanation": "IF ((A0029 AND NOT ((A0030 OR A0031)) OR A0032 AND NOT (A0033))) THEN ((A0034 OR A0035 OR A0036 OR A0037))",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "This criterion assesses a patient's future behavior and willingness to use contraception, which is determined through patient interview, not EHR data query.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0029",
          "A0030",
          "A0031",
          "A0032",
          "A0033",
          "A0034",
          "A0035",
          "A0036",
          "A0037"
        ],
        "atomicCount": 9,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 600058216,
            "conceptName": "Other Investigational Agent",
            "domain": "Observation",
            "vocabularyId": "NCIt_Full",
            "conceptCode": "C156875"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "MedicationStatement",
            "searchParams": {
              "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Other Investigational Agent",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.7,
            "rationale": "Mapped from OMOP NCIt_Full:C156875 (domain: Observation)",
            "sourceOmopConceptId": 600058216
          }
        ],
        "protocolText": "All female subjects not surgically sterile or postmenopausal (for at least 1 year) and non-vasectomized male subjects must practice at least one of the following methods of birth control:\n\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual cycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive sponge, diaphragm or vaginal ring with spermicidal jellies or cream).",
        "provenance": {
          "pageNumber": 29,
          "sectionId": null,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo..."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Female Sterility",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0030",
                "A0031"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Surgically sterile OR Postmenopausal for at least 1 year"
            },
            {
              "groupName": "Birth Control Method",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0034",
                "A0035",
                "A0036",
                "A0037"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Total abstinence from sexual intercourse for at least one complete menstrual cycle OR ... (4 variants)"
            },
            {
              "groupName": "Gender is Female",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0029"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Gender is Female"
            },
            {
              "groupName": "Gender is Male",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0032"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Gender is Male"
            },
            {
              "groupName": "Subject has had a vasectomy",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0033"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject has had a vasectomy"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Female Sterility, Birth Control Method, Gender is Female, and 2 more requirements"
        }
      },
      {
        "qebId": "QEB_INC_5.2.1.8",
        "originalCriterionId": "INC_5.2.1.8",
        "criterionType": "inclusion",
        "clinicalName": "Signed Informed Consent Form",
        "clinicalDescription": "Patient must voluntarily agree to participate and sign the consent form before any study procedures.",
        "clinicalCategory": "Informed Consent",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
        "sqlLogicExplanation": "A0038 AND A0039 AND A0040 AND A0041",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "Signing an informed consent form is a prospective, trial-specific administrative action and is not part of the patient's historical EHR data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0038",
          "A0039",
          "A0040",
          "A0041"
        ],
        "atomicCount": 4,
        "internalLogic": "AND",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
        "provenance": {
          "pageNumber": 29,
          "sectionId": null,
          "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures."
        },
        "clinicalSummary": {
          "conceptGroups": [],
          "screeningOnlyRequirements": [
            {
              "atomicId": "A0038",
              "description": "Informed consent was given voluntarily",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0039",
              "description": "Informed consent form is approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0040",
              "description": "Subject has signed an informed consent form",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0041",
              "description": "The signed informed consent form is dated",
              "note": "Site/documentation requirement, not patient filter"
            }
          ],
          "clinicalLogicSummary": "No queryable clinical concepts identified."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.1",
        "originalCriterionId": "EXC_5.2.2.1",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of CNS Malignancy",
        "clinicalDescription": "Patients with cancer that has spread to the brain or central nervous system are not eligible.",
        "clinicalCategory": "Disease Extent",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "(SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0042 OR A0043)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "A 'history' of CNS malignancy is queryable, but the 'clinically suspicious for' clause requires investigator judgment at screening and cannot be queried from structured data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0042",
          "A0043"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 600055953,
            "conceptName": "Prior Invasive Malignancy",
            "domain": "Observation",
            "vocabularyId": "NCIt_Full",
            "conceptCode": "C154619"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Prior Invasive Malignancy",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.7,
            "rationale": "Mapped from OMOP NCIt_Full:C154619 (domain: Observation)",
            "sourceOmopConceptId": 600055953
          }
        ],
        "protocolText": "The subject has a history or is clinically suspicious for cancer-related Central Nervous System (CNS) disease.",
        "provenance": {
          "pageNumber": 29,
          "sectionId": null,
          "textSnippet": "5.2.2 Phase 1 Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Cancer Related Cns Disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0042",
                "A0043"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "History of cancer-related Central Nervous System (CNS) disease OR Clinically suspicious for cancer-related Central Nervous System (CNS) disease"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Cancer Related Cns Disease"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.2",
        "originalCriterionId": "EXC_5.2.2.2",
        "criterionType": "exclusion",
        "clinicalName": "No Prior Stem Cell Transplant",
        "clinicalDescription": "Patients who have previously received an allogeneic or autologous stem cell transplant are not eligible.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "(SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623))",
        "sqlLogicExplanation": "(A0044 OR A0045)",
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0044",
          "A0045"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 4028623,
            "conceptName": "Transplantation of bone marrow",
            "domain": "Procedure",
            "vocabularyId": "SNOMED",
            "conceptCode": "23719005"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Procedure",
            "searchParams": {
              "query": "code=http://snomed.info/sct|23719005"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Transplantation of bone marrow",
            "cdiscCode": "CUSTOM",
            "domain": "PR",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:23719005 (domain: Procedure)",
            "sourceOmopConceptId": 4028623
          }
        ],
        "protocolText": "The subject has undergone an allogeneic or autologous stem cell transplant.",
        "provenance": {
          "pageNumber": 29,
          "sectionId": null,
          "textSnippet": "Nervous System (CNS) disease.\n2. The subject has undergone an allogeneic or autologous stem cell transplant."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Stem Cell Transplant",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0044",
                "A0045"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Undergone an allogeneic stem cell transplant OR Undergone an autologous stem cell transplant"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Stem Cell Transplant"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.3",
        "originalCriterionId": "EXC_5.2.2.3",
        "criterionType": "exclusion",
        "clinicalName": "No Recent History of Bleeding",
        "clinicalDescription": "Patients with a recent history of bleeding conditions or current signs of bleeding are excluded.",
        "clinicalCategory": "Medical History",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0046 OR A0047)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "Requires identifying a broad range of 'predisposing conditions' and assessing 'currently exhibits signs of bleeding,' which involves clinical judgment and physical examination.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0046",
          "A0047"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has a recent history (within 1 year prior to first dose of study drug) of an underlying, predisposing condition of bleeding or currently exhibits signs of bleeding.",
        "provenance": {
          "pageNumber": 29,
          "sectionId": null,
          "textSnippet": "2. The subject has undergone an allogeneic or autologous stem cell transplant.\n3. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Underlying, predisposing condition of bleeding",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0046"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Underlying, predisposing condition of bleeding"
            },
            {
              "groupName": "Currently exhibits signs of bleeding",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0047"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Currently exhibits signs of bleeding"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Underlying, predisposing condition of bleeding OR Currently exhibits signs of bleeding"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.4",
        "originalCriterionId": "EXC_5.2.2.4",
        "criterionType": "exclusion",
        "clinicalName": "No Active Peptic Ulcer or Gastritis",
        "clinicalDescription": "Patients with active stomach ulcers or other conditions that could cause gastrointestinal bleeding are not eligible.",
        "clinicalCategory": "Gastrointestinal Health",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0048 OR A0049 OR A0050)",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "The 'active' status of the disease cannot be reliably determined from structured data alone and requires review of recent clinical notes, imaging, or procedure reports.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0048",
          "A0049",
          "A0050"
        ],
        "atomicCount": 3,
        "internalLogic": "OR",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has active peptic ulcer disease or other potentially hemorrhagic esophagitis/gastritis.",
        "provenance": {
          "pageNumber": 29,
          "sectionId": null,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Gi Bleeding Risk",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0048",
                "A0049",
                "A0050"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Active peptic ulcer disease OR Potentially hemorrhagic esophagitis OR Potentially hemorrhagic gastritis"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Gi Bleeding Risk"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.5",
        "originalCriterionId": "EXC_5.2.2.5",
        "criterionType": "exclusion",
        "clinicalName": "No Active ITP or Platelet Refractoriness",
        "clinicalDescription": "Patients with active immune thrombocytopenic purpura or who do not respond to platelet transfusions are excluded.",
        "clinicalCategory": "Hematologic Conditions",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)",
        "sqlLogicExplanation": "(A0051 OR A0052)",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Determining 'active' ITP and especially 'refractory to platelet transfusions' requires detailed review of clinical notes, transfusion history, and corresponding lab value changes, which is not feasible with standard queries.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0051",
          "A0052"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          }
        ],
        "protocolText": "The subject has active immune thrombocytopenic purpura or a history of being refractory to platelet transfusions (within 1 year prior to the first dose of study drug).",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug)."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Active immune thrombocytopenic purpura",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0051"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Active immune thrombocytopenic purpura"
            },
            {
              "groupName": "History of being refractory to platelet transfusio...",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0052"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "History of being refractory to platelet transfusions"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Active immune thrombocytopenic purpura OR History of being refractory to platelet transfusio..."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.6",
        "originalCriterionId": "EXC_5.2.2.6",
        "criterionType": "exclusion",
        "clinicalName": "Aspirin Washout Period",
        "clinicalDescription": "Patients must not have taken aspirin within 7 days before starting the study drug.",
        "clinicalCategory": "Prohibited Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '7 days'",
        "sqlLogicExplanation": "A0053",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Cannot reliably determine patient adherence or use of over-the-counter medications from EHR data. Requires patient interview for confirmation.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0053"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received aspirin within 7 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "refractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).\n6. The subject has received aspirin within 7 days prior to the first dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Received aspirin",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0053"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received aspirin"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Received aspirin"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.7",
        "originalCriterionId": "EXC_5.2.2.7",
        "criterionType": "exclusion",
        "clinicalName": "Prohibition of Anticoagulants and Platelet Inhibitors",
        "clinicalDescription": "Patients taking blood thinners or other drugs that affect platelet function are not eligible.",
        "clinicalCategory": "Prohibited Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)) INTERSECT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0054 OR A0055) AND A0056",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Use of herbal supplements is not captured in EHRs. Determining if a patient 'requires' a therapy involves clinical judgment about whether it can be safely stopped.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0054",
          "A0055",
          "A0056"
        ],
        "atomicCount": 3,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          }
        ],
        "protocolText": "The subject is currently receiving or requires anticoagulation therapy or any drugs or herbal supplements that affect platelet function, with the exception of low-dose anticoagulation medications that are used to maintain the patency of a central intravenous catheter.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Bleeding Risk Medication",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0054",
                "A0055"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Currently receiving or requires anticoagulation therapy OR Currently receiving or requires any drugs or herbal supplements that affect platelet function"
            },
            {
              "groupName": "Low-dose anticoagulation medications used to maint...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0056"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Bleeding Risk Medication, Low-dose anticoagulation medications used to maint..."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.8",
        "originalCriterionId": "EXC_5.2.2.8",
        "criterionType": "exclusion",
        "clinicalName": "Washout Period for Systemic Steroid Therapy",
        "clinicalDescription": "Patients must not have received steroid therapy for their cancer within 7 days of starting the study drug.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "(SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) INTERSECT ((SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)))",
        "sqlLogicExplanation": "A0057 AND (A0058 OR A0059 OR A0060)",
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "The 'intent' of the therapy (anti-neoplastic) is not a structured data field and requires interpretation from clinical notes.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0057",
          "A0058",
          "A0059",
          "A0060"
        ],
        "atomicCount": 4,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 1243048,
            "conceptName": "Systemic corticosteroid therapy",
            "domain": "Procedure",
            "vocabularyId": "SNOMED",
            "conceptCode": "1290388005"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "MedicationStatement",
            "searchParams": {
              "query": "code=http://snomed.info/sct|1290388005"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Systemic corticosteroid therapy",
            "cdiscCode": "CUSTOM",
            "domain": "PR",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:1290388005 (domain: Procedure)",
            "sourceOmopConceptId": 1243048
          }
        ],
        "protocolText": "Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to the first dose of study drug with the exception of inhaled steroids for asthma, topical steroids, or replacement/stress corticosteroids.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Permitted Steroids",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0058",
                "A0059",
                "A0060"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received inhaled steroids for asthma OR Received topical steroids OR Received replacement or stress corticosteroids"
            },
            {
              "groupName": "Received steroid therapy for anti-neoplastic inten...",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0057"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received steroid therapy for anti-neoplastic intent"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Permitted Steroids, Received steroid therapy for anti-neoplastic inten..."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.9",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "clinicalName": "Washout Period for Prior Anti-Cancer Therapy",
        "clinicalDescription": "Patients must have a 14-day break from any previous cancer treatments before starting the study drug.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)))) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
        "sqlLogicExplanation": "((A0061 OR A0062 OR A0063 OR A0064 AND (A0065 OR A0066) OR A0067) OR NOT (A0068))",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "Assessing recovery from prior therapy toxicities to a specific grade ('less than grade 2') requires clinical assessment and review of records, not just a simple query.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0061",
          "A0062",
          "A0063",
          "A0064",
          "A0065",
          "A0066",
          "A0067",
          "A0068"
        ],
        "atomicCount": 8,
        "internalLogic": "COMPLEX",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received any anti-cancer therapy including chemotherapy, immunotherapy, radiotherapy, hormonal (with the exception of hormones for thyroid conditions or estrogen replacement therapy [ERT]), or any investigational therapy within 14 days prior to the first dose of study drug, or has not recovered to less than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous therapy.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Anti Cancer Therapy",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0061",
                "A0062",
                "A0063",
                "A0064"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received chemotherapy OR ... (4 variants)"
            },
            {
              "groupName": "Received hormones for thyroid conditions",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0065"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received hormones for thyroid conditions"
            },
            {
              "groupName": "Received estrogen replacement therapy (ERT)",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0066"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received estrogen replacement therapy (ERT)"
            },
            {
              "groupName": "Received any investigational therapy",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0067"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received any investigational therapy"
            },
            {
              "groupName": "Recovered to less than grade 2 from clinically sig...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0068"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Anti Cancer Therapy, Received hormones for thyroid conditions, Received estrogen replacement therapy (ERT), and 2 more requirements"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.10",
        "originalCriterionId": "EXC_5.2.2.10",
        "criterionType": "exclusion",
        "clinicalName": "Washout Period for Prior Biologic Therapy",
        "clinicalDescription": "Patients must have a 30-day break from any previous biologic treatments before starting the study drug.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlLogicExplanation": "A0069",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0069"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received a biologic within 30 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "therapy.\n10. The subject has received a biologic within 30 days prior to the first dose of study\ndrug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Received a biologic",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0069"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received a biologic"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Received a biologic"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.11",
        "originalCriterionId": "EXC_5.2.2.11",
        "criterionType": "exclusion",
        "clinicalName": "Grapefruit and Grapefruit Product Restriction",
        "clinicalDescription": "Patients must avoid consuming grapefruit or its products for 3 days before starting the study drug.",
        "clinicalCategory": "Dietary Restrictions",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0070 OR A0071)",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "Dietary information is not available in structured EHR data and must be obtained by interviewing the patient.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0070",
          "A0071"
        ],
        "atomicCount": 2,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has consumed grapefruit or grapefruit products within 3 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Grapefruit Consumption",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0070",
                "A0071"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Consumed grapefruit OR Consumed grapefruit products"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Grapefruit Consumption"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.12",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of Significant Uncontrolled Comorbidities",
        "clinicalDescription": "Patients with other significant medical conditions that could interfere with the study are not eligible.",
        "clinicalCategory": "Medical History",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '6 months') UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '6 months')) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0072 OR (A0073 OR A0074 OR A0075) OR A0076 OR A0077 OR A0078 OR A0079 OR A0080 OR A0081 OR A0082) AND A0083",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "The terms 'significant,' 'uncontrolled,' and 'in the opinion of the investigator' are subjective and require clinical interpretation that cannot be automated.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0072",
          "A0073",
          "A0074",
          "A0075",
          "A0076",
          "A0077",
          "A0078",
          "A0079",
          "A0080",
          "A0081",
          "A0082",
          "A0083"
        ],
        "atomicCount": 12,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 4329847,
            "conceptName": "Myocardial infarction",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "22298006"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|22298006,I21.9"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Myocardial infarction",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
            "sourceOmopConceptId": 4329847
          }
        ],
        "protocolText": "The subject has a significant history of cardiovascular disease (e.g., myocardial infarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, neurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic disease that in the opinion of the investigator would adversely affect his/her participating in this study.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Recent Thromboembolic Events",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0073",
                "A0074",
                "A0075"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Myocardial infarction OR Thrombotic event OR Thromboembolic event"
            },
            {
              "groupName": "Significant history of cardiovascular disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0072"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of cardiovascular disease"
            },
            {
              "groupName": "Significant history of renal disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0076"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of renal disease"
            },
            {
              "groupName": "Significant history of neurologic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0077"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of neurologic disease"
            },
            {
              "groupName": "Significant history of psychiatric disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0078"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of psychiatric disease"
            },
            {
              "groupName": "Significant history of endocrinologic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0079"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of endocrinologic disease"
            },
            {
              "groupName": "Significant history of metabolic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0080"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of metabolic disease"
            },
            {
              "groupName": "Significant history of immunologic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0081"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of immunologic disease"
            },
            {
              "groupName": "Significant history of hepatic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0082"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of hepatic disease"
            },
            {
              "groupName": "Condition would adversely affect study participati...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0083"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Condition would adversely affect study participation in the opinion of the investigator"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Recent Thromboembolic Events, Significant history of cardiovascular disease, Significant history of renal disease, and 7 more requirements"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.2.13",
        "originalCriterionId": "EXC_5.2.2.13",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of Pregnant or Breast-Feeding Females",
        "clinicalDescription": "Female patients who are pregnant or breast-feeding cannot participate in the study.",
        "clinicalCategory": "Reproductive Status",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "(-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
        "sqlLogicExplanation": "A0084 AND (A0085 OR A0086)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "Pregnancy and especially breast-feeding status are not reliably captured in structured EHR data and must be confirmed directly with the patient at screening.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0084",
          "A0085",
          "A0086"
        ],
        "atomicCount": 3,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 42528957,
            "conceptName": "Pregnancy status",
            "domain": "Observation",
            "vocabularyId": "LOINC",
            "conceptCode": "82810-3"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|82810-3,77386006"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Pregnancy status",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
            "sourceOmopConceptId": 42528957
          }
        ],
        "protocolText": "A female subject is pregnant or breast-feeding.",
        "provenance": {
          "pageNumber": 30,
          "sectionId": null,
          "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Female",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0084"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Female"
            },
            {
              "groupName": "Pregnant",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0085"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Pregnant"
            },
            {
              "groupName": "Breast-feeding",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0086"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Breast-feeding"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Female, Pregnant, Breast-feeding"
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.1",
        "originalCriterionId": "INC_5.2.3.1",
        "criterionType": "inclusion",
        "clinicalName": "Minimum Age of 18 Years",
        "clinicalDescription": "Patients must be 18 years of age or older to participate.",
        "clinicalCategory": "Demographics",
        "funnelStage": "Demographics and Performance Status",
        "funnelStageOrder": 2,
        "combinedSql": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
        "sqlLogicExplanation": "A0087",
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0087"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [
          {
            "conceptId": 4265453,
            "conceptName": "Age",
            "domain": "Observation",
            "vocabularyId": "SNOMED",
            "conceptCode": "397669002"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|30525-0"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Age",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:397669002 (domain: Observation)",
            "sourceOmopConceptId": 4265453
          }
        ],
        "protocolText": "The subject must be \u2265 18 years of age.",
        "provenance": {
          "pageNumber": 31,
          "sectionId": null,
          "textSnippet": "5.2.3 Phase 2a Inclusion Criteria\nA subject will be eligible for study participation if he/she meets the following criteria:\n1. The subject must be \u2265 18 years of age."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Age >= 18 years",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0087"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Age >= 18 years"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Age >= 18 years"
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.2",
        "originalCriterionId": "INC_5.2.3.2",
        "criterionType": "inclusion",
        "clinicalName": "Confirmed CLL Diagnosis Requiring Treatment",
        "clinicalDescription": "Patient must have a confirmed diagnosis of Chronic Lymphocytic Leukemia that requires treatment.",
        "clinicalCategory": "Disease Indication",
        "funnelStage": "CLL Diagnosis and Treatment Need",
        "funnelStageOrder": 1,
        "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)) INTERSECT (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)",
        "sqlLogicExplanation": "A0088 AND A0089",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "'Require treatment in the opinion of the investigator' is subjective and requires clinical judgment at the time of screening.",
        "estimatedEliminationRate": 99.99,
        "isKillerCriterion": true,
        "epidemiologicalEvidence": "Incidence of CLL is ~4.9 per 100,000 per year. (SEER Cancer Stat Facts: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. National Cancer Institute. Bethesda, MD).",
        "atomicIds": [
          "A0088",
          "A0089"
        ],
        "atomicCount": 2,
        "internalLogic": "AND",
        "omopConcepts": [
          {
            "conceptId": 4173824,
            "conceptName": "B-cell chronic lymphocytic leukemia variant",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "277474005"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|277474005,C91.1"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "B-cell chronic lymphocytic leukemia variant",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:277474005 (domain: Condition)",
            "sourceOmopConceptId": 4173824
          }
        ],
        "protocolText": "The subject must have CLL and require treatment in the opinion of the investigator.",
        "provenance": {
          "pageNumber": 31,
          "sectionId": null,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have CLL and require treatment in the opinion of the investigator."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Has Chronic Lymphocytic Leukemia (CLL)",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0088"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Has Chronic Lymphocytic Leukemia (CLL)"
            },
            {
              "groupName": "Requires treatment in the opinion of the investiga...",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0089"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Requires treatment in the opinion of the investigator"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Has Chronic Lymphocytic Leukemia (CLL) AND Requires treatment in the opinion of the investiga..."
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.3",
        "originalCriterionId": "INC_5.2.3.3",
        "criterionType": "inclusion",
        "clinicalName": "Limited Prior Chemotherapy for Relapsed Disease",
        "clinicalDescription": "Patients with relapsed disease must have received no more than five prior chemotherapy regimens.",
        "clinicalCategory": "Treatment History",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "A0090 AND A0091",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Counting distinct 'regimens' is a complex task that is not standardized in EHR data and typically requires manual abstraction from treatment summaries or flowsheets.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0090",
          "A0091"
        ],
        "atomicCount": 2,
        "internalLogic": "AND",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has relapsed disease and has received no more than 5 prior myelosuppressive/chemotherapy regimens.",
        "provenance": {
          "pageNumber": 31,
          "sectionId": null,
          "textSnippet": "2. The subject must have CLL and require treatment in the opinion of the investigator.\n3. The subject has relapsed disease and has received no more than 5 prior \nmyelosuppressive/chemotherapy regimens."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Relapsed disease",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0090"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Relapsed disease"
            },
            {
              "groupName": "Received 5 or fewer prior myelosuppressive/chemoth...",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0091"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Received 5 or fewer prior myelosuppressive/chemotherapy regimens"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Relapsed disease AND Received 5 or fewer prior myelosuppressive/chemoth..."
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.4",
        "originalCriterionId": "INC_5.2.3.4",
        "criterionType": "inclusion",
        "clinicalName": "Good Performance Status (ECOG \u2264 1)",
        "clinicalDescription": "Patient must be generally well and able to perform light activities with minimal symptoms.",
        "clinicalCategory": "Functional Status",
        "funnelStage": "Demographics and Performance Status",
        "funnelStageOrder": 2,
        "combinedSql": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND value_as_number >= 0 AND value_as_number <= 1",
        "sqlLogicExplanation": "A0092",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "ECOG scores are not consistently captured in structured data, are subjective, and must be assessed at the time of screening. Historical values are not sufficient.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0092"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [
          {
            "conceptId": 36305384,
            "conceptName": "ECOG Performance Status score",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "89247-1"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|89247-1"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "ECOG Performance Status score",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:89247-1 (domain: Measurement)",
            "sourceOmopConceptId": 36305384
          }
        ],
        "protocolText": "Subject has an Eastern Cooperative Oncology Group performance score of \u2264 1.",
        "provenance": {
          "pageNumber": 31,
          "sectionId": null,
          "textSnippet": "myelosuppressive/chemotherapy regimens.\n4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Eastern Cooperative Oncology Group (ECOG) performa...",
              "clinicalCategory": "performance_status",
              "atomicIds": [
                "A0092"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Eastern Cooperative Oncology Group (ECOG) performance score <= 1"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Eastern Cooperative Oncology Group (ECOG) performa..."
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.5",
        "originalCriterionId": "INC_5.2.3.5",
        "criterionType": "inclusion",
        "clinicalName": "Stable Dose of SSRI Antidepressants",
        "clinicalDescription": "Patients taking certain antidepressants must be on a stable dose for at least 21 days before starting the study drug.",
        "clinicalCategory": "Concomitant Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))))",
        "sqlLogicExplanation": "IF (A0093) THEN (NOT (A0094))",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Verifying dose 'stability' over a specific period (21 days) is challenging with structured data alone and often requires reviewing medication administration records, prescription history, and clinical notes.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0093",
          "A0094"
        ],
        "atomicCount": 2,
        "internalLogic": "IMPLICATION",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants (e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 31,
          "sectionId": null,
          "textSnippet": "4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n5. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Ssri Therapy",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0093",
                "A0094"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants OR Dose of SSRI changed"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Ssri Therapy"
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.6",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "clinicalName": "Adequate Organ and Bone Marrow Function",
        "clinicalDescription": "Patient must have acceptable blood counts, kidney function, and liver function based on screening lab tests.",
        "clinicalCategory": "Organ Function",
        "funnelStage": "Screening Laboratory and Organ Function",
        "funnelStageOrder": 6,
        "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1000) UNION ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number < 1000) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 75000) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 2.0) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number >= 50)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 3.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 3.0) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value_as_number <= 1.2) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value_as_number <= 1.2)",
        "sqlLogicExplanation": "NOT (A0095) AND (A0096 OR A0097 AND A0098) AND A0099 AND NOT (A0100) AND A0101 AND (A0102 OR A0103) AND A0104 AND A0105 AND (A0106 OR A0107) AND A0108 AND A0109",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "While lab values are structured, confirming they are 'independent of growth factor support' or 'independent of transfusion within 14 days' requires querying other data domains with precise timing. The bone marrow infiltration exception requires pathology report review.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0095",
          "A0096",
          "A0097",
          "A0098",
          "A0099",
          "A0100",
          "A0101",
          "A0102",
          "A0103",
          "A0104",
          "A0105",
          "A0106",
          "A0107",
          "A0108",
          "A0109"
        ],
        "atomicCount": 15,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 3017732,
            "conceptName": "Neutrophils [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26499-4"
          },
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          },
          {
            "conceptId": 3000963,
            "conceptName": "Hemoglobin [Mass/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "718-7"
          },
          {
            "conceptId": 3016723,
            "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "2160-0"
          },
          {
            "conceptId": 3013721,
            "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1920-8"
          },
          {
            "conceptId": 3006923,
            "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1742-6"
          },
          {
            "conceptId": 3024128,
            "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1975-2"
          },
          {
            "conceptId": 4099740,
            "conceptName": "Gilbert's syndrome",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "27503000"
          },
          {
            "conceptId": 3013466,
            "conceptName": "aPTT in Blood by Coagulation assay",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "3173-2"
          },
          {
            "conceptId": 3034426,
            "conceptName": "Prothrombin time (PT)",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "5902-2"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26499-4"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|718-7"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|2160-0"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1920-8"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1742-6"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1975-2"
            },
            "description": null
          },
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|27503000,E80.4"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|3173-2"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|5902-2"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Neutrophils [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26499-4 (domain: Measurement)",
            "sourceOmopConceptId": 3017732
          },
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          },
          {
            "conceptName": "Hemoglobin [Mass/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:718-7 (domain: Measurement)",
            "sourceOmopConceptId": 3000963
          },
          {
            "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:2160-0 (domain: Measurement)",
            "sourceOmopConceptId": 3016723
          },
          {
            "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1920-8 (domain: Measurement)",
            "sourceOmopConceptId": 3013721
          },
          {
            "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1742-6 (domain: Measurement)",
            "sourceOmopConceptId": 3006923
          },
          {
            "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1975-2 (domain: Measurement)",
            "sourceOmopConceptId": 3024128
          },
          {
            "conceptName": "Gilbert's syndrome",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:27503000 (domain: Condition)",
            "sourceOmopConceptId": 4099740
          },
          {
            "conceptName": "aPTT in Blood by Coagulation assay",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:3173-2 (domain: Measurement)",
            "sourceOmopConceptId": 3013466
          },
          {
            "conceptName": "Prothrombin time (PT)",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:5902-2 (domain: Measurement)",
            "sourceOmopConceptId": 3034426
          }
        ],
        "protocolText": "The subject must have adequate bone marrow independent of growth factor support (with the exception of subjects with ANC < 1000/\u03bcL and bone marrow heavily infiltrated with underlying disease [80% or more]), renal and hepatic function, per local laboratory reference range at Screening as follows:\n\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\u03bcL; Platelets \u2265 75,000/mm3 (entry platelet count must be independent of transfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;\n\u25cf Renal function: Serum creatinine \u2264 2.0 mg/dL or calculated creatinine clearance \u2265 50 mL/min;\n\u25cf Hepatic function and enzymes: AST and ALT \u2264 3.0 \u00d7 the upper normal limit (ULN) of institution's normal range; Bilirubin \u2264 1.5 \u00d7 ULN. Subjects with Gilbert's Syndrome may have a Bilirubin > 1.5 \u00d7 ULN;\n\u25cf Coagulation: aPTT, PT must not exceed 1.2 \u00d7 ULN.",
        "provenance": {
          "pageNumber": 32,
          "sectionId": null,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;"
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Received growth factor support to maintain bone ma...",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0095"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received growth factor support to maintain bone marrow function"
            },
            {
              "groupName": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Scre...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0096"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Screening"
            },
            {
              "groupName": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Scree...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0097"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Screening"
            },
            {
              "groupName": "Bone marrow heavily infiltrated with underlying di...",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0098"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Bone marrow heavily infiltrated with underlying disease >= 80% at Screening"
            },
            {
              "groupName": "Platelets >= 75,000/mm3 at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0099"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Platelets >= 75,000/mm3 at Screening"
            },
            {
              "groupName": "Received platelet transfusion",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0100"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received platelet transfusion"
            },
            {
              "groupName": "Hemoglobin >= 9.0 g/dL at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0101"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Hemoglobin >= 9.0 g/dL at Screening"
            },
            {
              "groupName": "Serum creatinine <= 2.0 mg/dL at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0102"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Serum creatinine <= 2.0 mg/dL at Screening"
            },
            {
              "groupName": "Calculated creatinine clearance >= 50 mL/min at Sc...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0103"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Calculated creatinine clearance >= 50 mL/min at Screening"
            },
            {
              "groupName": "AST <= 3.0 x ULN at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0104"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "AST <= 3.0 x ULN at Screening"
            },
            {
              "groupName": "ALT <= 3.0 x ULN at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0105"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "ALT <= 3.0 x ULN at Screening"
            },
            {
              "groupName": "Bilirubin <= 1.5 x ULN at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0106"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Bilirubin <= 1.5 x ULN at Screening"
            },
            {
              "groupName": "Subject has diagnosis of Gilbert's Syndrome",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0107"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject has diagnosis of Gilbert's Syndrome"
            },
            {
              "groupName": "aPTT must not exceed 1.2 x ULN at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0108"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "aPTT must not exceed 1.2 x ULN at Screening"
            },
            {
              "groupName": "PT must not exceed 1.2 x ULN at Screening",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0109"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "PT must not exceed 1.2 x ULN at Screening"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Received growth factor support to maintain bone ma..., Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Scre..., Absolute Neutrophil count (ANC) < 1000/\u03bcL at Scree..., and 12 more requirements"
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.7",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "clinicalName": "Negative Pregnancy Status for Female Patients",
        "clinicalDescription": "Female patients of childbearing potential must not be pregnant, confirmed by testing.",
        "clinicalCategory": "Reproductive Status",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "(-- Unknown table: person\n-- Atomic text: Female sex\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) UNION (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive)) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND value_as_number > 7)) UNION ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND value_as_number > 7) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive))))))",
        "sqlLogicExplanation": "A0110 AND (A0111 OR A0112 OR NOT (A0113) AND IF (A0114) THEN (NOT (A0115)))",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "The criterion requires a pregnancy test to be performed at the time of screening, which is a prospective action, not a query of existing data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0110",
          "A0111",
          "A0112",
          "A0113",
          "A0114",
          "A0115"
        ],
        "atomicCount": 6,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 42528957,
            "conceptName": "Pregnancy status",
            "domain": "Observation",
            "vocabularyId": "LOINC",
            "conceptCode": "82810-3"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|82810-3,77386006"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Pregnancy status",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
            "sourceOmopConceptId": 42528957
          }
        ],
        "protocolText": "Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or have negative results for a pregnancy test performed as follows:\n\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study drug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been > 7 days since obtaining the serum pregnancy test results.",
        "provenance": {
          "pageNumber": 32,
          "sectionId": null,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Female sex",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0110"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Female sex"
            },
            {
              "groupName": "Surgically sterile",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0111"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Surgically sterile"
            },
            {
              "groupName": "Postmenopausal for at least 1 year",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0112"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Postmenopausal for at least 1 year"
            }
          ],
          "screeningOnlyRequirements": [
            {
              "atomicId": "A0113",
              "description": "Positive serum pregnancy test at Screening",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0114",
              "description": "Time since serum pregnancy test results > 7 days on Lead-in Day 1",
              "note": "Site/documentation requirement, not patient filter"
            },
            {
              "atomicId": "A0115",
              "description": "Positive urine pregnancy test prior to dosing on Lead-in Day 1",
              "note": "Site/documentation requirement, not patient filter"
            }
          ],
          "clinicalLogicSummary": "Patient must meet: Female sex, Surgically sterile, Postmenopausal for at least 1 year"
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.8",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "clinicalName": "Contraception Requirement for Fertile Patients",
        "clinicalDescription": "Patients who can have children must agree to use an effective method of birth control during the study.",
        "clinicalCategory": "Reproductive Status",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (((-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)))) UNION ((-- Unknown table: person\n-- Atomic text: Male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)))))) UNION ((((-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE)))) UNION ((-- Unknown table: person\n-- Atomic text: Male\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */))))) INTERSECT ((SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))))",
        "sqlLogicExplanation": "IF ((A0116 AND NOT ((A0117 OR A0118)) OR A0119 AND NOT (A0120))) THEN ((A0121 OR A0122 OR A0123 OR A0124))",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "This criterion assesses a patient's future behavior and willingness to use contraception, which is determined through patient interview, not EHR data query.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0116",
          "A0117",
          "A0118",
          "A0119",
          "A0120",
          "A0121",
          "A0122",
          "A0123",
          "A0124"
        ],
        "atomicCount": 9,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 600058216,
            "conceptName": "Other Investigational Agent",
            "domain": "Observation",
            "vocabularyId": "NCIt_Full",
            "conceptCode": "C156875"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "MedicationStatement",
            "searchParams": {
              "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Other Investigational Agent",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.7,
            "rationale": "Mapped from OMOP NCIt_Full:C156875 (domain: Observation)",
            "sourceOmopConceptId": 600058216
          }
        ],
        "protocolText": "All female subjects not surgically sterile or postmenopausal (for at least 1 year) and non-vasectomized male subjects must practice at least one of the following methods of birth control:\n\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual cycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive sponge, diaphragm or vaginal ring with spermicidal jellies or cream).",
        "provenance": {
          "pageNumber": 32,
          "sectionId": null,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;"
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Female Not Childbearing Potential",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0117",
                "A0118"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Surgically sterile OR Postmenopausal for at least 1 year"
            },
            {
              "groupName": "Contraception Method",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0121",
                "A0122",
                "A0123",
                "A0124"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Practices total abstinence from sexual intercourse for a minimum of one complete menstrual cycle OR ... (4 variants)"
            },
            {
              "groupName": "Female",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0116"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Female"
            },
            {
              "groupName": "Male",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0119"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Male"
            },
            {
              "groupName": "History of vasectomy",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0120"
              ],
              "queryableStatus": "partially_queyrable",
              "treatmentImplication": null,
              "plainEnglish": "History of vasectomy"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Female Not Childbearing Potential, Contraception Method, Female, and 2 more requirements"
        }
      },
      {
        "qebId": "QEB_INC_5.2.3.9",
        "originalCriterionId": "INC_5.2.3.9",
        "criterionType": "inclusion",
        "clinicalName": "Signed Informed Consent Form",
        "clinicalDescription": "Patient must voluntarily agree to participate and sign the consent form before any study procedures.",
        "clinicalCategory": "Informed Consent",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlLogicExplanation": "A0125",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "Signing an informed consent form is a prospective, trial-specific administrative action and is not part of the patient's historical EHR data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0125"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "9. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Subject has voluntarily signed and dated an inform...",
              "clinicalCategory": "diagnostic_confirmation",
              "atomicIds": [
                "A0125"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Subject has voluntarily signed and dated an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Subject has voluntarily signed and dated an inform..."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.1",
        "originalCriterionId": "EXC_5.2.4.1",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of CNS Malignancy",
        "clinicalDescription": "Patients with cancer that has spread to the brain or central nervous system are not eligible.",
        "clinicalCategory": "Disease Extent",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "(SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0126 OR A0127)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "A 'history' of CNS malignancy is queryable, but the 'clinically suspicious for' clause requires investigator judgment at screening and cannot be queried from structured data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0126",
          "A0127"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 600055953,
            "conceptName": "Prior Invasive Malignancy",
            "domain": "Observation",
            "vocabularyId": "NCIt_Full",
            "conceptCode": "C154619"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Prior Invasive Malignancy",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.7,
            "rationale": "Mapped from OMOP NCIt_Full:C154619 (domain: Observation)",
            "sourceOmopConceptId": 600055953
          }
        ],
        "protocolText": "The subject has a history or is clinically suspicious for cancer-related Central Nervous System (CNS) disease.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "5.2.4 Phase 2a Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Cns Disease Presence",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0126",
                "A0127"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "History of cancer-related Central Nervous System (CNS) disease OR Clinically suspicious for cancer-related Central Nervous System (CNS) disease"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Cns Disease Presence"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.2",
        "originalCriterionId": "EXC_5.2.4.2",
        "criterionType": "exclusion",
        "clinicalName": "No Recent History of Bleeding",
        "clinicalDescription": "Patients with a recent history of bleeding conditions or current signs of bleeding are excluded.",
        "clinicalCategory": "Medical History",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0128 OR A0129)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "Requires identifying a broad range of 'predisposing conditions' and assessing 'currently exhibits signs of bleeding,' which involves clinical judgment and physical examination.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0128",
          "A0129"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has a recent history (within 1 year prior to first dose of study drug) of an underlying, predisposing condition of bleeding or currently exhibits signs of bleeding.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "Nervous System (CNS) disease.\n2. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Bleeding Risk",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0128",
                "A0129"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "History of an underlying, predisposing condition of bleeding OR Currently exhibits signs of bleeding"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Bleeding Risk"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.3",
        "originalCriterionId": "EXC_5.2.4.3",
        "criterionType": "exclusion",
        "clinicalName": "No Prior Stem Cell Transplant",
        "clinicalDescription": "Patients who have previously received an allogeneic or autologous stem cell transplant are not eligible.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "(SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623))",
        "sqlLogicExplanation": "(A0130 OR A0131)",
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0130",
          "A0131"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 4028623,
            "conceptName": "Transplantation of bone marrow",
            "domain": "Procedure",
            "vocabularyId": "SNOMED",
            "conceptCode": "23719005"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Procedure",
            "searchParams": {
              "query": "code=http://snomed.info/sct|23719005"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Transplantation of bone marrow",
            "cdiscCode": "CUSTOM",
            "domain": "PR",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:23719005 (domain: Procedure)",
            "sourceOmopConceptId": 4028623
          }
        ],
        "protocolText": "The subject has undergone an allogeneic or autologous stem cell transplant.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n3. The subject has undergone an allogeneic or autologous stem cell transplant."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Stem Cell Transplant",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0130",
                "A0131"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Undergone an allogeneic stem cell transplant OR Undergone an autologous stem cell transplant"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Stem Cell Transplant"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.4",
        "originalCriterionId": "EXC_5.2.4.4",
        "criterionType": "exclusion",
        "clinicalName": "No Active Peptic Ulcer or Gastritis",
        "clinicalDescription": "Patients with active stomach ulcers or other conditions that could cause gastrointestinal bleeding are not eligible.",
        "clinicalCategory": "Gastrointestinal Health",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0132 OR A0133 OR A0134)",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "The 'active' status of the disease cannot be reliably determined from structured data alone and requires review of recent clinical notes, imaging, or procedure reports.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0132",
          "A0133",
          "A0134"
        ],
        "atomicCount": 3,
        "internalLogic": "OR",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has active peptic ulcer disease or other potentially hemorrhagic esophagitis/gastritis.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Gi Hemorrhagic Risk",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0132",
                "A0133",
                "A0134"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Active peptic ulcer disease OR Potentially hemorrhagic esophagitis OR Potentially hemorrhagic gastritis"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Gi Hemorrhagic Risk"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.5",
        "originalCriterionId": "EXC_5.2.4.5",
        "criterionType": "exclusion",
        "clinicalName": "No Active ITP or Platelet Refractoriness",
        "clinicalDescription": "Patients with active immune thrombocytopenic purpura or who do not respond to platelet transfusions are excluded.",
        "clinicalCategory": "Hematologic Conditions",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)",
        "sqlLogicExplanation": "(A0135 OR A0136)",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Determining 'active' ITP and especially 'refractory to platelet transfusions' requires detailed review of clinical notes, transfusion history, and corresponding lab value changes, which is not feasible with standard queries.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0135",
          "A0136"
        ],
        "atomicCount": 2,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          }
        ],
        "protocolText": "The subject has active immune thrombocytopenic purpura or a history of being refractory to platelet transfusions (within 1 year prior to the first dose of study drug).",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "esophagitis/gastritis.\n5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study\ndrug)."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Active immune thrombocytopenic purpura",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0135"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Active immune thrombocytopenic purpura"
            },
            {
              "groupName": "History of being refractory to platelet transfusio...",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0136"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "History of being refractory to platelet transfusions"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Active immune thrombocytopenic purpura OR History of being refractory to platelet transfusio..."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.6",
        "originalCriterionId": "EXC_5.2.4.6",
        "criterionType": "exclusion",
        "clinicalName": "Prohibition of Anticoagulants and Platelet Inhibitors",
        "clinicalDescription": "Patients taking blood thinners or other drugs that affect platelet function are not eligible.",
        "clinicalCategory": "Prohibited Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)) INTERSECT (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0137 OR A0138) AND A0139",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Use of herbal supplements is not captured in EHRs. Determining if a patient 'requires' a therapy involves clinical judgment about whether it can be safely stopped.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0137",
          "A0138",
          "A0139"
        ],
        "atomicCount": 3,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          }
        ],
        "protocolText": "The subject is currently receiving or requires anticoagulation therapy or any drugs or herbal supplements that affect platelet function, with the exception of low-dose anticoagulation medications that are used to maintain the patency of a central intravenous catheter.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Anticoagulation Or Antiplatelet Therapy",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0137",
                "A0138"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Currently receiving or requires anticoagulation therapy OR Receiving drugs or herbal supplements that affect platelet function"
            },
            {
              "groupName": "Receiving low-dose anticoagulation for central int...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0139"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Receiving low-dose anticoagulation for central intravenous catheter patency"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Anticoagulation Or Antiplatelet Therapy, Receiving low-dose anticoagulation for central int..."
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.7",
        "originalCriterionId": "EXC_5.2.4.7",
        "criterionType": "exclusion",
        "clinicalName": "Washout Period for Systemic Steroid Therapy",
        "clinicalDescription": "Patients must not have received steroid therapy for their cancer within 7 days of starting the study drug.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "(SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) INTERSECT ((SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)))",
        "sqlLogicExplanation": "A0140 AND (A0141 OR A0142 OR A0143)",
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "The 'intent' of the therapy (anti-neoplastic) is not a structured data field and requires interpretation from clinical notes.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0140",
          "A0141",
          "A0142",
          "A0143"
        ],
        "atomicCount": 4,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 1243048,
            "conceptName": "Systemic corticosteroid therapy",
            "domain": "Procedure",
            "vocabularyId": "SNOMED",
            "conceptCode": "1290388005"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "MedicationStatement",
            "searchParams": {
              "query": "code=http://snomed.info/sct|1290388005"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Systemic corticosteroid therapy",
            "cdiscCode": "CUSTOM",
            "domain": "PR",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:1290388005 (domain: Procedure)",
            "sourceOmopConceptId": 1243048
          }
        ],
        "protocolText": "The subject has received steroid therapy for anti-neoplastic intent within 7 days prior to the first dose of study drug with the exception of inhaled steroids for asthma, topical steroids or replacement/stress corticosteroids.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Received steroid therapy for anti-neoplastic inten...",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0140"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received steroid therapy for anti-neoplastic intent"
            },
            {
              "groupName": "Received inhaled steroids for asthma",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0141"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received inhaled steroids for asthma"
            },
            {
              "groupName": "Received topical steroids",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0142"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received topical steroids"
            },
            {
              "groupName": "Received replacement/stress corticosteroids",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0143"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Received replacement/stress corticosteroids"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Received steroid therapy for anti-neoplastic inten..., Received inhaled steroids for asthma, Received topical steroids, and 1 more requirements"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.8",
        "originalCriterionId": "EXC_5.2.4.8",
        "criterionType": "exclusion",
        "clinicalName": "Aspirin Washout Period",
        "clinicalDescription": "Patients must not have taken aspirin within 7 days before starting the study drug.",
        "clinicalCategory": "Prohibited Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '7 days'",
        "sqlLogicExplanation": "A0144",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Cannot reliably determine patient adherence or use of over-the-counter medications from EHR data. Requires patient interview for confirmation.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0144"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received aspirin within 7 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 33,
          "sectionId": null,
          "textSnippet": "asthma, topical steroids or replacement/stress corticosteroids.\n8. The subject has received aspirin within 7 days prior to the first dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Received aspirin",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0144"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received aspirin"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Received aspirin"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.9",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "clinicalName": "Washout Period for Prior Anti-Cancer Therapy",
        "clinicalDescription": "Patients must have a 14-day break from any previous cancer treatments before starting the study drug.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)))) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
        "sqlLogicExplanation": "((A0145 OR A0146 OR A0147 OR A0148 AND (A0149 OR A0150) OR A0151) OR NOT (A0152))",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "Assessing recovery from prior therapy toxicities to a specific grade ('less than grade 2') requires clinical assessment and review of records, not just a simple query.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0145",
          "A0146",
          "A0147",
          "A0148",
          "A0149",
          "A0150",
          "A0151",
          "A0152"
        ],
        "atomicCount": 8,
        "internalLogic": "COMPLEX",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received any anti-cancer therapy including chemotherapy, immunotherapy, radiotherapy, hormonal (with the exception of hormones for thyroid conditions or estrogen replacement therapy [ERT]), or any investigational therapy within 14 days prior to the first dose of study drug, or has not recovered to less than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous therapy.",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Anti Cancer Therapy",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0145",
                "A0146",
                "A0147",
                "A0148"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received chemotherapy OR ... (4 variants)"
            },
            {
              "groupName": "Received hormones for thyroid conditions",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0149"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received hormones for thyroid conditions"
            },
            {
              "groupName": "Received estrogen replacement therapy (ERT)",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0150"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received estrogen replacement therapy (ERT)"
            },
            {
              "groupName": "Received any investigational therapy",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0151"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received any investigational therapy"
            },
            {
              "groupName": "Recovered to less than grade 2 from clinically sig...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0152"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Anti Cancer Therapy, Received hormones for thyroid conditions, Received estrogen replacement therapy (ERT), and 2 more requirements"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.10",
        "originalCriterionId": "EXC_5.2.4.10",
        "criterionType": "exclusion",
        "clinicalName": "Washout Period for Prior Biologic Therapy",
        "clinicalDescription": "Patients must have a 30-day break from any previous biologic treatments before starting the study drug.",
        "clinicalCategory": "Prior Therapy",
        "funnelStage": "Prior Anti-Cancer Therapy Review",
        "funnelStageOrder": 3,
        "combinedSql": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlLogicExplanation": "A0153",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0153"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received a biologic within 30 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "therapy.\n10. The subject has received a biologic within 30 days prior to the first dose of study\ndrug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Received a biologic agent",
              "clinicalCategory": "prior_therapy",
              "atomicIds": [
                "A0153"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received a biologic agent"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Received a biologic agent"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.11",
        "originalCriterionId": "EXC_5.2.4.11",
        "criterionType": "exclusion",
        "clinicalName": "Grapefruit and Grapefruit Product Restriction",
        "clinicalDescription": "Patients must avoid consuming grapefruit or its products for 3 days before starting the study drug.",
        "clinicalCategory": "Dietary Restrictions",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0154 OR A0155)",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "Dietary information is not available in structured EHR data and must be obtained by interviewing the patient.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0154",
          "A0155"
        ],
        "atomicCount": 2,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has consumed grapefruit or grapefruit products within 3 days prior to the first dose of study drug.",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Grapefruit Consumption",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0154",
                "A0155"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Consumed grapefruit OR Consumed grapefruit products"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Grapefruit Consumption"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.12",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of Significant Uncontrolled Comorbidities",
        "clinicalDescription": "Patients with other significant medical conditions that could interfere with the study are not eligible.",
        "clinicalCategory": "Medical History",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "(((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */))) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "((A0156 OR A0157 OR A0158) OR A0159 OR A0160 OR A0161 OR A0162 OR A0163 OR A0164 OR A0165 OR A0166) AND A0167",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "The terms 'significant,' 'uncontrolled,' and 'in the opinion of the investigator' are subjective and require clinical interpretation that cannot be automated.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0156",
          "A0157",
          "A0158",
          "A0159",
          "A0160",
          "A0161",
          "A0162",
          "A0163",
          "A0164",
          "A0165",
          "A0166",
          "A0167"
        ],
        "atomicCount": 12,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 4329847,
            "conceptName": "Myocardial infarction",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "22298006"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|22298006,I21.9"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Myocardial infarction",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
            "sourceOmopConceptId": 4329847
          }
        ],
        "protocolText": "The subject has a significant history of cardiovascular disease (e.g., myocardial infarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, neurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic disease that in the opinion of the investigator would adversely affect his/her participating in this study.",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Significant Cardiovascular Disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0156",
                "A0157",
                "A0158",
                "A0159"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Myocardial infarction OR ... (4 variants)"
            },
            {
              "groupName": "Significant history of renal disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0160"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of renal disease"
            },
            {
              "groupName": "Significant history of neurologic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0161"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of neurologic disease"
            },
            {
              "groupName": "Significant history of psychiatric disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0162"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of psychiatric disease"
            },
            {
              "groupName": "Significant history of endocrinologic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0163"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of endocrinologic disease"
            },
            {
              "groupName": "Significant history of metabolic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0164"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of metabolic disease"
            },
            {
              "groupName": "Significant history of immunologic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0165"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of immunologic disease"
            },
            {
              "groupName": "Significant history of hepatic disease",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0166"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Significant history of hepatic disease"
            },
            {
              "groupName": "Disease history would adversely affect participati...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0167"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Disease history would adversely affect participation in the study in the opinion of the investigator"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Significant Cardiovascular Disease, Significant history of renal disease, Significant history of neurologic disease, and 6 more requirements"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.13",
        "originalCriterionId": "EXC_5.2.4.13",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of Pregnant or Breast-Feeding Females",
        "clinicalDescription": "Female patients who are pregnant or breast-feeding cannot participate in the study.",
        "clinicalCategory": "Reproductive Status",
        "funnelStage": "Informed Consent and Reproductive Safety",
        "funnelStageOrder": 7,
        "combinedSql": "(-- Unknown table: person\n-- Atomic text: Subject is female\n-- Requires manual SQL generation) INTERSECT ((SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
        "sqlLogicExplanation": "A0168 AND (A0169 OR A0170)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "Pregnancy and especially breast-feeding status are not reliably captured in structured EHR data and must be confirmed directly with the patient at screening.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0168",
          "A0169",
          "A0170"
        ],
        "atomicCount": 3,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 42528957,
            "conceptName": "Pregnancy status",
            "domain": "Observation",
            "vocabularyId": "LOINC",
            "conceptCode": "82810-3"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|82810-3,77386006"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Pregnancy status",
            "cdiscCode": "CUSTOM",
            "domain": "VS",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:82810-3 (domain: Observation)",
            "sourceOmopConceptId": 42528957
          }
        ],
        "protocolText": "A female subject is pregnant or breast-feeding.",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Pregnancy Lactation Status",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0169",
                "A0170"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject is pregnant OR Subject is breast-feeding"
            },
            {
              "groupName": "Subject is female",
              "clinicalCategory": "demographics",
              "atomicIds": [
                "A0168"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject is female"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Pregnancy Lactation Status, Subject is female"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.14",
        "originalCriterionId": "EXC_5.2.4.14",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of HIV-Positive Patients",
        "clinicalDescription": "Patients who have tested positive for HIV are not eligible for this study.",
        "clinicalCategory": "Infectious Disease Status",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439727)",
        "sqlLogicExplanation": "A0171",
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0171"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [
          {
            "conceptId": 439727,
            "conceptName": "Human immunodeficiency virus infection",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "86406008"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|86406008,B20"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Human immunodeficiency virus infection",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:86406008 (domain: Condition)",
            "sourceOmopConceptId": 439727
          }
        ],
        "protocolText": "The subject has tested positive for HIV (due to potential drug-drug interactions between anti-retroviral medications and ABT-263, as well as anticipated ABT-263 mechanism based lymphopenia that may potentially increase the risk of opportunistic infections and potential drug-drug interactions with certain anti-infective agents).",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "14. The subject has tested positive for HIV (due to potential drug-drug interactions \nbetween anti-retroviral medications and ABT-263, as well as anticipated ABT-263 \nmechanism based lymphopenia that may potentially increase the risk of \nopportunistic infections and potential drug-drug interactions with certain \nanti-infective agents)."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Tested positive for HIV",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0171"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Tested positive for HIV"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Tested positive for HIV"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.15",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of Other Recent Active Malignancies",
        "clinicalDescription": "Patients must not have had another active cancer within the past 3 years, with some exceptions.",
        "clinicalCategory": "Medical History",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '3 years') INTERSECT ((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4301351))))",
        "sqlLogicExplanation": "A0172 AND (A0173 OR A0174 OR A0175 OR A0176 AND A0177 AND A0178)",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "Determining 'active' status and whether a prior malignancy meets the specific exception criteria (e.g., 'surgically resected with curative intent') requires detailed chart review.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0172",
          "A0173",
          "A0174",
          "A0175",
          "A0176",
          "A0177",
          "A0178"
        ],
        "atomicCount": 7,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 4301351,
            "conceptName": "Surgical procedure",
            "domain": "Procedure",
            "vocabularyId": "SNOMED",
            "conceptCode": "387713003"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Procedure",
            "searchParams": {
              "query": "code=http://snomed.info/sct|387713003"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Surgical procedure",
            "cdiscCode": "CUSTOM",
            "domain": "PR",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:387713003 (domain: Procedure)",
            "sourceOmopConceptId": 4301351
          }
        ],
        "protocolText": "The subject has a history of other active malignancies within the past 3 years prior to study entry, with the exception of:\n\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "provenance": {
          "pageNumber": 34,
          "sectionId": null,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Non Melanoma Skin Cancer",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0174",
                "A0175"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Basal cell carcinoma of the skin OR Squamous cell carcinoma of the skin"
            },
            {
              "groupName": "History of other active malignancy",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0172"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "History of other active malignancy"
            },
            {
              "groupName": "Adequately treated in situ carcinoma of the cervix...",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0173"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Adequately treated in situ carcinoma of the cervix uteri"
            },
            {
              "groupName": "Previous malignancy confined",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0176"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Previous malignancy confined"
            },
            {
              "groupName": "Previous malignancy surgically resected",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0177"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Previous malignancy surgically resected"
            },
            {
              "groupName": "Surgical resection was with curative intent",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0178"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Surgical resection was with curative intent"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Non Melanoma Skin Cancer, History of other active malignancy, Adequately treated in situ carcinoma of the cervix..., and 3 more requirements"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.16",
        "originalCriterionId": "EXC_5.2.4.16",
        "criterionType": "exclusion",
        "clinicalName": "Exclusion of Uncontrolled Systemic Infections",
        "clinicalDescription": "Patients with uncontrolled infections or recent febrile neutropenia are not eligible.",
        "clinicalCategory": "Medical History",
        "funnelStage": "Significant Medical History and Comorbidities",
        "funnelStageOrder": 4,
        "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)) UNION ((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)))",
        "sqlLogicExplanation": "(A0179 OR A0180 AND A0181)",
        "queryableStatus": "partially_queryable",
        "nonQueryableReason": "The term 'uncontrolled' is a subjective clinical assessment made at the time of screening and cannot be determined from historical structured data.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0179",
          "A0180",
          "A0181"
        ],
        "atomicCount": 3,
        "internalLogic": "OR",
        "omopConcepts": [
          {
            "conceptId": 4329847,
            "conceptName": "Myocardial infarction",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "22298006"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|22298006,I21.9"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Myocardial infarction",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:22298006 (domain: Condition)",
            "sourceOmopConceptId": 4329847
          }
        ],
        "protocolText": "The subject exhibits evidence of other clinically significant uncontrolled condition(s) including, but not limited to:\n\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug administration.",
        "provenance": {
          "pageNumber": 35,
          "sectionId": null,
          "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Uncontrolled Conditions",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0179"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Uncontrolled systemic infection (viral, bacterial, or fungal)"
            },
            {
              "groupName": "Febrile Neutropenia",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0180",
                "A0181"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Diagnosis of fever OR Diagnosis of neutropenia"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Uncontrolled Conditions OR Febrile Neutropenia"
        }
      },
      {
        "qebId": "QEB_EXC_5.2.4.17",
        "originalCriterionId": "EXC_5.2.4.17",
        "criterionType": "exclusion",
        "clinicalName": "Washout for Strong CYP3A Inhibitors",
        "clinicalDescription": "Patients must stop taking specific drugs known as strong CYP3A inhibitors at least 7 days before the study drug.",
        "clinicalCategory": "Prohibited Medications",
        "funnelStage": "Bleeding Risk and Prohibited Medications",
        "funnelStageOrder": 5,
        "combinedSql": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlLogicExplanation": "A0182",
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0182"
        ],
        "atomicCount": 1,
        "internalLogic": "SIMPLE",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "The subject has received known CYP3A inhibitors (e.g., ketoconazole) within 7 days prior to first dose of study drug.",
        "provenance": {
          "pageNumber": 35,
          "sectionId": null,
          "textSnippet": "administration.\n17. The subject has received known CYP3A inhibitors (e.g., ketoconazole) within\n7 days prior to first dose of study drug."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Cyp3A Inhibitors",
              "clinicalCategory": "safety_exclusion",
              "atomicIds": [
                "A0182"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Received known CYP3A inhibitors"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must NOT have: Cyp3A Inhibitors"
        }
      },
      {
        "qebId": "QEB_INC_5.2.5.1",
        "originalCriterionId": "INC_5.2.5.1",
        "criterionType": "inclusion",
        "clinicalName": "Continued Eligibility for Extension Study",
        "clinicalDescription": "Patients must continue to meet the main study's eligibility rules to enter the extension phase.",
        "clinicalCategory": "Study Phase Transition",
        "funnelStage": "",
        "funnelStageOrder": 0,
        "combinedSql": "(((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */))) UNION ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)))) INTERSECT (SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
        "sqlLogicExplanation": "(A0183 AND A0184 OR A0185 AND A0186) AND A0187",
        "queryableStatus": "requires_manual",
        "nonQueryableReason": "This is a summary criterion that requires the investigator to re-evaluate the patient against the original criteria, a manual process.",
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0183",
          "A0184",
          "A0185",
          "A0186",
          "A0187"
        ],
        "atomicCount": 5,
        "internalLogic": "COMPLEX",
        "omopConcepts": [],
        "fhirResources": [],
        "biomedicalConcepts": [],
        "protocolText": "Subjects who enter the Extension Study must continue to meet all Inclusion and Exclusion criteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. Subjects entering the Extension Study must also have stable lab values per applicable laboratory reference ranges.",
        "provenance": {
          "pageNumber": 35,
          "sectionId": null,
          "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Meets all Inclusion and Exclusion criteria from Ph...",
              "clinicalCategory": "diagnostic_confirmation",
              "atomicIds": [
                "A0183"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Meets all Inclusion and Exclusion criteria from Phase 1"
            },
            {
              "groupName": "Laboratory parameters from Phase 1",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0184"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Laboratory parameters from Phase 1"
            },
            {
              "groupName": "Meets all Inclusion and Exclusion criteria from Ph...",
              "clinicalCategory": "diagnostic_confirmation",
              "atomicIds": [
                "A0185"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Meets all Inclusion and Exclusion criteria from Phase 2a"
            },
            {
              "groupName": "Laboratory parameters from Phase 2a",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0186"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Laboratory parameters from Phase 2a"
            },
            {
              "groupName": "Stable lab values per applicable laboratory refere...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0187"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Stable lab values per applicable laboratory reference ranges"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Meets all Inclusion and Exclusion criteria from Ph..., Laboratory parameters from Phase 1, Meets all Inclusion and Exclusion criteria from Ph..., and 2 more requirements"
        }
      },
      {
        "qebId": "QEB_INC_5.2.5.2",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "clinicalName": "Hematology and Coagulation Criteria for Extension",
        "clinicalDescription": "Patients must meet specific blood count and blood clotting lab values to continue in the extension study.",
        "clinicalCategory": "Organ Function",
        "funnelStage": "",
        "funnelStageOrder": 0,
        "combinedSql": "(SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 25000) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number <= 50000)) UNION ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number <= 50000) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461)))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500 AND value_as_number <= 999.99)) UNION ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500 AND value_as_number <= 999.99) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 8.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value <= 1.2 * Upper Limit of Normal) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value <= 1.2 * Upper Limit of Normal)",
        "sqlLogicExplanation": "A0188 AND IF (A0189) THEN (A0190 AND A0191) AND A0192 AND IF (A0193) THEN (A0194) AND A0195 AND A0196 AND A0197",
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0188",
          "A0189",
          "A0190",
          "A0191",
          "A0192",
          "A0193",
          "A0194",
          "A0195",
          "A0196",
          "A0197"
        ],
        "atomicCount": 10,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 3007461,
            "conceptName": "Platelets [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26515-7"
          },
          {
            "conceptId": 3017732,
            "conceptName": "Neutrophils [#/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "26499-4"
          },
          {
            "conceptId": 3000963,
            "conceptName": "Hemoglobin [Mass/volume] in Blood",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "718-7"
          },
          {
            "conceptId": 3013466,
            "conceptName": "aPTT in Blood by Coagulation assay",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "3173-2"
          },
          {
            "conceptId": 3034426,
            "conceptName": "Prothrombin time (PT)",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "5902-2"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26515-7"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|26499-4"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|718-7"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|3173-2"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|5902-2"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Platelets [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26515-7 (domain: Measurement)",
            "sourceOmopConceptId": 3007461
          },
          {
            "conceptName": "Neutrophils [#/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:26499-4 (domain: Measurement)",
            "sourceOmopConceptId": 3017732
          },
          {
            "conceptName": "Hemoglobin [Mass/volume] in Blood",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:718-7 (domain: Measurement)",
            "sourceOmopConceptId": 3000963
          },
          {
            "conceptName": "aPTT in Blood by Coagulation assay",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:3173-2 (domain: Measurement)",
            "sourceOmopConceptId": 3013466
          },
          {
            "conceptName": "Prothrombin time (PT)",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:5902-2 (domain: Measurement)",
            "sourceOmopConceptId": 3034426
          }
        ],
        "protocolText": "Subjects must meet the following hematology and coagulation lab criteria:\n\n\u25cb Platelet counts must be \u2265 25,000/mm3 (untransfused). Platelet counts \u2264 50,000/mm3 must be stable and monitored at an increased frequency at the discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\u03bcL. ANC \u2265 500/\u03bcL and < 1,000/\u03bcL should be monitored at an increased frequency at the discretion of the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exceed 1.2 \u00d7 ULN.",
        "provenance": {
          "pageNumber": 35,
          "sectionId": null,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce..."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Platelet count >= 25,000/mm3 (untransfused)",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0188"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Platelet count >= 25,000/mm3 (untransfused)"
            },
            {
              "groupName": "Platelet count <= 50,000/mm3",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0189"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Platelet count <= 50,000/mm3"
            },
            {
              "groupName": "Platelet count is stable",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0190"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Platelet count is stable"
            },
            {
              "groupName": "Platelet count is monitored at an increased freque...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0191"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Platelet count is monitored at an increased frequency at the discretion of the investigator"
            },
            {
              "groupName": "Absolute Neutrophil count (ANC) >= 500/uL",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0192"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Absolute Neutrophil count (ANC) >= 500/uL"
            },
            {
              "groupName": "Absolute Neutrophil count (ANC) is between 500/uL ...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0193"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Absolute Neutrophil count (ANC) is between 500/uL and 1000/uL"
            },
            {
              "groupName": "ANC is monitored at an increased frequency at the ...",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0194"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "ANC is monitored at an increased frequency at the discretion of the investigator"
            },
            {
              "groupName": "Hemoglobin >= 8.0 g/dL",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0195"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Hemoglobin >= 8.0 g/dL"
            },
            {
              "groupName": "aPTT not to exceed 1.2 x ULN",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0196"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "aPTT not to exceed 1.2 x ULN"
            },
            {
              "groupName": "PT not to exceed 1.2 x ULN",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0197"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "PT not to exceed 1.2 x ULN"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Platelet count >= 25,000/mm3 (untransfused), Platelet count <= 50,000/mm3, Platelet count is stable, and 7 more requirements"
        }
      },
      {
        "qebId": "QEB_INC_5.2.5.3",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "clinicalName": "Chemistry Criteria for Extension Study",
        "clinicalDescription": "Patients must have acceptable kidney and liver function lab results to continue in the extension study.",
        "clinicalCategory": "Organ Function",
        "funnelStage": "",
        "funnelStageOrder": 0,
        "combinedSql": "(SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 3.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 5.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 5.0) INTERSECT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 3.0) UNION ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128)))",
        "sqlLogicExplanation": "A0198 AND A0199 AND A0200 AND A0201 AND (A0202 OR A0203 AND A0204)",
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": null,
        "estimatedEliminationRate": null,
        "isKillerCriterion": false,
        "epidemiologicalEvidence": null,
        "atomicIds": [
          "A0198",
          "A0199",
          "A0200",
          "A0201",
          "A0202",
          "A0203",
          "A0204"
        ],
        "atomicCount": 7,
        "internalLogic": "COMPLEX",
        "omopConcepts": [
          {
            "conceptId": 3016723,
            "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "2160-0"
          },
          {
            "conceptId": 3013721,
            "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1920-8"
          },
          {
            "conceptId": 3006923,
            "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1742-6"
          },
          {
            "conceptId": 3024128,
            "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "domain": "Measurement",
            "vocabularyId": "LOINC",
            "conceptCode": "1975-2"
          },
          {
            "conceptId": 4099740,
            "conceptName": "Gilbert's syndrome",
            "domain": "Condition",
            "vocabularyId": "SNOMED",
            "conceptCode": "27503000"
          }
        ],
        "fhirResources": [
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|2160-0"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1920-8"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1742-6"
            },
            "description": null
          },
          {
            "resourceType": "Observation",
            "searchParams": {
              "query": "code=http://loinc.org|1975-2"
            },
            "description": null
          },
          {
            "resourceType": "Condition",
            "searchParams": {
              "query": "code=http://snomed.info/sct|27503000,E80.4"
            },
            "description": null
          }
        ],
        "biomedicalConcepts": [
          {
            "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:2160-0 (domain: Measurement)",
            "sourceOmopConceptId": 3016723
          },
          {
            "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1920-8 (domain: Measurement)",
            "sourceOmopConceptId": 3013721
          },
          {
            "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1742-6 (domain: Measurement)",
            "sourceOmopConceptId": 3006923
          },
          {
            "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "cdiscCode": "CUSTOM",
            "domain": "LB",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP LOINC:1975-2 (domain: Measurement)",
            "sourceOmopConceptId": 3024128
          },
          {
            "conceptName": "Gilbert's syndrome",
            "cdiscCode": "CUSTOM",
            "domain": "MH",
            "confidence": 0.85,
            "rationale": "Mapped from OMOP SNOMED:27503000 (domain: Condition)",
            "sourceOmopConceptId": 4099740
          }
        ],
        "protocolText": "Subjects must meet the following chemistry criteria:\n\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry labs should be monitored at an increased frequency at the discretion of the investigator.\n\u25cb Serum creatinine \u2264 3.0 \u00d7 the upper normal limit (ULN) of institution's normal range.\n\u25cb AST and ALT \u2264 5.0 \u00d7 the upper normal limit (ULN) of institution's normal range.\n\u25cb Bilirubin \u2264 3.0 \u00d7 ULN. Subjects with Gilbert's Syndrome may be allowed to have a Bilirubin > 3.0 \u00d7 ULN based on a joint decision between the investigator and AbbVie medical monitor.",
        "provenance": {
          "pageNumber": 35,
          "sectionId": null,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range."
        },
        "clinicalSummary": {
          "conceptGroups": [
            {
              "groupName": "Liver Function Tests",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0200",
                "A0201"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "AST <= 5.0 x ULN OR ALT <= 5.0 x ULN"
            },
            {
              "groupName": "Bilirubin Level",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0202",
                "A0204"
              ],
              "queryableStatus": "requires_manual",
              "treatmentImplication": null,
              "plainEnglish": "Bilirubin <= 3.0 x ULN OR Bilirubin > 3.0 x ULN approved by investigator and medical monitor"
            },
            {
              "groupName": "Chemistry values do not exceed Grade 2",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0198"
              ],
              "queryableStatus": "partially_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Chemistry values do not exceed Grade 2"
            },
            {
              "groupName": "Serum creatinine <= 3.0 x ULN",
              "clinicalCategory": "organ_function",
              "atomicIds": [
                "A0199"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Serum creatinine <= 3.0 x ULN"
            },
            {
              "groupName": "Subject has Gilbert's Syndrome",
              "clinicalCategory": "disease_indication",
              "atomicIds": [
                "A0203"
              ],
              "queryableStatus": "fully_queryable",
              "treatmentImplication": null,
              "plainEnglish": "Subject has Gilbert's Syndrome"
            }
          ],
          "screeningOnlyRequirements": [],
          "clinicalLogicSummary": "Patient must meet: Liver Function Tests, Bilirubin Level, Chemistry values do not exceed Grade 2, and 2 more requirements"
        }
      }
    ],
    "executionGuide": {
      "recommendedOrder": [
        "QEB_INC_5.2.5.1",
        "QEB_INC_5.2.5.2",
        "QEB_INC_5.2.5.3",
        "QEB_INC_5.2.1.2",
        "QEB_INC_5.2.3.2",
        "QEB_INC_5.2.1.1",
        "QEB_INC_5.2.1.3",
        "QEB_INC_5.2.3.1",
        "QEB_INC_5.2.3.4",
        "QEB_EXC_5.2.2.2",
        "QEB_EXC_5.2.2.8",
        "QEB_EXC_5.2.2.9",
        "QEB_EXC_5.2.2.10",
        "QEB_INC_5.2.3.3",
        "QEB_EXC_5.2.4.3",
        "QEB_EXC_5.2.4.7",
        "QEB_EXC_5.2.4.9",
        "QEB_EXC_5.2.4.10",
        "QEB_EXC_5.2.2.1",
        "QEB_EXC_5.2.2.12",
        "QEB_EXC_5.2.4.1",
        "QEB_EXC_5.2.4.12",
        "QEB_EXC_5.2.4.14",
        "QEB_EXC_5.2.4.15",
        "QEB_EXC_5.2.4.16",
        "QEB_INC_5.2.1.4",
        "QEB_EXC_5.2.2.3",
        "QEB_EXC_5.2.2.4",
        "QEB_EXC_5.2.2.5",
        "QEB_EXC_5.2.2.6",
        "QEB_EXC_5.2.2.7",
        "QEB_EXC_5.2.2.11",
        "QEB_INC_5.2.3.5",
        "QEB_EXC_5.2.4.2",
        "QEB_EXC_5.2.4.4",
        "QEB_EXC_5.2.4.5",
        "QEB_EXC_5.2.4.6",
        "QEB_EXC_5.2.4.8",
        "QEB_EXC_5.2.4.11",
        "QEB_EXC_5.2.4.17",
        "QEB_INC_5.2.1.5",
        "QEB_INC_5.2.3.6",
        "QEB_INC_5.2.1.6",
        "QEB_INC_5.2.1.7",
        "QEB_INC_5.2.1.8",
        "QEB_EXC_5.2.2.13",
        "QEB_INC_5.2.3.7",
        "QEB_INC_5.2.3.8",
        "QEB_INC_5.2.3.9",
        "QEB_EXC_5.2.4.13"
      ],
      "killerCriteria": [
        "QEB_INC_5.2.1.2",
        "QEB_INC_5.2.3.2"
      ],
      "manualReviewRequired": [
        "QEB_INC_5.2.1.6",
        "QEB_INC_5.2.1.8",
        "QEB_EXC_5.2.2.11",
        "QEB_INC_5.2.3.7",
        "QEB_INC_5.2.3.9",
        "QEB_EXC_5.2.4.11",
        "QEB_INC_5.2.5.1"
      ],
      "executionNotes": "Execute criteria in recommended order for optimal patient elimination. Killer criteria should be prioritized as they eliminate the most patients."
    },
    "atomicCriteria": [
      {
        "atomicId": "A0001",
        "originalCriterionId": "INC_5.2.1.1",
        "criterionType": "inclusion",
        "atomicText": "Age >= 18 years",
        "normalizedText": "Age >= 18 years",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            4265453
          ],
          "conceptNames": [
            "Age"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "397669002"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 18"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "30525-0",
              "display": "Age"
            }
          ],
          "searchParams": "code=http://loinc.org|30525-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.1_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 1
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "5.2.1 Phase 1 Inclusion Criteria\nA subject will be eligible for study participation if he/she meets the following criteria:\n1. The subject must be \u2265 18 years of age.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Age is a standard, structured demographic field in all EHR systems. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0001",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Age is a standard, structured demographic field in all EHR systems."
          }
        }
      },
      {
        "atomicId": "A0002",
        "originalCriterionId": "INC_5.2.1.2",
        "criterionType": "inclusion",
        "atomicText": "Relapsed Chronic Lymphocytic Leukemia (CLL)",
        "normalizedText": "Relapsed Chronic Lymphocytic Leukemia (CLL)",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 99.9,
          "impactScore": 0.9990000000000001,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4173824
          ],
          "conceptNames": [
            "B-cell chronic lymphocytic leukemia variant"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "277474005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "277474005",
              "display": "B-cell chronic lymphocytic leukemia variant"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "C91.1",
              "display": "Chronic lymphocytic leukemia of B-cell type"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|277474005,C91.1",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.2_1a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 2
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "cll_relapsed_refractory_status",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.9,
          "reasoning": "The diagnosis of CLL is found in structured EHR data (ICD codes). The 'relapsed' status is a clinical state often inferred from treatment history and confirmed in clinical notes. Has OMOP mapping. Data in: Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0002",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.9,
            "reasoning": "The diagnosis of CLL is found in structured EHR data (ICD codes). The 'relapsed' status is a clinical state often inferred from treatment history and confirmed in clinical notes."
          }
        }
      },
      {
        "atomicId": "A0003",
        "originalCriterionId": "INC_5.2.1.2",
        "criterionType": "inclusion",
        "atomicText": "Refractory Chronic Lymphocytic Leukemia (CLL)",
        "normalizedText": "Refractory Chronic Lymphocytic Leukemia (CLL)",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 99.9,
          "impactScore": 0.9990000000000001,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4173824
          ],
          "conceptNames": [
            "B-cell chronic lymphocytic leukemia variant"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "277474005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "277474005",
              "display": "B-cell chronic lymphocytic leukemia variant"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "C91.1",
              "display": "Chronic lymphocytic leukemia of B-cell type"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|277474005,C91.1",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.2_1b",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 3
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "cll_relapsed_refractory_status",
        "expressionNodeId": "1b",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.9,
          "reasoning": "'Refractory' is a clinical assessment of treatment response, most reliably described in an oncologist's progress notes. The underlying CLL diagnosis is in structured data. Has OMOP mapping. Data in: Progress Note, Oncology Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0003",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Progress Note",
              "Oncology Note"
            ],
            "confidence": 0.9,
            "reasoning": "'Refractory' is a clinical assessment of treatment response, most reliably described in an oncologist's progress notes. The underlying CLL diagnosis is in structured data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "Oncology Note"
            ],
            "extractionPrompt": "Extract: Refractory Chronic Lymphocytic Leukemia (CLL)",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0004",
        "originalCriterionId": "INC_5.2.1.2",
        "criterionType": "inclusion",
        "atomicText": "Requires treatment in the opinion of the investigator",
        "normalizedText": "Requires treatment in the opinion of the investigator",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 99.9,
          "impactScore": 0.9990000000000001,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.2_2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 4
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "The phrase 'in the opinion of the investigator' explicitly requires a subjective assessment by the study investigator at the time of screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0004",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The phrase 'in the opinion of the investigator' explicitly requires a subjective assessment by the study investigator at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0005",
        "originalCriterionId": "INC_5.2.1.3",
        "criterionType": "inclusion",
        "atomicText": "Eastern Cooperative Oncology Group performance score of <= 1",
        "normalizedText": "Eastern Cooperative Oncology Group performance score of <= 1",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number >= 0 AND value_as_number <= 1"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.3_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 5
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "opinion of the investigator.\n3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "performance_status",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "ECOG performance status is a standard assessment conducted by the clinical team at the screening visit to evaluate the patient's current functional status. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0005",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "ECOG performance status is a standard assessment conducted by the clinical team at the screening visit to evaluate the patient's current functional status."
          }
        }
      },
      {
        "atomicId": "A0006",
        "originalCriterionId": "INC_5.2.1.4",
        "criterionType": "inclusion",
        "atomicText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
        "normalizedText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.4_1a_condition",
          "groupLogic": "IMPLICATION_CONDITION",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 6
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n4. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a_condition",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Current medications, like SSRIs, are typically found in structured EHR medication lists (e.g., RxNorm, NDC codes). No OMOP mapping. Data in: Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0006",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Current medications, like SSRIs, are typically found in structured EHR medication lists (e.g., RxNorm, NDC codes)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0007",
        "originalCriterionId": "INC_5.2.1.4",
        "criterionType": "inclusion",
        "atomicText": "Receiving a stable dose of SSRI anti-depressant",
        "normalizedText": "Receiving a stable dose of SSRI anti-depressant",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '21 days'",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.4_1b_requirement",
          "groupLogic": "IMPLICATION_REQUIREMENT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 7
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n4. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b_requirement",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.85,
          "reasoning": "The medication and its dosage history are in structured EHR data. Determining 'stable dose' involves reviewing this history, though confirmation may be in clinical notes. No OMOP mapping. Data in: Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0007",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note"
            ],
            "confidence": 0.85,
            "reasoning": "The medication and its dosage history are in structured EHR data. Determining 'stable dose' involves reviewing this history, though confirmation may be in clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Receiving a stable dose of SSRI anti-depressant",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0008",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL",
        "normalizedText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 1000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1a1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 8
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory value found in structured lab results, typically coded with LOINC. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0008",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory value found in structured lab results, typically coded with LOINC."
          }
        }
      },
      {
        "atomicId": "A0009",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Platelets >= 75,000/mm3",
        "normalizedText": "Platelets >= 75,000/mm3",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 75000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 75000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1a2a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 9
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a2a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Platelet count is a standard laboratory value found in structured lab results from a CBC. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0009",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Platelet count is a standard laboratory value found in structured lab results from a CBC."
          }
        }
      },
      {
        "atomicId": "A0010",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Received platelet transfusion",
        "normalizedText": "Received platelet transfusion",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1a2b1a",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 10
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a2b1a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.9,
          "reasoning": "Platelet transfusions are procedures that are captured in structured EHR data (e.g., CPT codes, blood bank records). Has OMOP mapping. Data in: Progress Note, Discharge Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0010",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note",
              "Discharge Summary"
            ],
            "confidence": 0.9,
            "reasoning": "Platelet transfusions are procedures that are captured in structured EHR data (e.g., CPT codes, blood bank records)."
          }
        }
      },
      {
        "atomicId": "A0011",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Hemoglobin >= 9.0 g/dL",
        "normalizedText": "Hemoglobin >= 9.0 g/dL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3000963
          ],
          "conceptNames": [
            "Hemoglobin [Mass/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "718-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 9.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "718-7",
              "display": "Hemoglobin [Mass/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|718-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1a3",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 11
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a3",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Hemoglobin is a standard laboratory value found in structured lab results. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0011",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Hemoglobin is a standard laboratory value found in structured lab results."
          }
        }
      },
      {
        "atomicId": "A0012",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Received growth factor support",
        "normalizedText": "Received growth factor support",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1a4a",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 12
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a4a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Growth factors are medications and their administration is recorded in structured medication data (e.g., MAR, RxNorm). No OMOP mapping. Data in: Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0012",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Growth factors are medications and their administration is recorded in structured medication data (e.g., MAR, RxNorm)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received growth factor support",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0013",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL",
        "normalizedText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number < 1000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number < 1000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1b1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 13
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1b1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory value found in structured lab results. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0013",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory value found in structured lab results."
          }
        }
      },
      {
        "atomicId": "A0014",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Bone marrow heavily infiltrated with underlying disease (80% or more)",
        "normalizedText": "Bone marrow heavily infiltrated with underlying disease (80% or more)",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number >= 80"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_1b2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 14
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "The percentage of bone marrow infiltration by disease is a key finding documented in a bone marrow biopsy pathology report. No OMOP mapping. Data in: Pathology, Bone Marrow Report",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0014",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Pathology",
              "Bone Marrow Report"
            ],
            "confidence": 1.0,
            "reasoning": "The percentage of bone marrow infiltration by disease is a key finding documented in a bone marrow biopsy pathology report."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology",
              "Bone Marrow Report"
            ],
            "extractionPrompt": "Extract: Bone marrow heavily infiltrated with underlying disease (80% or more)",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0015",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Serum creatinine <= 2.0 mg/dL",
        "normalizedText": "Serum creatinine <= 2.0 mg/dL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3016723
          ],
          "conceptNames": [
            "Creatinine [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "2160-0"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 2.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 2.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "2160-0",
              "display": "Creatinine [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|2160-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 15
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Serum creatinine is a standard laboratory value found in structured lab results. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0015",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Serum creatinine is a standard laboratory value found in structured lab results."
          }
        }
      },
      {
        "atomicId": "A0016",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Calculated creatinine clearance >= 50 mL/min",
        "normalizedText": "Calculated creatinine clearance >= 50 mL/min",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3016723
          ],
          "conceptNames": [
            "Creatinine [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "2160-0"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number >= 50",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 50"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "2160-0",
              "display": "Creatinine [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|2160-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 16
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "Creatinine clearance is not directly measured but is calculated at the time of screening using a formula (e.g., Cockcroft-Gault) with inputs like serum creatinine, age, and weight. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0016",
            "primaryDataSource": "calculated_value",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Creatinine clearance is not directly measured but is calculated at the time of screening using a formula (e.g., Cockcroft-Gault) with inputs like serum creatinine, age, and weight."
          }
        }
      },
      {
        "atomicId": "A0017",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "AST <= 3.0 x the upper normal limit (ULN)",
        "normalizedText": "AST <= 3.0 x the upper normal limit (ULN)",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3013721
          ],
          "conceptNames": [
            "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1920-8"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 3.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 3.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1920-8",
              "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1920-8",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_3a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 17
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "3a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Aspartate aminotransferase (AST) is a standard laboratory value found in structured lab results. The ULN is also part of the structured result. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0017",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Aspartate aminotransferase (AST) is a standard laboratory value found in structured lab results. The ULN is also part of the structured result."
          }
        }
      },
      {
        "atomicId": "A0018",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "ALT <= 3.0 x the upper normal limit (ULN)",
        "normalizedText": "ALT <= 3.0 x the upper normal limit (ULN)",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3006923
          ],
          "conceptNames": [
            "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1742-6"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 3.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 3.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1742-6",
              "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1742-6",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_3b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 18
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "3b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Alanine aminotransferase (ALT) is a standard laboratory value found in structured lab results. The ULN is also part of the structured result. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0018",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Alanine aminotransferase (ALT) is a standard laboratory value found in structured lab results. The ULN is also part of the structured result."
          }
        }
      },
      {
        "atomicId": "A0019",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Total Bilirubin <= 1.5 x ULN",
        "normalizedText": "Total Bilirubin <= 1.5 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3024128
          ],
          "conceptNames": [
            "Bilirubin.total [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1975-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 1.5"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1975-2",
              "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1975-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_3c1",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 19
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "3c1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Total Bilirubin is a standard laboratory value found in structured lab results. The ULN is also part of the structured result. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0019",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Total Bilirubin is a standard laboratory value found in structured lab results. The ULN is also part of the structured result."
          }
        }
      },
      {
        "atomicId": "A0020",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "Subject has Gilbert's Syndrome",
        "normalizedText": "Subject has Gilbert's Syndrome",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4099740
          ],
          "conceptNames": [
            "Gilbert's syndrome"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "27503000"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "27503000",
              "display": "Gilbert's syndrome"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "E80.4",
              "display": "Gilbert syndrome"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_3c2",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 20
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "3c2",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.95,
          "reasoning": "Gilbert's Syndrome is a medical diagnosis that would be listed in the patient's problem list with a corresponding ICD code in the structured EHR data. Has OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0020",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Gilbert's Syndrome is a medical diagnosis that would be listed in the patient's problem list with a corresponding ICD code in the structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0021",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "aPTT not to exceed 1.2 x ULN",
        "normalizedText": "aPTT not to exceed 1.2 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3013466
          ],
          "conceptNames": [
            "aPTT in Blood by Coagulation assay"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "3173-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value_as_number <= 1.2",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 1.2"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "3173-2",
              "display": "aPTT in Blood by Coagulation assay"
            }
          ],
          "searchParams": "code=http://loinc.org|3173-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_4a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 21
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "4a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Activated Partial Thromboplastin Time (aPTT) is a standard laboratory value found in structured lab results. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0021",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Activated Partial Thromboplastin Time (aPTT) is a standard laboratory value found in structured lab results."
          }
        }
      },
      {
        "atomicId": "A0022",
        "originalCriterionId": "INC_5.2.1.5",
        "criterionType": "inclusion",
        "atomicText": "PT not to exceed 1.2 x ULN",
        "normalizedText": "PT not to exceed 1.2 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3034426
          ],
          "conceptNames": [
            "Prothrombin time (PT)"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "5902-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value_as_number <= 1.2",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 1.2"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "5902-2",
              "display": "Prothrombin time (PT)"
            }
          ],
          "searchParams": "code=http://loinc.org|5902-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.5_4b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 22
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "4b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Prothrombin Time (PT) is a standard laboratory value found in structured lab results. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0022",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Prothrombin Time (PT) is a standard laboratory value found in structured lab results."
          }
        }
      },
      {
        "atomicId": "A0023",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "atomicText": "Subject is female",
        "normalizedText": "Subject is female",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Subject is female\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.6_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 23
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Gender is a core demographic field in structured EHR data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0023",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Gender is a core demographic field in structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Subject is female",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0024",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "atomicText": "Surgically sterile",
        "normalizedText": "Surgically sterile",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.6_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 24
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Surgical sterilization (e.g., hysterectomy) is documented via procedure codes in structured EHR data. It is also commonly mentioned in surgical history sections of clinical notes. No OMOP mapping. Data in: H&P, Surgical History",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0024",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "confidence": 0.9,
            "reasoning": "Surgical sterilization (e.g., hysterectomy) is documented via procedure codes in structured EHR data. It is also commonly mentioned in surgical history sections of clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "extractionPrompt": "Extract: Surgically sterile",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0025",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "atomicText": "Postmenopausal for at least 1 year",
        "normalizedText": "Postmenopausal for at least 1 year",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.6_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 25
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Menopausal status is a clinical determination based on patient history (e.g., last menstrual period) and is typically documented in the narrative of clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0025",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Menopausal status is a clinical determination based on patient history (e.g., last menstrual period) and is typically documented in the narrative of clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Postmenopausal for at least 1 year",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0026",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "atomicText": "Positive serum pregnancy test result at Screening",
        "normalizedText": "Positive serum pregnancy test result at Screening",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive result for serum hCG test.",
          "sqlExecutable": true,
          "valueConstraint": "Positive result for serum hCG test."
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.6_2c1a1",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 26
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "screening_only",
        "expressionNodeId": "2c1a1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "A pregnancy test is required to be performed at the screening visit, making it a new data collection event. The result itself is a structured lab value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0026",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "A pregnancy test is required to be performed at the screening visit, making it a new data collection event. The result itself is a structured lab value."
          }
        }
      },
      {
        "atomicId": "A0027",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "atomicText": "More than 7 days between obtaining serum pregnancy test and initial study drug administration",
        "normalizedText": "More than 7 days between obtaining serum pregnancy test and initial study drug administration",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.6_2c2_cond",
          "groupLogic": "IMPLICATION_CONDITION",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 27
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "screening_only",
        "expressionNodeId": "2c2_cond",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "This is a procedural check that must be performed at the time of drug administration by comparing the date of the screening pregnancy test to the current date. It's an assessment of study conduct. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0027",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "This is a procedural check that must be performed at the time of drug administration by comparing the date of the screening pregnancy test to the current date. It's an assessment of study conduct."
          }
        }
      },
      {
        "atomicId": "A0028",
        "originalCriterionId": "INC_5.2.1.6",
        "criterionType": "inclusion",
        "atomicText": "Positive urine pregnancy test on Cycle 1 Day 1 or Lead-in Day 1",
        "normalizedText": "Positive urine pregnancy test on Cycle 1 Day 1 or Lead-in Day 1",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive result for urine hCG test.",
          "sqlExecutable": true,
          "valueConstraint": "Positive result for urine hCG test."
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.6_2c2_req_a1",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 28
        },
        "provenance": {
          "pageNumber": 28,
          "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "screening_only",
        "expressionNodeId": "2c2_req_a1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "This criterion requires a new urine pregnancy test to be performed on a specific day of the study cycle, making it a real-time data collection event. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0028",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "This criterion requires a new urine pregnancy test to be performed on a specific day of the study cycle, making it a real-time data collection event."
          }
        }
      },
      {
        "atomicId": "A0029",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Gender is Female",
        "normalizedText": "Gender is Female",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Gender is Female\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_c1a1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 29
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "c1a1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Gender is a core demographic field in structured EHR data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0029",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Gender is a core demographic field in structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Gender is Female",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0030",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Surgically sterile",
        "normalizedText": "Surgically sterile",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_c1a2a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 30
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "female_sterility",
        "expressionNodeId": "c1a2a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Surgical sterilization (e.g., hysterectomy) is documented via procedure codes in structured EHR data. It is also commonly mentioned in surgical history sections of clinical notes. No OMOP mapping. Data in: H&P, Surgical History",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0030",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "confidence": 0.9,
            "reasoning": "Surgical sterilization (e.g., hysterectomy) is documented via procedure codes in structured EHR data. It is also commonly mentioned in surgical history sections of clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "extractionPrompt": "Extract: Surgically sterile",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0031",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Postmenopausal for at least 1 year",
        "normalizedText": "Postmenopausal for at least 1 year",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_c1a2b",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 31
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "female_sterility",
        "expressionNodeId": "c1a2b",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Menopausal status is determined from the patient's medical history regarding their last menstrual period, which is documented in narrative clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0031",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Menopausal status is determined from the patient's medical history regarding their last menstrual period, which is documented in narrative clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Postmenopausal for at least 1 year",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0032",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Gender is Male",
        "normalizedText": "Gender is Male",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Gender is Male\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_c1b1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 32
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "c1b1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Gender is a standard, structured demographic field within the EHR. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0032",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Gender is a standard, structured demographic field within the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Gender is Male",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0033",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Subject has had a vasectomy",
        "normalizedText": "Subject has had a vasectomy",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_c1b2a",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 33
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "c1b2a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "A past vasectomy is most reliably found in the surgical history section of clinical notes. It may also be present as a structured procedure code (CPT). No OMOP mapping. Data in: H&P, Surgical History",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0033",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "confidence": 0.9,
            "reasoning": "A past vasectomy is most reliably found in the surgical history section of clinical notes. It may also be present as a structured procedure code (CPT)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "extractionPrompt": "Extract: Subject has had a vasectomy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0034",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Total abstinence from sexual intercourse for at least one complete menstrual cycle",
        "normalizedText": "Total abstinence from sexual intercourse for at least one complete menstrual cycle",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_r1a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 34
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "birth_control_method",
        "expressionNodeId": "r1a",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 0.98,
          "reasoning": "This criterion requires a commitment from the patient regarding their behavior and lifestyle, which is a patient decision. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0034",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "This criterion requires a commitment from the patient regarding their behavior and lifestyle, which is a patient decision."
          }
        }
      },
      {
        "atomicId": "A0035",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Partner is vasectomized",
        "normalizedText": "Partner is vasectomized",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_r1b",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 35
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "birth_control_method",
        "expressionNodeId": "r1b",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 0.98,
          "reasoning": "This information is reported by the patient about their partner as part of their agreement to meet the study's contraception requirements. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0035",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "This information is reported by the patient about their partner as part of their agreement to meet the study's contraception requirements."
          }
        }
      },
      {
        "atomicId": "A0036",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
        "normalizedText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            600058216
          ],
          "conceptNames": [
            "Other Investigational Agent"
          ],
          "vocabularyIds": [
            "NCIt_Full"
          ],
          "conceptCodes": [
            "C156875"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "code": "C156875",
              "display": "Other Investigational Agent"
            }
          ],
          "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_r1c",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 36
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "birth_control_method",
        "expressionNodeId": "r1c",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.92,
          "reasoning": "The use of hormonal contraceptives is a medication history, which is most reliably found in structured medication data (e.g., RxNorm). It may also be documented in notes. Has OMOP mapping. Data in: Progress Note, Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0036",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note",
              "Medication Reconciliation"
            ],
            "confidence": 0.92,
            "reasoning": "The use of hormonal contraceptives is a medication history, which is most reliably found in structured medication data (e.g., RxNorm). It may also be documented in notes."
          }
        }
      },
      {
        "atomicId": "A0037",
        "originalCriterionId": "INC_5.2.1.7",
        "criterionType": "inclusion",
        "atomicText": "Use of double-barrier method",
        "normalizedText": "Use of double-barrier method",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.7_r1d",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 37
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "birth_control_method",
        "expressionNodeId": "r1d",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 0.98,
          "reasoning": "This requires the patient to agree to use a specific contraception method, which is a patient decision and commitment. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0037",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "This requires the patient to agree to use a specific contraception method, which is a patient decision and commitment."
          }
        }
      },
      {
        "atomicId": "A0038",
        "originalCriterionId": "INC_5.2.1.8",
        "criterionType": "inclusion",
        "atomicText": "Informed consent was given voluntarily",
        "normalizedText": "Informed consent was given voluntarily",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.8_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 38
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "screening_only",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "The act of giving consent voluntarily is the definition of a patient's decision to participate in a clinical trial. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0038",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The act of giving consent voluntarily is the definition of a patient's decision to participate in a clinical trial."
          }
        }
      },
      {
        "atomicId": "A0039",
        "originalCriterionId": "INC_5.2.1.8",
        "criterionType": "inclusion",
        "atomicText": "Informed consent form is approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
        "normalizedText": "Informed consent form is approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.8_2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 39
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "screening_only",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "While a regulatory requirement for the site, the patient's eligibility is contingent on signing the specific, IRB-approved form, which is part of their consent decision. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0039",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "While a regulatory requirement for the site, the patient's eligibility is contingent on signing the specific, IRB-approved form, which is part of their consent decision."
          }
        }
      },
      {
        "atomicId": "A0040",
        "originalCriterionId": "INC_5.2.1.8",
        "criterionType": "inclusion",
        "atomicText": "Subject has signed an informed consent form",
        "normalizedText": "Subject has signed an informed consent form",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.8_3a1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 40
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "screening_only",
        "clinicalConceptGroup": "informed_consent_documentation",
        "expressionNodeId": "3a1",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "Signing the informed consent form is the explicit action that constitutes the patient's decision to participate in the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0040",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Signing the informed consent form is the explicit action that constitutes the patient's decision to participate in the study."
          }
        }
      },
      {
        "atomicId": "A0041",
        "originalCriterionId": "INC_5.2.1.8",
        "criterionType": "inclusion",
        "atomicText": "The signed informed consent form is dated",
        "normalizedText": "The signed informed consent form is dated",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.1.8_3a2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 41
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "screening_only",
        "clinicalConceptGroup": "informed_consent_documentation",
        "expressionNodeId": "3a2",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "A dated signature is a required component for a valid informed consent document, which represents the patient's decision. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0041",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "A dated signature is a required component for a valid informed consent document, which represents the patient's decision."
          }
        }
      },
      {
        "atomicId": "A0042",
        "originalCriterionId": "EXC_5.2.2.1",
        "criterionType": "exclusion",
        "atomicText": "History of cancer-related Central Nervous System (CNS) disease",
        "normalizedText": "History of cancer-related Central Nervous System (CNS) disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            600055953
          ],
          "conceptNames": [
            "Prior Invasive Malignancy"
          ],
          "vocabularyIds": [
            "NCIt_Full"
          ],
          "conceptCodes": [
            "C154619"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "code": "C154619",
              "display": "Prior Invasive Malignancy"
            }
          ],
          "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.1_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 42
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "5.2.2 Phase 1 Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "cancer_related_cns_disease",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "A history of cancer-related CNS disease, such as brain metastases, is definitively diagnosed and documented in historical imaging reports (e.g., brain MRI). Has OMOP mapping. Data in: Radiology, Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0042",
            "primaryDataSource": "radiology_report",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Radiology",
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.95,
            "reasoning": "A history of cancer-related CNS disease, such as brain metastases, is definitively diagnosed and documented in historical imaging reports (e.g., brain MRI)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Radiology",
              "Progress Note",
              "H&P"
            ],
            "extractionPrompt": "Extract: History of cancer-related Central Nervous System (CNS) disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0043",
        "originalCriterionId": "EXC_5.2.2.1",
        "criterionType": "exclusion",
        "atomicText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
        "normalizedText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.1_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 43
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "5.2.2 Phase 1 Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "cancer_related_cns_disease",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.98,
          "reasoning": "Determining if a patient is 'clinically suspicious' for CNS disease requires a new physical examination and symptom assessment by the investigator at the time of screening. No OMOP mapping. Data in: Screening Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0043",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Screening Note",
              "H&P"
            ],
            "confidence": 0.98,
            "reasoning": "Determining if a patient is 'clinically suspicious' for CNS disease requires a new physical examination and symptom assessment by the investigator at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0044",
        "originalCriterionId": "EXC_5.2.2.2",
        "criterionType": "exclusion",
        "atomicText": "Undergone an allogeneic stem cell transplant",
        "normalizedText": "Undergone an allogeneic stem cell transplant",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            4028623
          ],
          "conceptNames": [
            "Transplantation of bone marrow"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "23719005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Procedure",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "23719005",
              "display": "Transplantation of bone marrow"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|23719005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.2_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 44
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "Nervous System (CNS) disease.\n2. The subject has undergone an allogeneic or autologous stem cell transplant.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "stem_cell_transplant",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "A history of a major procedure like a stem cell transplant is most reliably and comprehensively documented in narrative clinical notes, such as a transplant summary. Has OMOP mapping. Data in: Discharge Summary, H&P, Transplant Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0044",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Discharge Summary",
              "H&P",
              "Transplant Summary"
            ],
            "confidence": 0.95,
            "reasoning": "A history of a major procedure like a stem cell transplant is most reliably and comprehensively documented in narrative clinical notes, such as a transplant summary."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Discharge Summary",
              "H&P",
              "Transplant Summary"
            ],
            "extractionPrompt": "Extract: Undergone an allogeneic stem cell transplant",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0045",
        "originalCriterionId": "EXC_5.2.2.2",
        "criterionType": "exclusion",
        "atomicText": "Undergone an autologous stem cell transplant",
        "normalizedText": "Undergone an autologous stem cell transplant",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            4028623
          ],
          "conceptNames": [
            "Transplantation of bone marrow"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "23719005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Procedure",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "23719005",
              "display": "Transplantation of bone marrow"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|23719005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.2_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 45
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "Nervous System (CNS) disease.\n2. The subject has undergone an allogeneic or autologous stem cell transplant.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "stem_cell_transplant",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "A history of a major procedure like a stem cell transplant is most reliably and comprehensively documented in narrative clinical notes, such as a transplant summary. Has OMOP mapping. Data in: Discharge Summary, H&P, Transplant Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0045",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Discharge Summary",
              "H&P",
              "Transplant Summary"
            ],
            "confidence": 0.95,
            "reasoning": "A history of a major procedure like a stem cell transplant is most reliably and comprehensively documented in narrative clinical notes, such as a transplant summary."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Discharge Summary",
              "H&P",
              "Transplant Summary"
            ],
            "extractionPrompt": "Extract: Undergone an autologous stem cell transplant",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0046",
        "originalCriterionId": "EXC_5.2.2.3",
        "criterionType": "exclusion",
        "atomicText": "Underlying, predisposing condition of bleeding",
        "normalizedText": "Underlying, predisposing condition of bleeding",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.3_1a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 46
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "2. The subject has undergone an allogeneic or autologous stem cell transplant.\n3. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "An underlying condition predisposing to bleeding (e.g., hemophilia) is a medical diagnosis, which is most reliably found as a structured diagnosis code (ICD) in the EHR problem list. No OMOP mapping. Data in: H&P, Consult Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0046",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Consult Note"
            ],
            "confidence": 0.95,
            "reasoning": "An underlying condition predisposing to bleeding (e.g., hemophilia) is a medical diagnosis, which is most reliably found as a structured diagnosis code (ICD) in the EHR problem list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Consult Note"
            ],
            "extractionPrompt": "Extract: Underlying, predisposing condition of bleeding",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0047",
        "originalCriterionId": "EXC_5.2.2.3",
        "criterionType": "exclusion",
        "atomicText": "Currently exhibits signs of bleeding",
        "normalizedText": "Currently exhibits signs of bleeding",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.3_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 47
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "2. The subject has undergone an allogeneic or autologous stem cell transplant.\n3. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.98,
          "reasoning": "This requires a new physical examination at the time of screening to assess for any current, active signs of bleeding. No OMOP mapping. Data in: Screening Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0047",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [
              "Screening Note"
            ],
            "confidence": 0.98,
            "reasoning": "This requires a new physical examination at the time of screening to assess for any current, active signs of bleeding."
          }
        }
      },
      {
        "atomicId": "A0048",
        "originalCriterionId": "EXC_5.2.2.4",
        "criterionType": "exclusion",
        "atomicText": "Active peptic ulcer disease",
        "normalizedText": "Active peptic ulcer disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.4_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 48
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "gi_bleeding_risk",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Active peptic ulcer disease is a clinical diagnosis that would be captured as a structured ICD code in the patient's problem list. No OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0048",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Active peptic ulcer disease is a clinical diagnosis that would be captured as a structured ICD code in the patient's problem list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Active peptic ulcer disease",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0049",
        "originalCriterionId": "EXC_5.2.2.4",
        "criterionType": "exclusion",
        "atomicText": "Potentially hemorrhagic esophagitis",
        "normalizedText": "Potentially hemorrhagic esophagitis",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.4_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 49
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "gi_bleeding_risk",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "This is a clinical diagnosis that would be captured as a structured ICD code, often supported by findings in an endoscopy report. No OMOP mapping. Data in: H&P, Endoscopy Report",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0049",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Endoscopy Report"
            ],
            "confidence": 0.9,
            "reasoning": "This is a clinical diagnosis that would be captured as a structured ICD code, often supported by findings in an endoscopy report."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Endoscopy Report"
            ],
            "extractionPrompt": "Extract: Potentially hemorrhagic esophagitis",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0050",
        "originalCriterionId": "EXC_5.2.2.4",
        "criterionType": "exclusion",
        "atomicText": "Potentially hemorrhagic gastritis",
        "normalizedText": "Potentially hemorrhagic gastritis",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.4_3",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 50
        },
        "provenance": {
          "pageNumber": 29,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "gi_bleeding_risk",
        "expressionNodeId": "3",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "This is a clinical diagnosis that would be captured as a structured ICD code, often supported by findings in an endoscopy report. No OMOP mapping. Data in: H&P, Endoscopy Report",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0050",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Endoscopy Report"
            ],
            "confidence": 0.9,
            "reasoning": "This is a clinical diagnosis that would be captured as a structured ICD code, often supported by findings in an endoscopy report."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Endoscopy Report"
            ],
            "extractionPrompt": "Extract: Potentially hemorrhagic gastritis",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0051",
        "originalCriterionId": "EXC_5.2.2.5",
        "criterionType": "exclusion",
        "atomicText": "Active immune thrombocytopenic purpura",
        "normalizedText": "Active immune thrombocytopenic purpura",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.5_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 51
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Active immune thrombocytopenic purpura is a specific medical diagnosis that is reliably found as a structured ICD code in the EHR problem list. No OMOP mapping. Data in: H&P, Consult Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0051",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Consult Note"
            ],
            "confidence": 0.95,
            "reasoning": "Active immune thrombocytopenic purpura is a specific medical diagnosis that is reliably found as a structured ICD code in the EHR problem list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Consult Note"
            ],
            "extractionPrompt": "Extract: Active immune thrombocytopenic purpura",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0052",
        "originalCriterionId": "EXC_5.2.2.5",
        "criterionType": "exclusion",
        "atomicText": "History of being refractory to platelet transfusions",
        "normalizedText": "History of being refractory to platelet transfusions",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.5_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 52
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.9,
          "reasoning": "Being refractory to platelet transfusions is a complex clinical history finding that would be detailed in narrative clinical notes, such as hematology consults. Has OMOP mapping. Data in: Progress Note, Consult Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0052",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "Progress Note",
              "Consult Note"
            ],
            "confidence": 0.9,
            "reasoning": "Being refractory to platelet transfusions is a complex clinical history finding that would be detailed in narrative clinical notes, such as hematology consults."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "Consult Note"
            ],
            "extractionPrompt": "Extract: History of being refractory to platelet transfusions",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0053",
        "originalCriterionId": "EXC_5.2.2.6",
        "criterionType": "exclusion",
        "atomicText": "Received aspirin",
        "normalizedText": "Received aspirin",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '7 days'",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.6_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 53
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "refractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).\n6. The subject has received aspirin within 7 days prior to the first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Aspirin use is a medication history, which is most reliably found in the structured medication list (e.g., RxNorm, NDC) of the EHR. No OMOP mapping. Data in: Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0053",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "confidence": 0.98,
            "reasoning": "Aspirin use is a medication history, which is most reliably found in the structured medication list (e.g., RxNorm, NDC) of the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "extractionPrompt": "Extract: Received aspirin",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0054",
        "originalCriterionId": "EXC_5.2.2.7",
        "criterionType": "exclusion",
        "atomicText": "Currently receiving or requires anticoagulation therapy",
        "normalizedText": "Currently receiving or requires anticoagulation therapy",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.7_1a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 54
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "bleeding_risk_medication",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Current anticoagulation therapy is found in the patient's active medication list, which is structured EHR data. No OMOP mapping. Data in: Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0054",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "confidence": 0.98,
            "reasoning": "Current anticoagulation therapy is found in the patient's active medication list, which is structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "extractionPrompt": "Extract: Currently receiving or requires anticoagulation therapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0055",
        "originalCriterionId": "EXC_5.2.2.7",
        "criterionType": "exclusion",
        "atomicText": "Currently receiving or requires any drugs or herbal supplements that affect platelet function",
        "normalizedText": "Currently receiving or requires any drugs or herbal supplements that affect platelet function",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.7_1b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 55
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "bleeding_risk_medication",
        "expressionNodeId": "1b",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.9,
          "reasoning": "While prescription drugs are in structured data, this criterion includes herbal supplements, which are most often captured through patient interview and documented in narrative clinical notes. Has OMOP mapping. Data in: Medication Reconciliation, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0055",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Medication Reconciliation",
              "H&P"
            ],
            "confidence": 0.9,
            "reasoning": "While prescription drugs are in structured data, this criterion includes herbal supplements, which are most often captured through patient interview and documented in narrative clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication Reconciliation",
              "H&P"
            ],
            "extractionPrompt": "Extract: Currently receiving or requires any drugs or herbal supplements that affect platelet function",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0056",
        "originalCriterionId": "EXC_5.2.2.7",
        "criterionType": "exclusion",
        "atomicText": "Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter",
        "normalizedText": "Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "low-dose and for catheter patency"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.7_2",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 56
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "The use of low-dose anticoagulation is a medication, found in structured EHR data. The specific reason for use would be in notes, but the medication itself is the key data point. No OMOP mapping. Data in: Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0056",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "confidence": 0.95,
            "reasoning": "The use of low-dose anticoagulation is a medication, found in structured EHR data. The specific reason for use would be in notes, but the medication itself is the key data point."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "extractionPrompt": "Extract: Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0057",
        "originalCriterionId": "EXC_5.2.2.8",
        "criterionType": "exclusion",
        "atomicText": "Received steroid therapy for anti-neoplastic intent",
        "normalizedText": "Received steroid therapy for anti-neoplastic intent",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.8_1a",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 57
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "While the steroid medication may be in structured data, the 'intent' of the therapy (anti-neoplastic) is critical clinical context found only in narrative oncology notes. Has OMOP mapping. Data in: Progress Note, Chemotherapy Administration Record",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0057",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Progress Note",
              "Chemotherapy Administration Record"
            ],
            "confidence": 0.95,
            "reasoning": "While the steroid medication may be in structured data, the 'intent' of the therapy (anti-neoplastic) is critical clinical context found only in narrative oncology notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "Chemotherapy Administration Record"
            ],
            "extractionPrompt": "Extract: Received steroid therapy for anti-neoplastic intent",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0058",
        "originalCriterionId": "EXC_5.2.2.8",
        "criterionType": "exclusion",
        "atomicText": "Received inhaled steroids for asthma",
        "normalizedText": "Received inhaled steroids for asthma",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.8_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 58
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "permitted_steroids",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.95,
          "reasoning": "Inhaled steroids are medications linked to a diagnosis (asthma), both of which are typically available as structured data in the EHR. Has OMOP mapping. Data in: Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0058",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "confidence": 0.95,
            "reasoning": "Inhaled steroids are medications linked to a diagnosis (asthma), both of which are typically available as structured data in the EHR."
          }
        }
      },
      {
        "atomicId": "A0059",
        "originalCriterionId": "EXC_5.2.2.8",
        "criterionType": "exclusion",
        "atomicText": "Received topical steroids",
        "normalizedText": "Received topical steroids",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.8_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 59
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "permitted_steroids",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.95,
          "reasoning": "Topical steroids are medications, and their use would be captured in the structured medication history of the EHR. Has OMOP mapping. Data in: Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0059",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "confidence": 0.95,
            "reasoning": "Topical steroids are medications, and their use would be captured in the structured medication history of the EHR."
          }
        }
      },
      {
        "atomicId": "A0060",
        "originalCriterionId": "EXC_5.2.2.8",
        "criterionType": "exclusion",
        "atomicText": "Received replacement or stress corticosteroids",
        "normalizedText": "Received replacement or stress corticosteroids",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.8_2c",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 60
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "permitted_steroids",
        "expressionNodeId": "2c",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.92,
          "reasoning": "The use of corticosteroids is a medication history found in structured EHR data. The reason (replacement/stress) is often linked to a structured diagnosis code as well. Has OMOP mapping. Data in: Medication Reconciliation",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0060",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Reconciliation"
            ],
            "confidence": 0.92,
            "reasoning": "The use of corticosteroids is a medication history found in structured EHR data. The reason (replacement/stress) is often linked to a structured diagnosis code as well."
          }
        }
      },
      {
        "atomicId": "A0061",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received chemotherapy",
        "normalizedText": "Received chemotherapy",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 61
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Prior chemotherapy history is most reliably and comprehensively documented in oncology clinical notes and treatment summaries. While structured medication administration data may exist, it can be incomplete or lack context. No OMOP mapping. Data in: Oncology Note, Progress Note, Treatment Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0061",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "confidence": 0.95,
            "reasoning": "Prior chemotherapy history is most reliably and comprehensively documented in oncology clinical notes and treatment summaries. While structured medication administration data may exist, it can be incomplete or lack context."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "extractionPrompt": "Extract: Received chemotherapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0062",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received immunotherapy",
        "normalizedText": "Received immunotherapy",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 62
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Prior immunotherapy history is best captured in narrative clinical notes, which provide details on regimens and dates. Structured data may not reliably capture these specialized treatments. No OMOP mapping. Data in: Oncology Note, Progress Note, Treatment Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0062",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "confidence": 0.95,
            "reasoning": "Prior immunotherapy history is best captured in narrative clinical notes, which provide details on regimens and dates. Structured data may not reliably capture these specialized treatments."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "extractionPrompt": "Extract: Received immunotherapy",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0063",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received radiotherapy",
        "normalizedText": "Received radiotherapy",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a3",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 63
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a3",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Details of prior radiotherapy (dates, dose, location) are found in specialized radiation oncology notes or treatment summaries. CPT codes in structured data lack this necessary detail. No OMOP mapping. Data in: Radiation Oncology Note, Treatment Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0063",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Radiation Oncology Note",
              "Treatment Summary"
            ],
            "confidence": 0.95,
            "reasoning": "Details of prior radiotherapy (dates, dose, location) are found in specialized radiation oncology notes or treatment summaries. CPT codes in structured data lack this necessary detail."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Radiation Oncology Note",
              "Treatment Summary"
            ],
            "extractionPrompt": "Extract: Received radiotherapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0064",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received hormonal anti-cancer therapy",
        "normalizedText": "Received hormonal anti-cancer therapy",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a4a",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 64
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a4a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Hormonal anti-cancer therapies are prescribed medications and are typically well-documented in structured medication lists (RxNorm). Clinical notes provide context but structured data is more direct. No OMOP mapping. Data in: Oncology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0064",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Oncology Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "Hormonal anti-cancer therapies are prescribed medications and are typically well-documented in structured medication lists (RxNorm). Clinical notes provide context but structured data is more direct."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received hormonal anti-cancer therapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0065",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received hormones for thyroid conditions",
        "normalizedText": "Received hormones for thyroid conditions",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a4b1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 65
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a4b1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Hormones for thyroid conditions are standard medications found in the structured medication history (e.g., RxNorm codes). No OMOP mapping. Data in: Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0065",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.98,
            "reasoning": "Hormones for thyroid conditions are standard medications found in the structured medication history (e.g., RxNorm codes)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "H&P"
            ],
            "extractionPrompt": "Extract: Received hormones for thyroid conditions",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0066",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received estrogen replacement therapy (ERT)",
        "normalizedText": "Received estrogen replacement therapy (ERT)",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a4b2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 66
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a4b2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Estrogen replacement therapy is a standard medication that would be listed in the structured medication history. No OMOP mapping. Data in: Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0066",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.98,
            "reasoning": "Estrogen replacement therapy is a standard medication that would be listed in the structured medication history."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "H&P"
            ],
            "extractionPrompt": "Extract: Received estrogen replacement therapy (ERT)",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0067",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Received any investigational therapy",
        "normalizedText": "Received any investigational therapy",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_1a5",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 67
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a5",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Participation in prior clinical trials and receipt of investigational therapy is almost exclusively documented in narrative clinical notes, as these agents do not have standard codes. No OMOP mapping. Data in: Oncology Note, Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0067",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.95,
            "reasoning": "Participation in prior clinical trials and receipt of investigational therapy is almost exclusively documented in narrative clinical notes, as these agents do not have standard codes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "H&P"
            ],
            "extractionPrompt": "Extract: Received any investigational therapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0068",
        "originalCriterionId": "EXC_5.2.2.9",
        "criterionType": "exclusion",
        "atomicText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
        "normalizedText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number < 2"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.9_2a",
          "groupLogic": "NOT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 68
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.98,
          "reasoning": "This requires a new assessment of the patient's current status and grading of toxicity (e.g., using CTCAE) at the time of screening to determine if they have recovered from prior therapy. No OMOP mapping. Data in: Screening Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0068",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Screening Note",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "This requires a new assessment of the patient's current status and grading of toxicity (e.g., using CTCAE) at the time of screening to determine if they have recovered from prior therapy."
          }
        }
      },
      {
        "atomicId": "A0069",
        "originalCriterionId": "EXC_5.2.2.10",
        "criterionType": "exclusion",
        "atomicText": "Received a biologic",
        "normalizedText": "Received a biologic",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.10_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 69
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "therapy.\n10. The subject has received a biologic within 30 days prior to the first dose of study\ndrug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.92,
          "reasoning": "Similar to chemotherapy, the history of biologic therapy is most reliably found in narrative notes. Structured data (e.g., infusion codes) may exist but often lacks the complete context. No OMOP mapping. Data in: Oncology Note, Progress Note, Treatment Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0069",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "confidence": 0.92,
            "reasoning": "Similar to chemotherapy, the history of biologic therapy is most reliably found in narrative notes. Structured data (e.g., infusion codes) may exist but often lacks the complete context."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "extractionPrompt": "Extract: Received a biologic",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0070",
        "originalCriterionId": "EXC_5.2.2.11",
        "criterionType": "exclusion",
        "atomicText": "Consumed grapefruit",
        "normalizedText": "Consumed grapefruit",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.11_1a1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 70
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "grapefruit_consumption",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "Consumption of specific foods like grapefruit is not tracked in the EHR and must be determined by asking the patient directly at screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0070",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Consumption of specific foods like grapefruit is not tracked in the EHR and must be determined by asking the patient directly at screening."
          }
        }
      },
      {
        "atomicId": "A0071",
        "originalCriterionId": "EXC_5.2.2.11",
        "criterionType": "exclusion",
        "atomicText": "Consumed grapefruit products",
        "normalizedText": "Consumed grapefruit products",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.11_1a2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 71
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "grapefruit_consumption",
        "expressionNodeId": "1a2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "Consumption of specific food products is not tracked in the EHR and must be determined by asking the patient directly at screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0071",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Consumption of specific food products is not tracked in the EHR and must be determined by asking the patient directly at screening."
          }
        }
      },
      {
        "atomicId": "A0072",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of cardiovascular disease",
        "normalizedText": "Significant history of cardiovascular disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 72
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "The term 'significant history' requires context beyond just diagnosis codes. Clinical notes (H&P, specialist consults) provide the narrative to determine significance, while structured diagnosis codes serve as a secondary source. No OMOP mapping. Data in: H&P, Cardiology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0072",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Cardiology Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "The term 'significant history' requires context beyond just diagnosis codes. Clinical notes (H&P, specialist consults) provide the narrative to determine significance, while structured diagnosis codes serve as a secondary source."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Cardiology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of cardiovascular disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0073",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Myocardial infarction",
        "normalizedText": "Myocardial infarction",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4329847
          ],
          "conceptNames": [
            "Myocardial infarction"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "22298006"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "22298006",
              "display": "Myocardial infarction"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "I21.9",
              "display": "Acute myocardial infarction, unspecified"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1b1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 73
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "recent_thromboembolic_events",
        "expressionNodeId": "1b1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.98,
          "reasoning": "Myocardial infarction is a discrete medical event with a specific ICD diagnosis code, making structured EHR data the primary source. Has OMOP mapping. Data in: H&P, Discharge Summary, Cardiology Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0073",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Discharge Summary",
              "Cardiology Note"
            ],
            "confidence": 0.98,
            "reasoning": "Myocardial infarction is a discrete medical event with a specific ICD diagnosis code, making structured EHR data the primary source."
          }
        }
      },
      {
        "atomicId": "A0074",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Thrombotic event",
        "normalizedText": "Thrombotic event",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '6 months'",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1b2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 74
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "recent_thromboembolic_events",
        "expressionNodeId": "1b2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "A thrombotic event is a specific diagnosis that is captured with ICD codes in structured EHR data. No OMOP mapping. Data in: H&P, Discharge Summary, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0074",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Discharge Summary",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "A thrombotic event is a specific diagnosis that is captured with ICD codes in structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Discharge Summary",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Thrombotic event",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0075",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Thromboembolic event",
        "normalizedText": "Thromboembolic event",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '6 months'",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1b3",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 75
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "recent_thromboembolic_events",
        "expressionNodeId": "1b3",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "A thromboembolic event is a specific diagnosis that is captured with ICD codes in structured EHR data. No OMOP mapping. Data in: H&P, Discharge Summary, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0075",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Discharge Summary",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "A thromboembolic event is a specific diagnosis that is captured with ICD codes in structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Discharge Summary",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Thromboembolic event",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0076",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of renal disease",
        "normalizedText": "Significant history of renal disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1c",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 76
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1c",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "The term 'significant history' requires interpretation of the patient's medical history, which is best found in clinical notes. Structured data (diagnosis codes, lab results like creatinine) provides supporting evidence. No OMOP mapping. Data in: H&P, Nephrology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0076",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Nephrology Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "The term 'significant history' requires interpretation of the patient's medical history, which is best found in clinical notes. Structured data (diagnosis codes, lab results like creatinine) provides supporting evidence."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Nephrology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of renal disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0077",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of neurologic disease",
        "normalizedText": "Significant history of neurologic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1d",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 77
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1d",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Determining a 'significant history' of neurologic disease relies on the narrative and context provided in clinical notes. Structured diagnosis codes are a useful but secondary source. No OMOP mapping. Data in: H&P, Neurology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0077",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Neurology Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "Determining a 'significant history' of neurologic disease relies on the narrative and context provided in clinical notes. Structured diagnosis codes are a useful but secondary source."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Neurology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of neurologic disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0078",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of psychiatric disease",
        "normalizedText": "Significant history of psychiatric disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1e",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 78
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1e",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "The context and severity needed to judge a 'significant history' of psychiatric disease are found in clinical notes. Structured diagnosis codes alone are insufficient. No OMOP mapping. Data in: H&P, Psychiatry Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0078",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Psychiatry Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "The context and severity needed to judge a 'significant history' of psychiatric disease are found in clinical notes. Structured diagnosis codes alone are insufficient."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Psychiatry Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of psychiatric disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0079",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of endocrinologic disease",
        "normalizedText": "Significant history of endocrinologic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1f",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 79
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1f",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "A 'significant history' of endocrinologic disease is best understood from the narrative in clinical notes, which provides more detail than just diagnosis codes. No OMOP mapping. Data in: H&P, Endocrinology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0079",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Endocrinology Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "A 'significant history' of endocrinologic disease is best understood from the narrative in clinical notes, which provides more detail than just diagnosis codes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Endocrinology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of endocrinologic disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0080",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of metabolic disease",
        "normalizedText": "Significant history of metabolic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1g",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 80
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1g",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "The assessment of a 'significant history' of metabolic disease requires the context and detail found in clinical notes, supplemented by structured diagnosis and lab data. No OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0080",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "The assessment of a 'significant history' of metabolic disease requires the context and detail found in clinical notes, supplemented by structured diagnosis and lab data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of metabolic disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0081",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of immunologic disease",
        "normalizedText": "Significant history of immunologic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1h",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 81
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1h",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "The term 'significant history' points to the need for narrative context from clinical notes to understand the severity and nature of an immunologic disease. No OMOP mapping. Data in: H&P, Immunology Note, Rheumatology Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0081",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Immunology Note",
              "Rheumatology Note"
            ],
            "confidence": 0.9,
            "reasoning": "The term 'significant history' points to the need for narrative context from clinical notes to understand the severity and nature of an immunologic disease."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Immunology Note",
              "Rheumatology Note"
            ],
            "extractionPrompt": "Extract: Significant history of immunologic disease",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0082",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of hepatic disease",
        "normalizedText": "Significant history of hepatic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_1i",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 82
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1i",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Determining a 'significant history' of hepatic disease requires review of clinical notes for context, supported by structured diagnosis codes and lab values (e.g., LFTs). No OMOP mapping. Data in: H&P, Hepatology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0082",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "H&P",
              "Hepatology Note",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "Determining a 'significant history' of hepatic disease requires review of clinical notes for context, supported by structured diagnosis codes and lab values (e.g., LFTs)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Hepatology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Significant history of hepatic disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0083",
        "originalCriterionId": "EXC_5.2.2.12",
        "criterionType": "exclusion",
        "atomicText": "Condition would adversely affect study participation in the opinion of the investigator",
        "normalizedText": "Condition would adversely affect study participation in the opinion of the investigator",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.12_2",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 83
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "The phrase 'in the opinion of the investigator' explicitly indicates that this criterion requires a subjective evaluation by the clinical investigator at the time of screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0083",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The phrase 'in the opinion of the investigator' explicitly indicates that this criterion requires a subjective evaluation by the clinical investigator at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0084",
        "originalCriterionId": "EXC_5.2.2.13",
        "criterionType": "exclusion",
        "atomicText": "Female",
        "normalizedText": "Female",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.13_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 84
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Sex/gender is a standard demographic field found in structured EHR data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0084",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Sex/gender is a standard demographic field found in structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Female",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0085",
        "originalCriterionId": "EXC_5.2.2.13",
        "criterionType": "exclusion",
        "atomicText": "Pregnant",
        "normalizedText": "Pregnant",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.13_1b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 85
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "Current pregnancy status must be confirmed with a new test (e.g., serum or urine hCG) at the time of screening. A historical record is not sufficient. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0085",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Current pregnancy status must be confirmed with a new test (e.g., serum or urine hCG) at the time of screening. A historical record is not sufficient."
          }
        }
      },
      {
        "atomicId": "A0086",
        "originalCriterionId": "EXC_5.2.2.13",
        "criterionType": "exclusion",
        "atomicText": "Breast-feeding",
        "normalizedText": "Breast-feeding",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.2.13_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 86
        },
        "provenance": {
          "pageNumber": 30,
          "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "Whether a patient is currently breast-feeding is not a standard EHR field and must be determined by asking the patient at the time of screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0086",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Whether a patient is currently breast-feeding is not a standard EHR field and must be determined by asking the patient at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0087",
        "originalCriterionId": "INC_5.2.3.1",
        "criterionType": "inclusion",
        "atomicText": "Age >= 18 years",
        "normalizedText": "Age >= 18 years",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            4265453
          ],
          "conceptNames": [
            "Age"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "397669002"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 18"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "30525-0",
              "display": "Age"
            }
          ],
          "searchParams": "code=http://loinc.org|30525-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.1_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 87
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "5.2.3 Phase 2a Inclusion Criteria\nA subject will be eligible for study participation if he/she meets the following criteria:\n1. The subject must be \u2265 18 years of age.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Age is a standard demographic field derived from the date of birth in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0087",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Age is a standard demographic field derived from the date of birth in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0088",
        "originalCriterionId": "INC_5.2.3.2",
        "criterionType": "inclusion",
        "atomicText": "Has Chronic Lymphocytic Leukemia (CLL)",
        "normalizedText": "Has Chronic Lymphocytic Leukemia (CLL)",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 99.0,
          "impactScore": 0.99,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4173824
          ],
          "conceptNames": [
            "B-cell chronic lymphocytic leukemia variant"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "277474005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "277474005",
              "display": "B-cell chronic lymphocytic leukemia variant"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "C91.1",
              "display": "Chronic lymphocytic leukemia of B-cell type"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|277474005,C91.1",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.2_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 88
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have CLL and require treatment in the opinion of the investigator.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.98,
          "reasoning": "The definitive diagnosis of Chronic Lymphocytic Leukemia (CLL) is made via pathology, specifically flow cytometry. This is the gold standard source, though an ICD code will also be present in structured data. Has OMOP mapping. Data in: Pathology, Flow Cytometry Report",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0088",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Pathology",
              "Flow Cytometry Report"
            ],
            "confidence": 0.98,
            "reasoning": "The definitive diagnosis of Chronic Lymphocytic Leukemia (CLL) is made via pathology, specifically flow cytometry. This is the gold standard source, though an ICD code will also be present in structured data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology",
              "Flow Cytometry Report"
            ],
            "extractionPrompt": "Extract: Has Chronic Lymphocytic Leukemia (CLL)",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0089",
        "originalCriterionId": "INC_5.2.3.2",
        "criterionType": "inclusion",
        "atomicText": "Requires treatment in the opinion of the investigator",
        "normalizedText": "Requires treatment in the opinion of the investigator",
        "category": "primary_anchor",
        "funnelImpact": {
          "eliminationRate": 99.0,
          "impactScore": 0.99,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.2_2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 89
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have CLL and require treatment in the opinion of the investigator.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "The phrase 'in the opinion of the investigator' makes this a subjective assessment that must be made by the investigator at the time of enrollment. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0089",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The phrase 'in the opinion of the investigator' makes this a subjective assessment that must be made by the investigator at the time of enrollment."
          }
        }
      },
      {
        "atomicId": "A0090",
        "originalCriterionId": "INC_5.2.3.3",
        "criterionType": "inclusion",
        "atomicText": "Relapsed disease",
        "normalizedText": "Relapsed disease",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.3_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 90
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "2. The subject must have CLL and require treatment in the opinion of the investigator.\n3. The subject has relapsed disease and has received no more than 5 prior \nmyelosuppressive/chemotherapy regimens.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.92,
          "reasoning": "The clinical determination of 'relapsed disease' is a conclusion documented by an oncologist in a clinical note, often based on evidence from recent imaging, labs, and patient symptoms. Radiology reports provide the evidence, but the clinical status is declared in the note. No OMOP mapping. Data in: Oncology Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0090",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "radiology_report",
            "noteTypes": [
              "Oncology Note",
              "Progress Note"
            ],
            "confidence": 0.92,
            "reasoning": "The clinical determination of 'relapsed disease' is a conclusion documented by an oncologist in a clinical note, often based on evidence from recent imaging, labs, and patient symptoms. Radiology reports provide the evidence, but the clinical status is declared in the note."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Relapsed disease",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0091",
        "originalCriterionId": "INC_5.2.3.3",
        "criterionType": "inclusion",
        "atomicText": "Received 5 or fewer prior myelosuppressive/chemotherapy regimens",
        "normalizedText": "Received 5 or fewer prior myelosuppressive/chemotherapy regimens",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number <= 5"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.3_2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 91
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "2. The subject must have CLL and require treatment in the opinion of the investigator.\n3. The subject has relapsed disease and has received no more than 5 prior \nmyelosuppressive/chemotherapy regimens.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "The number of prior 'regimens' is a clinical interpretation of treatment history, most reliably found by reviewing oncologist notes and treatment summaries. Individual drugs may be in structured data, but not the regimen count. No OMOP mapping. Data in: Oncology Note, Progress Note, Treatment Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0091",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "confidence": 0.95,
            "reasoning": "The number of prior 'regimens' is a clinical interpretation of treatment history, most reliably found by reviewing oncologist notes and treatment summaries. Individual drugs may be in structured data, but not the regimen count."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Progress Note",
              "Treatment Summary"
            ],
            "extractionPrompt": "Extract: Received 5 or fewer prior myelosuppressive/chemotherapy regimens",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0092",
        "originalCriterionId": "INC_5.2.3.4",
        "criterionType": "inclusion",
        "atomicText": "Eastern Cooperative Oncology Group (ECOG) performance score <= 1",
        "normalizedText": "Eastern Cooperative Oncology Group (ECOG) performance score <= 1",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            36305384
          ],
          "conceptNames": [
            "ECOG Performance Status score"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "89247-1"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND value_as_number >= 0 AND value_as_number <= 1",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 0 AND value_as_number <= 1"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "89247-1",
              "display": "ECOG Performance Status score"
            }
          ],
          "searchParams": "code=http://loinc.org|89247-1",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.4_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 92
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "myelosuppressive/chemotherapy regimens.\n4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "performance_status",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "ECOG performance status is a clinical assessment performed by an investigator at a specific point in time, typically at screening, to evaluate a patient's functional status. Has OMOP mapping. Data in: Screening Note, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0092",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Screening Note",
              "Progress Note"
            ],
            "confidence": 0.99,
            "reasoning": "ECOG performance status is a clinical assessment performed by an investigator at a specific point in time, typically at screening, to evaluate a patient's functional status."
          }
        }
      },
      {
        "atomicId": "A0093",
        "originalCriterionId": "INC_5.2.3.5",
        "criterionType": "inclusion",
        "atomicText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
        "normalizedText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.5_1a",
          "groupLogic": "IMPLICATION_CONDITION",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 93
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n5. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "ssri_therapy",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Current medications, like SSRIs, are most reliably found in the structured medication list (e.g., RxNorm codes) of the EHR. No OMOP mapping. Data in: Medication List, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0093",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication List",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "Current medications, like SSRIs, are most reliably found in the structured medication list (e.g., RxNorm codes) of the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication List",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0094",
        "originalCriterionId": "INC_5.2.3.5",
        "criterionType": "inclusion",
        "atomicText": "Dose of SSRI changed",
        "normalizedText": "Dose of SSRI changed",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.5_1b1a",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 94
        },
        "provenance": {
          "pageNumber": 31,
          "textSnippet": "4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n5. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "ssri_therapy",
        "expressionNodeId": "1b1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "A change in medication dose would be captured in structured medication order and administration records within the EHR. No OMOP mapping. Data in: Medication List, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0094",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication List",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "A change in medication dose would be captured in structured medication order and administration records within the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication List",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Dose of SSRI changed",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0095",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Received growth factor support to maintain bone marrow function",
        "normalizedText": "Received growth factor support to maintain bone marrow function",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1a1",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 95
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Growth factor support is a medication (e.g., filgrastim) that would be documented in structured medication administration records (MAR) or orders. No OMOP mapping. Data in: Medication Administration Record, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0095",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Administration Record",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "Growth factor support is a medication (e.g., filgrastim) that would be documented in structured medication administration records (MAR) or orders."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication Administration Record",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received growth factor support to maintain bone marrow function",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0096",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Screening",
        "normalizedText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 1000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1b1",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 96
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1b1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current value. The result is a structured lab value, but the criterion requires a new assessment. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0096",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current value. The result is a structured lab value, but the criterion requires a new assessment."
          }
        }
      },
      {
        "atomicId": "A0097",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Screening",
        "normalizedText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number < 1000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number < 1000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1b2a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 97
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1b2a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current value. The result is a structured lab value, but the criterion requires a new assessment. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0097",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current value. The result is a structured lab value, but the criterion requires a new assessment."
          }
        }
      },
      {
        "atomicId": "A0098",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Bone marrow heavily infiltrated with underlying disease >= 80% at Screening",
        "normalizedText": "Bone marrow heavily infiltrated with underlying disease >= 80% at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number >= 80"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1b2b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 98
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b2b",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "The percentage of bone marrow infiltration is a finding determined by a pathologist from a bone marrow biopsy. The 'at Screening' indicates a new biopsy and report are required. No OMOP mapping. Data in: Pathology, Bone Marrow Report",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0098",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": null,
            "noteTypes": [
              "Pathology",
              "Bone Marrow Report"
            ],
            "confidence": 0.98,
            "reasoning": "The percentage of bone marrow infiltration is a finding determined by a pathologist from a bone marrow biopsy. The 'at Screening' indicates a new biopsy and report are required."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology",
              "Bone Marrow Report"
            ],
            "extractionPrompt": "Extract: Bone marrow heavily infiltrated with underlying disease >= 80% at Screening",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0099",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Platelets >= 75,000/mm3 at Screening",
        "normalizedText": "Platelets >= 75,000/mm3 at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 75000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 75000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1c1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 99
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1c1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current platelet count. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0099",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current platelet count."
          }
        }
      },
      {
        "atomicId": "A0100",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Received platelet transfusion",
        "normalizedText": "Received platelet transfusion",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1c2a1",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 100
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1c2a1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.95,
          "reasoning": "Platelet transfusions are procedures that are recorded in structured data, such as blood bank records or procedure codes (HCPCS). Has OMOP mapping. Data in: Progress Note, Nursing Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0100",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note",
              "Nursing Note"
            ],
            "confidence": 0.95,
            "reasoning": "Platelet transfusions are procedures that are recorded in structured data, such as blood bank records or procedure codes (HCPCS)."
          }
        }
      },
      {
        "atomicId": "A0101",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Hemoglobin >= 9.0 g/dL at Screening",
        "normalizedText": "Hemoglobin >= 9.0 g/dL at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3000963
          ],
          "conceptNames": [
            "Hemoglobin [Mass/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "718-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 9.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "718-7",
              "display": "Hemoglobin [Mass/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|718-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_1d",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 101
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1d",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current hemoglobin value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0101",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current hemoglobin value."
          }
        }
      },
      {
        "atomicId": "A0102",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Serum creatinine <= 2.0 mg/dL at Screening",
        "normalizedText": "Serum creatinine <= 2.0 mg/dL at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3016723
          ],
          "conceptNames": [
            "Creatinine [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "2160-0"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 2.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 2.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "2160-0",
              "display": "Creatinine [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|2160-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 102
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current serum creatinine value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0102",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current serum creatinine value."
          }
        }
      },
      {
        "atomicId": "A0103",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Calculated creatinine clearance >= 50 mL/min at Screening",
        "normalizedText": "Calculated creatinine clearance >= 50 mL/min at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3016723
          ],
          "conceptNames": [
            "Creatinine [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "2160-0"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number >= 50",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 50"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "2160-0",
              "display": "Creatinine [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|2160-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 103
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "The criterion explicitly states 'Calculated creatinine clearance', which requires using a formula (e.g., Cockcroft-Gault) with recent lab values and demographics at the time of screening. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0103",
            "primaryDataSource": "calculated_value",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The criterion explicitly states 'Calculated creatinine clearance', which requires using a formula (e.g., Cockcroft-Gault) with recent lab values and demographics at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0104",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "AST <= 3.0 x ULN at Screening",
        "normalizedText": "AST <= 3.0 x ULN at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3013721
          ],
          "conceptNames": [
            "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1920-8"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 3.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 3.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1920-8",
              "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1920-8",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_3a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 104
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "3a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current AST value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0104",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current AST value."
          }
        }
      },
      {
        "atomicId": "A0105",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "ALT <= 3.0 x ULN at Screening",
        "normalizedText": "ALT <= 3.0 x ULN at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3006923
          ],
          "conceptNames": [
            "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1742-6"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 3.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 3.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1742-6",
              "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1742-6",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_3b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 105
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "3b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current ALT value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0105",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current ALT value."
          }
        }
      },
      {
        "atomicId": "A0106",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Bilirubin <= 1.5 x ULN at Screening",
        "normalizedText": "Bilirubin <= 1.5 x ULN at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3024128
          ],
          "conceptNames": [
            "Bilirubin.total [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1975-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 1.5"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1975-2",
              "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1975-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_3c1",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 106
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "3c1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current Bilirubin value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0106",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current Bilirubin value."
          }
        }
      },
      {
        "atomicId": "A0107",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "Subject has diagnosis of Gilbert's Syndrome",
        "normalizedText": "Subject has diagnosis of Gilbert's Syndrome",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4099740
          ],
          "conceptNames": [
            "Gilbert's syndrome"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "27503000"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "27503000",
              "display": "Gilbert's syndrome"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "E80.4",
              "display": "Gilbert syndrome"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_3c2",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 107
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "3c2",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.98,
          "reasoning": "Gilbert's Syndrome is a medical diagnosis that would be coded (e.g., ICD-10) in the patient's problem list within the structured EHR. Has OMOP mapping. Data in: H&P, Problem List",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0107",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Problem List"
            ],
            "confidence": 0.98,
            "reasoning": "Gilbert's Syndrome is a medical diagnosis that would be coded (e.g., ICD-10) in the patient's problem list within the structured EHR."
          }
        }
      },
      {
        "atomicId": "A0108",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "aPTT must not exceed 1.2 x ULN at Screening",
        "normalizedText": "aPTT must not exceed 1.2 x ULN at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3013466
          ],
          "conceptNames": [
            "aPTT in Blood by Coagulation assay"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "3173-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value_as_number <= 1.2",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 1.2"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "3173-2",
              "display": "aPTT in Blood by Coagulation assay"
            }
          ],
          "searchParams": "code=http://loinc.org|3173-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_4a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 108
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "4a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current aPTT value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0108",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current aPTT value."
          }
        }
      },
      {
        "atomicId": "A0109",
        "originalCriterionId": "INC_5.2.3.6",
        "criterionType": "inclusion",
        "atomicText": "PT must not exceed 1.2 x ULN at Screening",
        "normalizedText": "PT must not exceed 1.2 x ULN at Screening",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 30.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3034426
          ],
          "conceptNames": [
            "Prothrombin time (PT)"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "5902-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value_as_number <= 1.2",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 1.2"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "5902-2",
              "display": "Prothrombin time (PT)"
            }
          ],
          "searchParams": "code=http://loinc.org|5902-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.6_4b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 109
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "4b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current PT value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0109",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "The phrase 'at Screening' indicates a new lab test is required to be performed at the time of enrollment to get a current PT value."
          }
        }
      },
      {
        "atomicId": "A0110",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "atomicText": "Female sex",
        "normalizedText": "Female sex",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female sex\n-- Requires manual SQL generation",
          "sqlExecutable": false,
          "valueConstraint": "Female"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.7_0",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 110
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "0",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Sex is a standard, structured demographic field in the EHR. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0110",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Sex is a standard, structured demographic field in the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Female sex",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0111",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "atomicText": "Surgically sterile",
        "normalizedText": "Surgically sterile",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.7_1",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 111
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.92,
          "reasoning": "Surgical sterility is determined by a history of procedures like hysterectomy or bilateral oophorectomy, which are often captured with structured procedure codes (CPT, ICD-10-PCS) in the surgical history. No OMOP mapping. Data in: H&P, Surgical History",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0111",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "confidence": 0.92,
            "reasoning": "Surgical sterility is determined by a history of procedures like hysterectomy or bilateral oophorectomy, which are often captured with structured procedure codes (CPT, ICD-10-PCS) in the surgical history."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "extractionPrompt": "Extract: Surgically sterile",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0112",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "atomicText": "Postmenopausal for at least 1 year",
        "normalizedText": "Postmenopausal for at least 1 year",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number >= 1"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.7_2",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 112
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Postmenopausal status is a clinical determination based on patient history (e.g., age, time since last menses) and is typically documented in narrative clinical notes rather than a standard structured field. No OMOP mapping. Data in: H&P, Progress Note, GYN Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0112",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "H&P",
              "Progress Note",
              "GYN Note"
            ],
            "confidence": 0.95,
            "reasoning": "Postmenopausal status is a clinical determination based on patient history (e.g., age, time since last menses) and is typically documented in narrative clinical notes rather than a standard structured field."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note",
              "GYN Note"
            ],
            "extractionPrompt": "Extract: Postmenopausal for at least 1 year",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0113",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "atomicText": "Positive serum pregnancy test at Screening",
        "normalizedText": "Positive serum pregnancy test at Screening",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive",
          "sqlExecutable": true,
          "valueConstraint": "Positive"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.7_3a1a",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 113
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "screening_only",
        "clinicalConceptGroup": "pregnancy_test",
        "expressionNodeId": "3a1a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "A serum pregnancy test 'at Screening' is a new lab test that must be performed at enrollment to confirm current status. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0113",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "A serum pregnancy test 'at Screening' is a new lab test that must be performed at enrollment to confirm current status."
          }
        }
      },
      {
        "atomicId": "A0114",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "atomicText": "Time since serum pregnancy test results > 7 days on Lead-in Day 1",
        "normalizedText": "Time since serum pregnancy test results > 7 days on Lead-in Day 1",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND value_as_number > 7",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number > 7"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.7_3b_cond",
          "groupLogic": "IMPLICATION_CONDITION",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 114
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "screening_only",
        "expressionNodeId": "3b_cond",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "This criterion is a check on the timing of another real-time assessment (the pregnancy test). The date of the test result, which is the key data point, is generated as part of that new assessment. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0114",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "This criterion is a check on the timing of another real-time assessment (the pregnancy test). The date of the test result, which is the key data point, is generated as part of that new assessment."
          }
        }
      },
      {
        "atomicId": "A0115",
        "originalCriterionId": "INC_5.2.3.7",
        "criterionType": "inclusion",
        "atomicText": "Positive urine pregnancy test prior to dosing on Lead-in Day 1",
        "normalizedText": "Positive urine pregnancy test prior to dosing on Lead-in Day 1",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive",
          "sqlExecutable": true,
          "valueConstraint": "Positive"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.7_3b_req1",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 115
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "screening_only",
        "clinicalConceptGroup": "pregnancy_test",
        "expressionNodeId": "3b_req1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "A urine pregnancy test 'prior to dosing' is a new lab test that must be performed at a specific time point during enrollment. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0115",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "A urine pregnancy test 'prior to dosing' is a new lab test that must be performed at a specific time point during enrollment."
          }
        }
      },
      {
        "atomicId": "A0116",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Female",
        "normalizedText": "Female",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_c1a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 116
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "c1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Sex is a standard, structured demographic field in the EHR. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0116",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Sex is a standard, structured demographic field in the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Female",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0117",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Surgically sterile",
        "normalizedText": "Surgically sterile",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_c1b1",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 117
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "female_not_childbearing_potential",
        "expressionNodeId": "c1b1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.92,
          "reasoning": "Surgical sterility is determined by a history of procedures like hysterectomy or bilateral oophorectomy, which are often captured with structured procedure codes (CPT, ICD-10-PCS) in the surgical history. No OMOP mapping. Data in: H&P, Surgical History",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0117",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "confidence": 0.92,
            "reasoning": "Surgical sterility is determined by a history of procedures like hysterectomy or bilateral oophorectomy, which are often captured with structured procedure codes (CPT, ICD-10-PCS) in the surgical history."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "extractionPrompt": "Extract: Surgically sterile",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0118",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Postmenopausal for at least 1 year",
        "normalizedText": "Postmenopausal for at least 1 year",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_c1b2",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 118
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "female_not_childbearing_potential",
        "expressionNodeId": "c1b2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Postmenopausal status is a clinical determination based on patient history (e.g., age, time since last menses) and is typically documented in narrative clinical notes rather than a standard structured field. No OMOP mapping. Data in: H&P, Progress Note, GYN Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0118",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "H&P",
              "Progress Note",
              "GYN Note"
            ],
            "confidence": 0.95,
            "reasoning": "Postmenopausal status is a clinical determination based on patient history (e.g., age, time since last menses) and is typically documented in narrative clinical notes rather than a standard structured field."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note",
              "GYN Note"
            ],
            "extractionPrompt": "Extract: Postmenopausal for at least 1 year",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0119",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Male",
        "normalizedText": "Male",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Male\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_c2a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 119
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "c2a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Sex is a standard, structured demographic field in the EHR. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0119",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Sex is a standard, structured demographic field in the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Male",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0120",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "History of vasectomy",
        "normalizedText": "History of vasectomy",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_c2b1",
          "groupLogic": "NOT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 120
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queyrable",
        "expressionNodeId": "c2b1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.92,
          "reasoning": "A history of vasectomy is a past surgical procedure that would be found in the surgical history, often with a corresponding procedure code in the structured EHR data. No OMOP mapping. Data in: H&P, Surgical History",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0120",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "confidence": 0.92,
            "reasoning": "A history of vasectomy is a past surgical procedure that would be found in the surgical history, often with a corresponding procedure code in the structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Surgical History"
            ],
            "extractionPrompt": "Extract: History of vasectomy",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0121",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Practices total abstinence from sexual intercourse for a minimum of one complete menstrual cycle",
        "normalizedText": "Practices total abstinence from sexual intercourse for a minimum of one complete menstrual cycle",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_r1",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 121
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "contraception_method",
        "expressionNodeId": "r1",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "This criterion describes a patient's behavior and commitment (abstinence) which must be agreed to and attested by the patient at enrollment. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0121",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "This criterion describes a patient's behavior and commitment (abstinence) which must be agreed to and attested by the patient at enrollment."
          }
        }
      },
      {
        "atomicId": "A0122",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Partner is vasectomized",
        "normalizedText": "Partner is vasectomized",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_r2",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 122
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "contraception_method",
        "expressionNodeId": "r2",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "This information is about the patient's partner and is part of the patient's attestation regarding contraception methods, which is a patient decision. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0122",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "This information is about the patient's partner and is part of the patient's attestation regarding contraception methods, which is a patient decision."
          }
        }
      },
      {
        "atomicId": "A0123",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
        "normalizedText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            600058216
          ],
          "conceptNames": [
            "Other Investigational Agent"
          ],
          "vocabularyIds": [
            "NCIt_Full"
          ],
          "conceptCodes": [
            "C156875"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "code": "C156875",
              "display": "Other Investigational Agent"
            }
          ],
          "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_r3",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 123
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "contraception_method",
        "expressionNodeId": "r3",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.9,
          "reasoning": "Use of hormonal contraceptives is a medication history, which would be found in the structured medication list (RxNorm/NDC). Clinical notes might provide more context on duration. Has OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0123",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "Use of hormonal contraceptives is a medication history, which would be found in the structured medication list (RxNorm/NDC). Clinical notes might provide more context on duration."
          }
        }
      },
      {
        "atomicId": "A0124",
        "originalCriterionId": "INC_5.2.3.8",
        "criterionType": "inclusion",
        "atomicText": "Practices double-barrier method of birth control",
        "normalizedText": "Practices double-barrier method of birth control",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.8_r4",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 124
        },
        "provenance": {
          "pageNumber": 32,
          "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "contraception_method",
        "expressionNodeId": "r4",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "This criterion describes a patient's commitment to a specific behavior (double-barrier method) and requires patient agreement. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0124",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "This criterion describes a patient's commitment to a specific behavior (double-barrier method) and requires patient agreement."
          }
        }
      },
      {
        "atomicId": "A0125",
        "originalCriterionId": "INC_5.2.3.9",
        "criterionType": "inclusion",
        "atomicText": "Subject has voluntarily signed and dated an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
        "normalizedText": "Subject has voluntarily signed and dated an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.3.9_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 125
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "9. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
          "confidence": 1.0
        },
        "queryableStatus": "not_applicable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "NOT_APPLICABLE",
          "queryableStatus": "not_applicable",
          "confidence": 1.0,
          "reasoning": "The criterion explicitly requires the patient to have 'voluntarily signed and dated an informed consent', which is the definition of a patient decision. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0125",
            "primaryDataSource": "patient_decision",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The criterion explicitly requires the patient to have 'voluntarily signed and dated an informed consent', which is the definition of a patient decision."
          }
        }
      },
      {
        "atomicId": "A0126",
        "originalCriterionId": "EXC_5.2.4.1",
        "criterionType": "exclusion",
        "atomicText": "History of cancer-related Central Nervous System (CNS) disease",
        "normalizedText": "History of cancer-related Central Nervous System (CNS) disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            600055953
          ],
          "conceptNames": [
            "Prior Invasive Malignancy"
          ],
          "vocabularyIds": [
            "NCIt_Full"
          ],
          "conceptCodes": [
            "C154619"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "code": "C154619",
              "display": "Prior Invasive Malignancy"
            }
          ],
          "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.1_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 126
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "5.2.4 Phase 2a Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "cns_disease_presence",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "A history of cancer-related CNS disease is primarily diagnosed and documented through imaging studies (e.g., MRI, CT). The radiology report is the source of truth for this finding. Has OMOP mapping. Data in: Radiology, Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0126",
            "primaryDataSource": "radiology_report",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Radiology",
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.95,
            "reasoning": "A history of cancer-related CNS disease is primarily diagnosed and documented through imaging studies (e.g., MRI, CT). The radiology report is the source of truth for this finding."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Radiology",
              "Progress Note",
              "H&P"
            ],
            "extractionPrompt": "Extract: History of cancer-related Central Nervous System (CNS) disease",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0127",
        "originalCriterionId": "EXC_5.2.4.1",
        "criterionType": "exclusion",
        "atomicText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
        "normalizedText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.1_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 127
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "5.2.4 Phase 2a Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "cns_disease_presence",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.9,
          "reasoning": "The term 'clinically suspicious' implies a new assessment of the patient's current signs and symptoms by a clinician at the time of screening. No OMOP mapping. Data in: Progress Note, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0127",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "clinical_judgment",
            "noteTypes": [
              "Progress Note",
              "H&P"
            ],
            "confidence": 0.9,
            "reasoning": "The term 'clinically suspicious' implies a new assessment of the patient's current signs and symptoms by a clinician at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0128",
        "originalCriterionId": "EXC_5.2.4.2",
        "criterionType": "exclusion",
        "atomicText": "History of an underlying, predisposing condition of bleeding",
        "normalizedText": "History of an underlying, predisposing condition of bleeding",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.2_1a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 128
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "Nervous System (CNS) disease.\n2. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "bleeding_risk",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "An underlying, predisposing condition of bleeding (e.g., hemophilia) is a formal diagnosis that would be captured with an ICD code in the patient's structured problem list. No OMOP mapping. Data in: H&P, Consult Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0128",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Consult Note"
            ],
            "confidence": 0.95,
            "reasoning": "An underlying, predisposing condition of bleeding (e.g., hemophilia) is a formal diagnosis that would be captured with an ICD code in the patient's structured problem list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Consult Note"
            ],
            "extractionPrompt": "Extract: History of an underlying, predisposing condition of bleeding",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0129",
        "originalCriterionId": "EXC_5.2.4.2",
        "criterionType": "exclusion",
        "atomicText": "Currently exhibits signs of bleeding",
        "normalizedText": "Currently exhibits signs of bleeding",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.2_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 129
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "Nervous System (CNS) disease.\n2. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "bleeding_risk",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "The phrase 'currently exhibits signs' requires a direct observation and physical examination of the patient at the time of screening. No OMOP mapping. Data in: H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0129",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [
              "H&P"
            ],
            "confidence": 1.0,
            "reasoning": "The phrase 'currently exhibits signs' requires a direct observation and physical examination of the patient at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0130",
        "originalCriterionId": "EXC_5.2.4.3",
        "criterionType": "exclusion",
        "atomicText": "Undergone an allogeneic stem cell transplant",
        "normalizedText": "Undergone an allogeneic stem cell transplant",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            4028623
          ],
          "conceptNames": [
            "Transplantation of bone marrow"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "23719005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Procedure",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "23719005",
              "display": "Transplantation of bone marrow"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|23719005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.3_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 130
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n3. The subject has undergone an allogeneic or autologous stem cell transplant.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "stem_cell_transplant",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.98,
          "reasoning": "An allogeneic stem cell transplant is a major medical procedure that would be recorded with a standard procedure code (e.g., CPT) in the structured EHR data. Has OMOP mapping. Data in: Discharge Summary, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0130",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Discharge Summary",
              "H&P"
            ],
            "confidence": 0.98,
            "reasoning": "An allogeneic stem cell transplant is a major medical procedure that would be recorded with a standard procedure code (e.g., CPT) in the structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0131",
        "originalCriterionId": "EXC_5.2.4.3",
        "criterionType": "exclusion",
        "atomicText": "Undergone an autologous stem cell transplant",
        "normalizedText": "Undergone an autologous stem cell transplant",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            4028623
          ],
          "conceptNames": [
            "Transplantation of bone marrow"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "23719005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Procedure",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "23719005",
              "display": "Transplantation of bone marrow"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|23719005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.3_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 131
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n3. The subject has undergone an allogeneic or autologous stem cell transplant.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "stem_cell_transplant",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.98,
          "reasoning": "An autologous stem cell transplant is a major medical procedure that would be recorded with a standard procedure code (e.g., CPT) in the structured EHR data. Has OMOP mapping. Data in: Discharge Summary, H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0131",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Discharge Summary",
              "H&P"
            ],
            "confidence": 0.98,
            "reasoning": "An autologous stem cell transplant is a major medical procedure that would be recorded with a standard procedure code (e.g., CPT) in the structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0132",
        "originalCriterionId": "EXC_5.2.4.4",
        "criterionType": "exclusion",
        "atomicText": "Active peptic ulcer disease",
        "normalizedText": "Active peptic ulcer disease",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.4_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 132
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "gi_hemorrhagic_risk",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "'Active peptic ulcer disease' is a current diagnosis that would be listed in the patient's problem list with an associated ICD code. No OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0132",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "'Active peptic ulcer disease' is a current diagnosis that would be listed in the patient's problem list with an associated ICD code."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Active peptic ulcer disease",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0133",
        "originalCriterionId": "EXC_5.2.4.4",
        "criterionType": "exclusion",
        "atomicText": "Potentially hemorrhagic esophagitis",
        "normalizedText": "Potentially hemorrhagic esophagitis",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.4_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 133
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "gi_hemorrhagic_risk",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Esophagitis is a medical diagnosis that would be captured by an ICD code. The narrative details would be in a procedure note, but the coded diagnosis is the primary structured source. No OMOP mapping. Data in: H&P, GI Procedure Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0133",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "GI Procedure Note"
            ],
            "confidence": 0.9,
            "reasoning": "Esophagitis is a medical diagnosis that would be captured by an ICD code. The narrative details would be in a procedure note, but the coded diagnosis is the primary structured source."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "GI Procedure Note"
            ],
            "extractionPrompt": "Extract: Potentially hemorrhagic esophagitis",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0134",
        "originalCriterionId": "EXC_5.2.4.4",
        "criterionType": "exclusion",
        "atomicText": "Potentially hemorrhagic gastritis",
        "normalizedText": "Potentially hemorrhagic gastritis",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.4_3",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 134
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "gi_hemorrhagic_risk",
        "expressionNodeId": "3",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "Gastritis is a medical diagnosis that would be captured by an ICD code. The narrative details would be in a procedure note, but the coded diagnosis is the primary structured source. No OMOP mapping. Data in: H&P, GI Procedure Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0134",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "GI Procedure Note"
            ],
            "confidence": 0.9,
            "reasoning": "Gastritis is a medical diagnosis that would be captured by an ICD code. The narrative details would be in a procedure note, but the coded diagnosis is the primary structured source."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "GI Procedure Note"
            ],
            "extractionPrompt": "Extract: Potentially hemorrhagic gastritis",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0135",
        "originalCriterionId": "EXC_5.2.4.5",
        "criterionType": "exclusion",
        "atomicText": "Active immune thrombocytopenic purpura",
        "normalizedText": "Active immune thrombocytopenic purpura",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.5_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 135
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "esophagitis/gastritis.\n5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study\ndrug).",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Active immune thrombocytopenic purpura is a specific diagnosis that would be recorded with an ICD code in the structured problem list. No OMOP mapping. Data in: H&P, Hematology Consult Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0135",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Hematology Consult Note"
            ],
            "confidence": 0.98,
            "reasoning": "Active immune thrombocytopenic purpura is a specific diagnosis that would be recorded with an ICD code in the structured problem list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Hematology Consult Note"
            ],
            "extractionPrompt": "Extract: Active immune thrombocytopenic purpura",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0136",
        "originalCriterionId": "EXC_5.2.4.5",
        "criterionType": "exclusion",
        "atomicText": "History of being refractory to platelet transfusions",
        "normalizedText": "History of being refractory to platelet transfusions",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.5_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 136
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "esophagitis/gastritis.\n5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study\ndrug).",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "Being 'refractory to platelet transfusions' is a complex clinical history describing a response to treatment. This narrative is best detailed in progress or hematology consult notes. Has OMOP mapping. Data in: Progress Note, Hematology Consult Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0136",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "Progress Note",
              "Hematology Consult Note"
            ],
            "confidence": 0.95,
            "reasoning": "Being 'refractory to platelet transfusions' is a complex clinical history describing a response to treatment. This narrative is best detailed in progress or hematology consult notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "Hematology Consult Note"
            ],
            "extractionPrompt": "Extract: History of being refractory to platelet transfusions",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0137",
        "originalCriterionId": "EXC_5.2.4.6",
        "criterionType": "exclusion",
        "atomicText": "Currently receiving or requires anticoagulation therapy",
        "normalizedText": "Currently receiving or requires anticoagulation therapy",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.6_1a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 137
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anticoagulation_or_antiplatelet_therapy",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "'Currently receiving... anticoagulation therapy' refers to the active medication list, which is structured data (RxNorm/NDC). No OMOP mapping. Data in: Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0137",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Progress Note"
            ],
            "confidence": 1.0,
            "reasoning": "'Currently receiving... anticoagulation therapy' refers to the active medication list, which is structured data (RxNorm/NDC)."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Currently receiving or requires anticoagulation therapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0138",
        "originalCriterionId": "EXC_5.2.4.6",
        "criterionType": "exclusion",
        "atomicText": "Receiving drugs or herbal supplements that affect platelet function",
        "normalizedText": "Receiving drugs or herbal supplements that affect platelet function",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.6_1b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 138
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "anticoagulation_or_antiplatelet_therapy",
        "expressionNodeId": "1b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.9,
          "reasoning": "Information on prescribed drugs is most reliably found in the structured medication list. Herbal supplements are often documented only in clinical notes after patient interview. Has OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0138",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.9,
            "reasoning": "Information on prescribed drugs is most reliably found in the structured medication list. Herbal supplements are often documented only in clinical notes after patient interview."
          }
        }
      },
      {
        "atomicId": "A0139",
        "originalCriterionId": "EXC_5.2.4.6",
        "criterionType": "exclusion",
        "atomicText": "Receiving low-dose anticoagulation for central intravenous catheter patency",
        "normalizedText": "Receiving low-dose anticoagulation for central intravenous catheter patency",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "low-dose AND for catheter patency"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.6_2",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 139
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "This describes a specific medication being administered, which would be on the active medication list in the structured EHR data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0139",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "This describes a specific medication being administered, which would be on the active medication list in the structured EHR data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Receiving low-dose anticoagulation for central intravenous catheter patency",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0140",
        "originalCriterionId": "EXC_5.2.4.7",
        "criterionType": "exclusion",
        "atomicText": "Received steroid therapy for anti-neoplastic intent",
        "normalizedText": "Received steroid therapy for anti-neoplastic intent",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.7_1a",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 140
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.95,
          "reasoning": "The *intent* of a therapy ('for anti-neoplastic intent') is clinical context that is almost exclusively found in narrative oncology notes. The medication itself may be in structured data. Has OMOP mapping. Data in: Oncology Treatment Summary, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0140",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "The *intent* of a therapy ('for anti-neoplastic intent') is clinical context that is almost exclusively found in narrative oncology notes. The medication itself may be in structured data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received steroid therapy for anti-neoplastic intent",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0141",
        "originalCriterionId": "EXC_5.2.4.7",
        "criterionType": "exclusion",
        "atomicText": "Received inhaled steroids for asthma",
        "normalizedText": "Received inhaled steroids for asthma",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.7_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 141
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Inhaled steroids for asthma are standard medications that would be present in the structured medication list. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0141",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Inhaled steroids for asthma are standard medications that would be present in the structured medication list."
          }
        }
      },
      {
        "atomicId": "A0142",
        "originalCriterionId": "EXC_5.2.4.7",
        "criterionType": "exclusion",
        "atomicText": "Received topical steroids",
        "normalizedText": "Received topical steroids",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.7_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 142
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Topical steroids are prescribed medications found in the structured medication list. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0142",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Topical steroids are prescribed medications found in the structured medication list."
          }
        }
      },
      {
        "atomicId": "A0143",
        "originalCriterionId": "EXC_5.2.4.7",
        "criterionType": "exclusion",
        "atomicText": "Received replacement/stress corticosteroids",
        "normalizedText": "Received replacement/stress corticosteroids",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            1243048
          ],
          "conceptNames": [
            "Systemic corticosteroid therapy"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "1290388005"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "MedicationStatement",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "1290388005",
              "display": "Systemic corticosteroid therapy"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|1290388005",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.7_2c",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 143
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2c",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Replacement or stress corticosteroids are prescribed medications found in the structured medication list. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0143",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Replacement or stress corticosteroids are prescribed medications found in the structured medication list."
          }
        }
      },
      {
        "atomicId": "A0144",
        "originalCriterionId": "EXC_5.2.4.8",
        "criterionType": "exclusion",
        "atomicText": "Received aspirin",
        "normalizedText": "Received aspirin",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '7 days'",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.8_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 144
        },
        "provenance": {
          "pageNumber": 33,
          "textSnippet": "asthma, topical steroids or replacement/stress corticosteroids.\n8. The subject has received aspirin within 7 days prior to the first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Aspirin use, whether prescribed or over-the-counter, is typically recorded in the structured medication list. No OMOP mapping. Data in: H&P",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0144",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P"
            ],
            "confidence": 0.95,
            "reasoning": "Aspirin use, whether prescribed or over-the-counter, is typically recorded in the structured medication list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P"
            ],
            "extractionPrompt": "Extract: Received aspirin",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0145",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received chemotherapy",
        "normalizedText": "Received chemotherapy",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 50.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 145
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Detailed prior chemotherapy history, including regimens, cycles, and dates, is best captured in narrative oncology treatment summaries and flowsheets. No OMOP mapping. Data in: Oncology Treatment Summary, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0145",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "Detailed prior chemotherapy history, including regimens, cycles, and dates, is best captured in narrative oncology treatment summaries and flowsheets."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received chemotherapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0146",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received immunotherapy",
        "normalizedText": "Received immunotherapy",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 146
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Similar to chemotherapy, the specifics of prior immunotherapy are documented in oncology-specific clinical notes. No OMOP mapping. Data in: Oncology Treatment Summary, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0146",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "Similar to chemotherapy, the specifics of prior immunotherapy are documented in oncology-specific clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received immunotherapy",
            "expectedValues": [],
            "valueType": "numeric",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0147",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received radiotherapy",
        "normalizedText": "Received radiotherapy",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a3",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 147
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a3",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Prior radiotherapy details, such as location, dose, and dates, are found in radiation oncology summary reports, which are a form of clinical note. No OMOP mapping. Data in: Radiation Oncology Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0147",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "Radiation Oncology Summary"
            ],
            "confidence": 1.0,
            "reasoning": "Prior radiotherapy details, such as location, dose, and dates, are found in radiation oncology summary reports, which are a form of clinical note."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Radiation Oncology Summary"
            ],
            "extractionPrompt": "Extract: Received radiotherapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0148",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received hormonal anti-cancer therapy",
        "normalizedText": "Received hormonal anti-cancer therapy",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a4a",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 148
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "anti_cancer_therapy",
        "expressionNodeId": "1a4a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Prior hormonal anti-cancer therapy is part of the oncology treatment history, best found in narrative clinical notes. No OMOP mapping. Data in: Oncology Treatment Summary, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0148",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "confidence": 0.98,
            "reasoning": "Prior hormonal anti-cancer therapy is part of the oncology treatment history, best found in narrative clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Treatment Summary",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received hormonal anti-cancer therapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0149",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received hormones for thyroid conditions",
        "normalizedText": "Received hormones for thyroid conditions",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a4b1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 149
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a4b1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Hormones for non-cancer conditions like thyroid disease are standard medications recorded in the structured medication list. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0149",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Hormones for non-cancer conditions like thyroid disease are standard medications recorded in the structured medication list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received hormones for thyroid conditions",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0150",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received estrogen replacement therapy (ERT)",
        "normalizedText": "Received estrogen replacement therapy (ERT)",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a4b2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 150
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a4b2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Estrogen replacement therapy is a standard medication that would be recorded in the structured medication list. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0150",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Estrogen replacement therapy is a standard medication that would be recorded in the structured medication list."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received estrogen replacement therapy (ERT)",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0151",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Received any investigational therapy",
        "normalizedText": "Received any investigational therapy",
        "category": "prior_therapy",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_1a5",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 151
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a5",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Prior investigational therapy is most reliably found in detailed treatment history narratives within clinical notes, as it may not be captured in structured medication data. No OMOP mapping. Data in: Progress Note, Oncology Note, Discharge Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0151",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Progress Note",
              "Oncology Note",
              "Discharge Summary"
            ],
            "confidence": 0.95,
            "reasoning": "Prior investigational therapy is most reliably found in detailed treatment history narratives within clinical notes, as it may not be captured in structured medication data."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note",
              "Oncology Note",
              "Discharge Summary"
            ],
            "extractionPrompt": "Extract: Received any investigational therapy",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0152",
        "originalCriterionId": "EXC_5.2.4.9",
        "criterionType": "exclusion",
        "atomicText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
        "normalizedText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "value_as_number < 2"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.9_2a",
          "groupLogic": "NOT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 152
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.9,
          "reasoning": "This requires a current assessment at screening to determine if the patient has recovered from prior toxicities. This involves reviewing past notes and a current clinical evaluation (e.g., physical exam, patient interview). No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0152",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.9,
            "reasoning": "This requires a current assessment at screening to determine if the patient has recovered from prior toxicities. This involves reviewing past notes and a current clinical evaluation (e.g., physical exam, patient interview)."
          }
        }
      },
      {
        "atomicId": "A0153",
        "originalCriterionId": "EXC_5.2.4.10",
        "criterionType": "exclusion",
        "atomicText": "Received a biologic agent",
        "normalizedText": "Received a biologic agent",
        "category": "treatment_history",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.10_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 153
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "therapy.\n10. The subject has received a biologic within 30 days prior to the first dose of study\ndrug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "prior_therapy",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "History of receiving a biologic agent is part of the prior treatment history. While it may be in structured medication lists, the full context and details are more reliably found in oncology treatment summaries or notes. No OMOP mapping. Data in: Oncology Note, Infusion Note, Medication Administration Record",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0153",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Oncology Note",
              "Infusion Note",
              "Medication Administration Record"
            ],
            "confidence": 0.9,
            "reasoning": "History of receiving a biologic agent is part of the prior treatment history. While it may be in structured medication lists, the full context and details are more reliably found in oncology treatment summaries or notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Oncology Note",
              "Infusion Note",
              "Medication Administration Record"
            ],
            "extractionPrompt": "Extract: Received a biologic agent",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0154",
        "originalCriterionId": "EXC_5.2.4.11",
        "criterionType": "exclusion",
        "atomicText": "Consumed grapefruit",
        "normalizedText": "Consumed grapefruit",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.11_1a1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 154
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "grapefruit_consumption",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "Consumption of specific foods like grapefruit is not documented in the medical record and must be determined by asking the patient directly at the time of screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0154",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "Consumption of specific foods like grapefruit is not documented in the medical record and must be determined by asking the patient directly at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0155",
        "originalCriterionId": "EXC_5.2.4.11",
        "criterionType": "exclusion",
        "atomicText": "Consumed grapefruit products",
        "normalizedText": "Consumed grapefruit products",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.11_1a2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 155
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "grapefruit_consumption",
        "expressionNodeId": "1a2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "Consumption of specific food products is not documented in the medical record and must be determined by asking the patient directly at the time of screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0155",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "Consumption of specific food products is not documented in the medical record and must be determined by asking the patient directly at the time of screening."
          }
        }
      },
      {
        "atomicId": "A0156",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Myocardial infarction",
        "normalizedText": "Myocardial infarction",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4329847
          ],
          "conceptNames": [
            "Myocardial infarction"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "22298006"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "22298006",
              "display": "Myocardial infarction"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "I21.9",
              "display": "Acute myocardial infarction, unspecified"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1a_op_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 156
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "significant_cardiovascular_disease",
        "expressionNodeId": "1a_op_1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.98,
          "reasoning": "Myocardial infarction is a standard medical diagnosis that is captured as a structured diagnosis code (ICD-10) in the patient's problem list or medical history. Has OMOP mapping. Data in: H&P, Discharge Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0156",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Discharge Summary"
            ],
            "confidence": 0.98,
            "reasoning": "Myocardial infarction is a standard medical diagnosis that is captured as a structured diagnosis code (ICD-10) in the patient's problem list or medical history."
          }
        }
      },
      {
        "atomicId": "A0157",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Thrombotic event",
        "normalizedText": "Thrombotic event",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1a_op_2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 157
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "significant_cardiovascular_disease",
        "expressionNodeId": "1a_op_2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "A thrombotic event is a medical diagnosis captured as a structured diagnosis code (ICD-10) in the patient's problem list or medical history. No OMOP mapping. Data in: H&P, Discharge Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0157",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Discharge Summary"
            ],
            "confidence": 0.98,
            "reasoning": "A thrombotic event is a medical diagnosis captured as a structured diagnosis code (ICD-10) in the patient's problem list or medical history."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Discharge Summary"
            ],
            "extractionPrompt": "Extract: Thrombotic event",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0158",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Thromboembolic event",
        "normalizedText": "Thromboembolic event",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1a_op_3",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 158
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "significant_cardiovascular_disease",
        "expressionNodeId": "1a_op_3",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "A thromboembolic event is a medical diagnosis captured as a structured diagnosis code (ICD-10) in the patient's problem list or medical history. No OMOP mapping. Data in: H&P, Discharge Summary",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0158",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Discharge Summary"
            ],
            "confidence": 0.98,
            "reasoning": "A thromboembolic event is a medical diagnosis captured as a structured diagnosis code (ICD-10) in the patient's problem list or medical history."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Discharge Summary"
            ],
            "extractionPrompt": "Extract: Thromboembolic event",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0159",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of cardiovascular disease",
        "normalizedText": "Significant history of cardiovascular disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 159
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "significant_cardiovascular_disease",
        "expressionNodeId": "1b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0159",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0160",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of renal disease",
        "normalizedText": "Significant history of renal disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1c",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 160
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1c",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0160",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0161",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of neurologic disease",
        "normalizedText": "Significant history of neurologic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1d",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 161
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1d",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0161",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0162",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of psychiatric disease",
        "normalizedText": "Significant history of psychiatric disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1e",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 162
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1e",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0162",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0163",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of endocrinologic disease",
        "normalizedText": "Significant history of endocrinologic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1f",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 163
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1f",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0163",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0164",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of metabolic disease",
        "normalizedText": "Significant history of metabolic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1g",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 164
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1g",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0164",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0165",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of immunologic disease",
        "normalizedText": "Significant history of immunologic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1h",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 165
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1h",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0165",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0166",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Significant history of hepatic disease",
        "normalizedText": "Significant history of hepatic disease",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_1i",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 166
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1i",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0166",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "The term 'significant' requires an investigator to review the patient's history (from notes and structured data) and make a subjective clinical judgment about its relevance to the study."
          }
        }
      },
      {
        "atomicId": "A0167",
        "originalCriterionId": "EXC_5.2.4.12",
        "criterionType": "exclusion",
        "atomicText": "Disease history would adversely affect participation in the study in the opinion of the investigator",
        "normalizedText": "Disease history would adversely affect participation in the study in the opinion of the investigator",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.25,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.12_2",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 167
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 1.0,
          "reasoning": "The phrase 'in the opinion of the investigator' makes this criterion explicitly a matter of clinical judgment. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0167",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "The phrase 'in the opinion of the investigator' makes this criterion explicitly a matter of clinical judgment."
          }
        }
      },
      {
        "atomicId": "A0168",
        "originalCriterionId": "EXC_5.2.4.13",
        "criterionType": "exclusion",
        "atomicText": "Subject is female",
        "normalizedText": "Subject is female",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "person",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Subject is female\n-- Requires manual SQL generation",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.13_1",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 168
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 1.0,
          "reasoning": "Sex is a standard, structured demographic field in the EHR. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0168",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Sex is a standard, structured demographic field in the EHR."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Subject is female",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0169",
        "originalCriterionId": "EXC_5.2.4.13",
        "criterionType": "exclusion",
        "atomicText": "Subject is pregnant",
        "normalizedText": "Subject is pregnant",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [
            42528957
          ],
          "conceptNames": [
            "Pregnancy status"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "82810-3"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "82810-3",
              "display": "Pregnancy status"
            },
            {
              "system": "http://snomed.info/sct",
              "code": "77386006",
              "display": "Pregnancy"
            }
          ],
          "searchParams": "code=http://loinc.org|82810-3,77386006",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.13_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 169
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "pregnancy_lactation_status",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "Pregnancy status for a clinical trial must be confirmed with a new test at the time of screening. It is a real-time assessment, not based on historical data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0169",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "Pregnancy status for a clinical trial must be confirmed with a new test at the time of screening. It is a real-time assessment, not based on historical data."
          }
        }
      },
      {
        "atomicId": "A0170",
        "originalCriterionId": "EXC_5.2.4.13",
        "criterionType": "exclusion",
        "atomicText": "Subject is breast-feeding",
        "normalizedText": "Subject is breast-feeding",
        "category": "demographics",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.13_2b",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 170
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "demographics",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "pregnancy_lactation_status",
        "expressionNodeId": "2b",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.99,
          "reasoning": "Breast-feeding status is determined by asking the patient directly at the time of screening. It is not a standard field in the medical record. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0170",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.99,
            "reasoning": "Breast-feeding status is determined by asking the patient directly at the time of screening. It is not a standard field in the medical record."
          }
        }
      },
      {
        "atomicId": "A0171",
        "originalCriterionId": "EXC_5.2.4.14",
        "criterionType": "exclusion",
        "atomicText": "Tested positive for HIV",
        "normalizedText": "Tested positive for HIV",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            439727
          ],
          "conceptNames": [
            "Human immunodeficiency virus infection"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "86406008"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439727)",
          "sqlExecutable": true,
          "valueConstraint": "Positive"
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "86406008",
              "display": "Human immunodeficiency virus infection"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "B20",
              "display": "Human immunodeficiency virus [HIV] disease"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|86406008,B20",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.14_1",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 171
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "14. The subject has tested positive for HIV (due to potential drug-drug interactions \nbetween anti-retroviral medications and ABT-263, as well as anticipated ABT-263 \nmechanism based lymphopenia that may potentially increase the risk of \nopportunistic infections and potential drug-drug interactions with certain \nanti-infective agents).",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.98,
          "reasoning": "A positive HIV test is a laboratory result, which is stored as structured data (LOINC code and value) in the EHR. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0171",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "A positive HIV test is a laboratory result, which is stored as structured data (LOINC code and value) in the EHR."
          }
        }
      },
      {
        "atomicId": "A0172",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "History of other active malignancy",
        "normalizedText": "History of other active malignancy",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '3 years'",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_1a",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 172
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "A history of other malignancies is a complex diagnosis. While it may be coded, the full context, including dates, treatments, and status (active vs. resolved), is most reliably found by reviewing clinical notes and pathology reports. No OMOP mapping. Data in: H&P, Oncology Note, Pathology",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0172",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": "pathology_report",
            "noteTypes": [
              "H&P",
              "Oncology Note",
              "Pathology"
            ],
            "confidence": 0.9,
            "reasoning": "A history of other malignancies is a complex diagnosis. While it may be coded, the full context, including dates, treatments, and status (active vs. resolved), is most reliably found by reviewing clinical notes and pathology reports."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Oncology Note",
              "Pathology"
            ],
            "extractionPrompt": "Extract: History of other active malignancy",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0173",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "Adequately treated in situ carcinoma of the cervix uteri",
        "normalizedText": "Adequately treated in situ carcinoma of the cervix uteri",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_2a",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 173
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "The diagnosis of 'in situ carcinoma of the cervix uteri' is definitively made from a pathology or cytology report. The 'adequately treated' part would be confirmed in clinical notes. No OMOP mapping. Data in: Pathology, Cytology, Oncology Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0173",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Pathology",
              "Cytology",
              "Oncology Note"
            ],
            "confidence": 0.95,
            "reasoning": "The diagnosis of 'in situ carcinoma of the cervix uteri' is definitively made from a pathology or cytology report. The 'adequately treated' part would be confirmed in clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology",
              "Cytology",
              "Oncology Note"
            ],
            "extractionPrompt": "Extract: Adequately treated in situ carcinoma of the cervix uteri",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0174",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "Basal cell carcinoma of the skin",
        "normalizedText": "Basal cell carcinoma of the skin",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_2b1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 174
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "non_melanoma_skin_cancer",
        "expressionNodeId": "2b1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Basal cell carcinoma is a histological diagnosis, with the pathology report being the source of truth. No OMOP mapping. Data in: Pathology",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0174",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Pathology"
            ],
            "confidence": 0.98,
            "reasoning": "Basal cell carcinoma is a histological diagnosis, with the pathology report being the source of truth."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology"
            ],
            "extractionPrompt": "Extract: Basal cell carcinoma of the skin",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0175",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "Squamous cell carcinoma of the skin",
        "normalizedText": "Squamous cell carcinoma of the skin",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_2b2",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 175
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "non_melanoma_skin_cancer",
        "expressionNodeId": "2b2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.98,
          "reasoning": "Squamous cell carcinoma is a histological diagnosis, with the pathology report being the source of truth. No OMOP mapping. Data in: Pathology",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0175",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [
              "Pathology"
            ],
            "confidence": 0.98,
            "reasoning": "Squamous cell carcinoma is a histological diagnosis, with the pathology report being the source of truth."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology"
            ],
            "extractionPrompt": "Extract: Squamous cell carcinoma of the skin",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0176",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "Previous malignancy confined",
        "normalizedText": "Previous malignancy confined",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_2c1",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 176
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2c1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.92,
          "reasoning": "Information on whether a malignancy was 'confined' is part of staging, which is primarily determined by the pathology report (e.g., margins, invasion) and supplemented by imaging reports. No OMOP mapping. Data in: Pathology, Radiology",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0176",
            "primaryDataSource": "pathology_report",
            "secondaryDataSource": "radiology_report",
            "noteTypes": [
              "Pathology",
              "Radiology"
            ],
            "confidence": 0.92,
            "reasoning": "Information on whether a malignancy was 'confined' is part of staging, which is primarily determined by the pathology report (e.g., margins, invasion) and supplemented by imaging reports."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Pathology",
              "Radiology"
            ],
            "extractionPrompt": "Extract: Previous malignancy confined",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0177",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "Previous malignancy surgically resected",
        "normalizedText": "Previous malignancy surgically resected",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_2c2",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 177
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2c2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "A surgical resection is a procedure that is captured with structured CPT codes in the EHR. The operative report in clinical notes provides detailed confirmation. No OMOP mapping. Data in: Operative Report",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0177",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Operative Report"
            ],
            "confidence": 0.95,
            "reasoning": "A surgical resection is a procedure that is captured with structured CPT codes in the EHR. The operative report in clinical notes provides detailed confirmation."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Operative Report"
            ],
            "extractionPrompt": "Extract: Previous malignancy surgically resected",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0178",
        "originalCriterionId": "EXC_5.2.4.15",
        "criterionType": "exclusion",
        "atomicText": "Surgical resection was with curative intent",
        "normalizedText": "Surgical resection was with curative intent",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "procedure_occurrence",
          "conceptIds": [
            4301351
          ],
          "conceptNames": [
            "Surgical procedure"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "387713003"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4301351)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Procedure",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "387713003",
              "display": "Surgical procedure"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|387713003",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.15_2c3",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 178
        },
        "provenance": {
          "pageNumber": 34,
          "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
          "confidence": 1.0
        },
        "queryableStatus": "hybrid_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2c3",
        "queryabilityClassification": {
          "category": "HYBRID_QUERYABLE",
          "queryableStatus": "hybrid_queryable",
          "confidence": 0.98,
          "reasoning": "The 'intent' of a surgery (curative vs. palliative) is a clinical determination documented in narrative form within operative reports or oncology progress notes, not in a structured field. Has OMOP mapping. Data in: Operative Report, Oncology Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0178",
            "primaryDataSource": "clinical_notes",
            "secondaryDataSource": null,
            "noteTypes": [
              "Operative Report",
              "Oncology Note"
            ],
            "confidence": 0.98,
            "reasoning": "The 'intent' of a surgery (curative vs. palliative) is a clinical determination documented in narrative form within operative reports or oncology progress notes, not in a structured field."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Operative Report",
              "Oncology Note"
            ],
            "extractionPrompt": "Extract: Surgical resection was with curative intent",
            "expectedValues": [],
            "valueType": "boolean",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0179",
        "originalCriterionId": "EXC_5.2.4.16",
        "criterionType": "exclusion",
        "atomicText": "Uncontrolled systemic infection (viral, bacterial, or fungal)",
        "normalizedText": "Uncontrolled systemic infection (viral, bacterial, or fungal)",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4329847
          ],
          "conceptNames": [
            "Myocardial infarction"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "22298006"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "22298006",
              "display": "Myocardial infarction"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "I21.9",
              "display": "Acute myocardial infarction, unspecified"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.16_1",
          "groupLogic": "OR",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 179
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "partially_queryable",
        "clinicalConceptGroup": "uncontrolled_conditions",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "Determining if an infection is 'uncontrolled' requires a current clinical evaluation at screening, including physical exam, review of recent vital signs, and possibly new lab tests. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0179",
            "primaryDataSource": "real_time_assessment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "Determining if an infection is 'uncontrolled' requires a current clinical evaluation at screening, including physical exam, review of recent vital signs, and possibly new lab tests."
          }
        }
      },
      {
        "atomicId": "A0180",
        "originalCriterionId": "EXC_5.2.4.16",
        "criterionType": "exclusion",
        "atomicText": "Diagnosis of fever",
        "normalizedText": "Diagnosis of fever",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.16_2a1",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 180
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "febrile_neutropenia",
        "expressionNodeId": "2a1",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.9,
          "reasoning": "A diagnosis of fever can be found as a structured ICD code in the patient's problem list or encounter history. It can also be confirmed by a real-time vital sign measurement at screening. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0180",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "real_time_assessment",
            "noteTypes": [],
            "confidence": 0.9,
            "reasoning": "A diagnosis of fever can be found as a structured ICD code in the patient's problem list or encounter history. It can also be confirmed by a real-time vital sign measurement at screening."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Diagnosis of fever",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0181",
        "originalCriterionId": "EXC_5.2.4.16",
        "criterionType": "exclusion",
        "atomicText": "Diagnosis of neutropenia",
        "normalizedText": "Diagnosis of neutropenia",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.16_2a2",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 181
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "febrile_neutropenia",
        "expressionNodeId": "2a2",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "A diagnosis of neutropenia is typically recorded as a structured ICD code in the patient's problem list, which is the most reliable source. It may also be mentioned in clinical notes. No OMOP mapping. Data in: H&P, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0181",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "A diagnosis of neutropenia is typically recorded as a structured ICD code in the patient's problem list, which is the most reliable source. It may also be mentioned in clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "H&P",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Diagnosis of neutropenia",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0182",
        "originalCriterionId": "EXC_5.2.4.17",
        "criterionType": "exclusion",
        "atomicText": "Received known CYP3A inhibitors",
        "normalizedText": "Received known CYP3A inhibitors",
        "category": "safety_exclusion",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "drug_exposure",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "e.g., ketoconazole"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_EXC_5.2.4.17_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "NOT",
          "isExclusion": true,
          "sequenceHint": 182
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "administration.\n17. The subject has received known CYP3A inhibitors (e.g., ketoconazole) within\n7 days prior to first dose of study drug.",
          "confidence": 1.0
        },
        "queryableStatus": "llm_extractable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "safety_exclusion",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "cyp3a_inhibitors",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "LLM_EXTRACTABLE",
          "queryableStatus": "llm_extractable",
          "confidence": 0.95,
          "reasoning": "Information on medications received is most reliably found in structured medication administration records (e.g., RxNorm, NDC codes). Prior medication history is also commonly documented in clinical notes. No OMOP mapping. Data in: Medication Administration Record, Progress Note",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0182",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "Medication Administration Record",
              "Progress Note"
            ],
            "confidence": 0.95,
            "reasoning": "Information on medications received is most reliably found in structured medication administration records (e.g., RxNorm, NDC codes). Prior medication history is also commonly documented in clinical notes."
          },
          "nlpQuerySpec": {
            "noteTypes": [
              "Medication Administration Record",
              "Progress Note"
            ],
            "extractionPrompt": "Extract: Received known CYP3A inhibitors",
            "expectedValues": [],
            "valueType": "categorical",
            "temporalConstraint": "most_recent",
            "confidenceThreshold": 0.7
          }
        }
      },
      {
        "atomicId": "A0183",
        "originalCriterionId": "INC_5.2.5.1",
        "criterionType": "inclusion",
        "atomicText": "Meets all Inclusion and Exclusion criteria from Phase 1",
        "normalizedText": "Meets all Inclusion and Exclusion criteria from Phase 1",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.1_1a1",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 183
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1a1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.98,
          "reasoning": "This is a meta-criterion that requires the investigator to confirm that all other specified criteria are met. This is a summary assessment and an act of clinical judgment. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0183",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "This is a meta-criterion that requires the investigator to confirm that all other specified criteria are met. This is a summary assessment and an act of clinical judgment."
          }
        }
      },
      {
        "atomicId": "A0184",
        "originalCriterionId": "INC_5.2.5.1",
        "criterionType": "inclusion",
        "atomicText": "Laboratory parameters from Phase 1",
        "normalizedText": "Laboratory parameters from Phase 1",
        "category": "organ_function",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.1_1a2",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 184
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1a2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "This criterion requires an investigator to confirm that the patient's lab values meet the requirements from a previous phase. This is an assessment or judgment based on underlying structured lab data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0184",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "This criterion requires an investigator to confirm that the patient's lab values meet the requirements from a previous phase. This is an assessment or judgment based on underlying structured lab data."
          }
        }
      },
      {
        "atomicId": "A0185",
        "originalCriterionId": "INC_5.2.5.1",
        "criterionType": "inclusion",
        "atomicText": "Meets all Inclusion and Exclusion criteria from Phase 2a",
        "normalizedText": "Meets all Inclusion and Exclusion criteria from Phase 2a",
        "category": "diagnostic_confirmation",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "observation",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.1_1b1",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 185
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "diagnostic_confirmation",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.98,
          "reasoning": "This is a meta-criterion that requires the investigator to confirm that all other specified criteria are met. This is a summary assessment and an act of clinical judgment. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0185",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "This is a meta-criterion that requires the investigator to confirm that all other specified criteria are met. This is a summary assessment and an act of clinical judgment."
          }
        }
      },
      {
        "atomicId": "A0186",
        "originalCriterionId": "INC_5.2.5.1",
        "criterionType": "inclusion",
        "atomicText": "Laboratory parameters from Phase 2a",
        "normalizedText": "Laboratory parameters from Phase 2a",
        "category": "organ_function",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.1_1b2",
          "groupLogic": "EXCEPT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 186
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "This criterion requires an investigator to confirm that the patient's lab values meet the requirements from a previous phase. This is an assessment or judgment based on underlying structured lab data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0186",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "This criterion requires an investigator to confirm that the patient's lab values meet the requirements from a previous phase. This is an assessment or judgment based on underlying structured lab data."
          }
        }
      },
      {
        "atomicId": "A0187",
        "originalCriterionId": "INC_5.2.5.1",
        "criterionType": "inclusion",
        "atomicText": "Stable lab values per applicable laboratory reference ranges",
        "normalizedText": "Stable lab values per applicable laboratory reference ranges",
        "category": "organ_function",
        "funnelImpact": {
          "eliminationRate": 0.0,
          "impactScore": 0.0,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.1_2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 187
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.9,
          "reasoning": "The term 'stable' requires a subjective assessment by the investigator, who must review a series of lab values over time. The underlying data is from structured lab results. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0187",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.9,
            "reasoning": "The term 'stable' requires a subjective assessment by the investigator, who must review a series of lab values over time. The underlying data is from structured lab results."
          }
        }
      },
      {
        "atomicId": "A0188",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Platelet count >= 25,000/mm3 (untransfused)",
        "normalizedText": "Platelet count >= 25,000/mm3 (untransfused)",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 25000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 25000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_1a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 188
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Platelet count is a standard laboratory test result found in structured EHR data. The 'untransfused' status might be checked in notes, but the primary data point is the lab value. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0188",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Platelet count is a standard laboratory test result found in structured EHR data. The 'untransfused' status might be checked in notes, but the primary data point is the lab value."
          }
        }
      },
      {
        "atomicId": "A0189",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Platelet count <= 50,000/mm3",
        "normalizedText": "Platelet count <= 50,000/mm3",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number <= 50000",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 50000"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_1b_cond",
          "groupLogic": "IMPLICATION_CONDITION",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 189
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "1b_cond",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Platelet count is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0189",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Platelet count is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0190",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Platelet count is stable",
        "normalizedText": "Platelet count is stable",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_1b_req1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 190
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b_req1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.9,
          "reasoning": "The term 'stable' requires a subjective assessment by the investigator, who must review a series of lab values over time. The underlying data is from structured lab results. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0190",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.9,
            "reasoning": "The term 'stable' requires a subjective assessment by the investigator, who must review a series of lab values over time. The underlying data is from structured lab results."
          }
        }
      },
      {
        "atomicId": "A0191",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Platelet count is monitored at an increased frequency at the discretion of the investigator",
        "normalizedText": "Platelet count is monitored at an increased frequency at the discretion of the investigator",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3007461
          ],
          "conceptNames": [
            "Platelets [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26515-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26515-7",
              "display": "Platelets [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26515-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_1b_req2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 191
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "1b_req2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "This criterion is dependent on the 'discretion of the investigator,' which is a direct application of clinical judgment to determine the monitoring schedule. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0191",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "This criterion is dependent on the 'discretion of the investigator,' which is a direct application of clinical judgment to determine the monitoring schedule."
          }
        }
      },
      {
        "atomicId": "A0192",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Absolute Neutrophil count (ANC) >= 500/uL",
        "normalizedText": "Absolute Neutrophil count (ANC) >= 500/uL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 500"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_2a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 192
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0192",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0193",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Absolute Neutrophil count (ANC) is between 500/uL and 1000/uL",
        "normalizedText": "Absolute Neutrophil count (ANC) is between 500/uL and 1000/uL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500 AND value_as_number <= 999.99",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 500 AND value_as_number <= 999.99"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_2b_cond",
          "groupLogic": "IMPLICATION_CONDITION",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 193
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2b_cond",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0193",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Absolute Neutrophil Count (ANC) is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0194",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "ANC is monitored at an increased frequency at the discretion of the investigator",
        "normalizedText": "ANC is monitored at an increased frequency at the discretion of the investigator",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3017732
          ],
          "conceptNames": [
            "Neutrophils [#/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "26499-4"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "26499-4",
              "display": "Neutrophils [#/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|26499-4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_2b_req",
          "groupLogic": "IMPLICATION_REQUIREMENT",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 194
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "expressionNodeId": "2b_req",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.95,
          "reasoning": "This criterion is dependent on the 'discretion of the investigator,' which is a direct application of clinical judgment to determine the monitoring schedule. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0194",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 0.95,
            "reasoning": "This criterion is dependent on the 'discretion of the investigator,' which is a direct application of clinical judgment to determine the monitoring schedule."
          }
        }
      },
      {
        "atomicId": "A0195",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "Hemoglobin >= 8.0 g/dL",
        "normalizedText": "Hemoglobin >= 8.0 g/dL",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3000963
          ],
          "conceptNames": [
            "Hemoglobin [Mass/volume] in Blood"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "718-7"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 8.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number >= 8.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "718-7",
              "display": "Hemoglobin [Mass/volume] in Blood"
            }
          ],
          "searchParams": "code=http://loinc.org|718-7",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_3",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 195
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "3",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Hemoglobin is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0195",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Hemoglobin is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0196",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "aPTT not to exceed 1.2 x ULN",
        "normalizedText": "aPTT not to exceed 1.2 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3013466
          ],
          "conceptNames": [
            "aPTT in Blood by Coagulation assay"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "3173-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value <= 1.2 * Upper Limit of Normal",
          "sqlExecutable": true,
          "valueConstraint": "value <= 1.2 * Upper Limit of Normal"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "3173-2",
              "display": "aPTT in Blood by Coagulation assay"
            }
          ],
          "searchParams": "code=http://loinc.org|3173-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_4a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 196
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "4a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "aPTT (Activated Partial Thromboplastin Time) is a standard laboratory test result found in structured EHR data. Comparison to ULN is a direct check against the lab's reference range. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0196",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "aPTT (Activated Partial Thromboplastin Time) is a standard laboratory test result found in structured EHR data. Comparison to ULN is a direct check against the lab's reference range."
          }
        }
      },
      {
        "atomicId": "A0197",
        "originalCriterionId": "INC_5.2.5.2",
        "criterionType": "inclusion",
        "atomicText": "PT not to exceed 1.2 x ULN",
        "normalizedText": "PT not to exceed 1.2 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 25.0,
          "impactScore": 0.8,
          "isKillerCriterion": true
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3034426
          ],
          "conceptNames": [
            "Prothrombin time (PT)"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "5902-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value <= 1.2 * Upper Limit of Normal",
          "sqlExecutable": true,
          "valueConstraint": "value <= 1.2 * Upper Limit of Normal"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "5902-2",
              "display": "Prothrombin time (PT)"
            }
          ],
          "searchParams": "code=http://loinc.org|5902-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.2_4b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 197
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "4b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "PT (Prothrombin Time) is a standard laboratory test result found in structured EHR data. Comparison to ULN is a direct check against the lab's reference range. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0197",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "PT (Prothrombin Time) is a standard laboratory test result found in structured EHR data. Comparison to ULN is a direct check against the lab's reference range."
          }
        }
      },
      {
        "atomicId": "A0198",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "Chemistry values do not exceed Grade 2",
        "normalizedText": "Chemistry values do not exceed Grade 2",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [],
          "conceptNames": [],
          "vocabularyIds": [],
          "conceptCodes": [],
          "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
          "sqlExecutable": false,
          "valueConstraint": "values must be <= Grade 2 per CTCAE"
        },
        "fhirQuery": null,
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 198
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "partially_queryable",
        "expressionNodeId": "1",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.9,
          "reasoning": "Determining if a chemistry value exceeds a certain grade (e.g., per CTCAE) requires an investigator to interpret the raw lab value and apply a grading scale. This is an act of clinical judgment based on structured data. No OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0198",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.9,
            "reasoning": "Determining if a chemistry value exceeds a certain grade (e.g., per CTCAE) requires an investigator to interpret the raw lab value and apply a grading scale. This is an act of clinical judgment based on structured data."
          }
        }
      },
      {
        "atomicId": "A0199",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "Serum creatinine <= 3.0 x ULN",
        "normalizedText": "Serum creatinine <= 3.0 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3016723
          ],
          "conceptNames": [
            "Creatinine [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "2160-0"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 3.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 3.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "2160-0",
              "display": "Creatinine [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|2160-0",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 199
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "2",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Serum creatinine is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0199",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Serum creatinine is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0200",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "AST <= 5.0 x ULN",
        "normalizedText": "AST <= 5.0 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3013721
          ],
          "conceptNames": [
            "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1920-8"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 5.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 5.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1920-8",
              "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1920-8",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_3a",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 200
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "liver_function_tests",
        "expressionNodeId": "3a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "AST (Aspartate Aminotransferase) is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0200",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "AST (Aspartate Aminotransferase) is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0201",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "ALT <= 5.0 x ULN",
        "normalizedText": "ALT <= 5.0 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3006923
          ],
          "conceptNames": [
            "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1742-6"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 5.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 5.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1742-6",
              "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1742-6",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_3b",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 201
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "liver_function_tests",
        "expressionNodeId": "3b",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "ALT (Alanine Aminotransferase) is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0201",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "ALT (Alanine Aminotransferase) is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0202",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "Bilirubin <= 3.0 x ULN",
        "normalizedText": "Bilirubin <= 3.0 x ULN",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3024128
          ],
          "conceptNames": [
            "Bilirubin.total [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1975-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 3.0",
          "sqlExecutable": true,
          "valueConstraint": "value_as_number <= 3.0"
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1975-2",
              "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1975-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_4a",
          "groupLogic": "OR",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 202
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "fully_queryable",
        "clinicalConceptGroup": "bilirubin_level",
        "expressionNodeId": "4a",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 1.0,
          "reasoning": "Bilirubin is a standard laboratory test result found in structured EHR data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0202",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": null,
            "noteTypes": [],
            "confidence": 1.0,
            "reasoning": "Bilirubin is a standard laboratory test result found in structured EHR data."
          }
        }
      },
      {
        "atomicId": "A0203",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "Subject has Gilbert's Syndrome",
        "normalizedText": "Subject has Gilbert's Syndrome",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "condition_occurrence",
          "conceptIds": [
            4099740
          ],
          "conceptNames": [
            "Gilbert's syndrome"
          ],
          "vocabularyIds": [
            "SNOMED"
          ],
          "conceptCodes": [
            "27503000"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Condition",
          "codes": [
            {
              "system": "http://snomed.info/sct",
              "code": "27503000",
              "display": "Gilbert's syndrome"
            },
            {
              "system": "http://hl7.org/fhir/sid/icd-10-cm",
              "code": "E80.4",
              "display": "Gilbert syndrome"
            }
          ],
          "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_4b1",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 203
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "fully_queryable",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "disease_indication",
        "stage2QueryableStatus": "fully_queryable",
        "expressionNodeId": "4b1",
        "queryabilityClassification": {
          "category": "QUERYABLE",
          "queryableStatus": "fully_queryable",
          "confidence": 0.95,
          "reasoning": "Gilbert's Syndrome is a clinical diagnosis that would be recorded as a structured ICD code in the patient's problem list. It would also be documented in the medical history section of clinical notes. Has OMOP mapping. Data in: H&P, Problem List",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0203",
            "primaryDataSource": "ehr_structured",
            "secondaryDataSource": "clinical_notes",
            "noteTypes": [
              "H&P",
              "Problem List"
            ],
            "confidence": 0.95,
            "reasoning": "Gilbert's Syndrome is a clinical diagnosis that would be recorded as a structured ICD code in the patient's problem list. It would also be documented in the medical history section of clinical notes."
          }
        }
      },
      {
        "atomicId": "A0204",
        "originalCriterionId": "INC_5.2.5.3",
        "criterionType": "inclusion",
        "atomicText": "Bilirubin > 3.0 x ULN approved by investigator and medical monitor",
        "normalizedText": "Bilirubin > 3.0 x ULN approved by investigator and medical monitor",
        "category": "functional",
        "funnelImpact": {
          "eliminationRate": 20.0,
          "impactScore": 0.2,
          "isKillerCriterion": false
        },
        "omopQuery": {
          "tableName": "measurement",
          "conceptIds": [
            3024128
          ],
          "conceptNames": [
            "Bilirubin.total [Mass/volume] in Serum or Plasma"
          ],
          "vocabularyIds": [
            "LOINC"
          ],
          "conceptCodes": [
            "1975-2"
          ],
          "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128",
          "sqlExecutable": true
        },
        "fhirQuery": {
          "resourceType": "Observation",
          "codes": [
            {
              "system": "http://loinc.org",
              "code": "1975-2",
              "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
            }
          ],
          "searchParams": "code=http://loinc.org|1975-2",
          "queryExecutable": true,
          "valueFilter": null,
          "dateFilter": null
        },
        "executionContext": {
          "logicalGroup": "G_INC_5.2.5.3_4b2",
          "groupLogic": "AND",
          "combineWithPrevious": "AND",
          "isExclusion": false,
          "sequenceHint": 204
        },
        "provenance": {
          "pageNumber": 35,
          "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
          "confidence": 1.0
        },
        "queryableStatus": "screening_only",
        "nonQueryableReason": "No OMOP concepts mapped",
        "stage2ClinicalCategory": "organ_function",
        "stage2QueryableStatus": "requires_manual",
        "clinicalConceptGroup": "bilirubin_level",
        "expressionNodeId": "4b2",
        "queryabilityClassification": {
          "category": "SCREENING_ONLY",
          "queryableStatus": "screening_only",
          "confidence": 0.98,
          "reasoning": "This criterion explicitly requires approval from the investigator and medical monitor, which is a direct application of clinical judgment. The decision is based on the underlying bilirubin lab value from structured data. Has OMOP mapping.",
          "overridable": true,
          "dataSource": {
            "atomicId": "A0204",
            "primaryDataSource": "clinical_judgment",
            "secondaryDataSource": "ehr_structured",
            "noteTypes": [],
            "confidence": 0.98,
            "reasoning": "This criterion explicitly requires approval from the investigator and medical monitor, which is a direct application of clinical judgment. The decision is based on the underlying bilirubin lab value from structured data."
          }
        }
      }
    ],
    "logicalGroups": [
      {
        "qebId": "QEB_INC_5.2.1.1",
        "criterionType": "inclusion",
        "criterionText": "The subject must be \u2265 18 years of age.",
        "clinicalName": "Minimum Age of 18 Years",
        "atomicIds": [
          "A0001"
        ],
        "funnelStage": 2,
        "funnelStageName": "Demographics and Performance Status",
        "isKiller": false,
        "queryableStatus": "fully_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.1.2",
        "criterionType": "inclusion",
        "criterionText": "The subject must have relapsed or refractory CLL and require treatment in the opinion of the investigator.",
        "clinicalName": "Diagnosis of Relapsed or Refractory CLL",
        "atomicIds": [
          "A0002",
          "A0003",
          "A0004"
        ],
        "funnelStage": 1,
        "funnelStageName": "CLL Diagnosis and Treatment Need",
        "isKiller": true,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.1.3",
        "criterionType": "inclusion",
        "criterionText": "The subject has an Eastern Cooperative Oncology Group performance score of \u2264 1.",
        "clinicalName": "Good Performance Status (ECOG \u2264 1)",
        "atomicIds": [
          "A0005"
        ],
        "funnelStage": 2,
        "funnelStageName": "Demographics and Performance Status",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.1.4",
        "criterionType": "inclusion",
        "criterionText": "Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants (e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the first dose of study drug.",
        "clinicalName": "Stable Dose of SSRI Antidepressants",
        "atomicIds": [
          "A0006",
          "A0007"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_INC_5.2.1.5",
        "criterionType": "inclusion",
        "criterionText": "The subject must have adequate bone marrow independent of growth factor support (with the exception of subjects with ANC < 1000/\u03bcL and bone marrow heavily infiltrated with underlying disease [80% or more]), renal and hepatic function, per local laboratory reference range at Screening as follows:\n\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\u03bcL; Platelets \u2265 75,000/mm3 (entry platelet count must be independent of transfusion within 14 days of Screening), Hemoglobin \u2265 9.0 g/dL;\n\u25cf Renal fun",
        "clinicalName": "Adequate Organ and Bone Marrow Function",
        "atomicIds": [
          "A0008",
          "A0009",
          "A0010",
          "A0011",
          "A0012",
          "A0013",
          "A0014",
          "A0015",
          "A0016",
          "A0017",
          "A0018",
          "A0019",
          "A0020",
          "A0021",
          "A0022"
        ],
        "funnelStage": 6,
        "funnelStageName": "Screening Laboratory and Organ Function",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.1.6",
        "criterionType": "inclusion",
        "criterionText": "Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or have negative results for a pregnancy test performed as follows:\n\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study drug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Cycle 1 Day 1 or Lead-in Day 1 (lead-in period) if it has been > 7 days since obtaining the serum pregnancy test results.",
        "clinicalName": "Negative Pregnancy Status for Female Patients",
        "atomicIds": [
          "A0023",
          "A0024",
          "A0025",
          "A0026",
          "A0027",
          "A0028"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_INC_5.2.1.7",
        "criterionType": "inclusion",
        "criterionText": "All female subjects not surgically sterile or postmenopausal (for at least 1 year) and non-vasectomized male subjects must practice at least one of the following methods of birth control:\n\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual cycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive sponge, diaphragm or vagin",
        "clinicalName": "Contraception Requirement for Fertile Patients",
        "atomicIds": [
          "A0029",
          "A0030",
          "A0031",
          "A0032",
          "A0033",
          "A0034",
          "A0035",
          "A0036",
          "A0037"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_INC_5.2.1.8",
        "criterionType": "inclusion",
        "criterionText": "The subject must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
        "clinicalName": "Signed Informed Consent Form",
        "atomicIds": [
          "A0038",
          "A0039",
          "A0040",
          "A0041"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_EXC_5.2.2.1",
        "criterionType": "exclusion",
        "criterionText": "The subject has a history or is clinically suspicious for cancer-related Central Nervous System (CNS) disease.",
        "clinicalName": "Exclusion of CNS Malignancy",
        "atomicIds": [
          "A0042",
          "A0043"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.2",
        "criterionType": "exclusion",
        "criterionText": "The subject has undergone an allogeneic or autologous stem cell transplant.",
        "clinicalName": "No Prior Stem Cell Transplant",
        "atomicIds": [
          "A0044",
          "A0045"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "hybrid_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.3",
        "criterionType": "exclusion",
        "criterionText": "The subject has a recent history (within 1 year prior to first dose of study drug) of an underlying, predisposing condition of bleeding or currently exhibits signs of bleeding.",
        "clinicalName": "No Recent History of Bleeding",
        "atomicIds": [
          "A0046",
          "A0047"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.4",
        "criterionType": "exclusion",
        "criterionText": "The subject has active peptic ulcer disease or other potentially hemorrhagic esophagitis/gastritis.",
        "clinicalName": "No Active Peptic Ulcer or Gastritis",
        "atomicIds": [
          "A0048",
          "A0049",
          "A0050"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.5",
        "criterionType": "exclusion",
        "criterionText": "The subject has active immune thrombocytopenic purpura or a history of being refractory to platelet transfusions (within 1 year prior to the first dose of study drug).",
        "clinicalName": "No Active ITP or Platelet Refractoriness",
        "atomicIds": [
          "A0051",
          "A0052"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.6",
        "criterionType": "exclusion",
        "criterionText": "The subject has received aspirin within 7 days prior to the first dose of study drug.",
        "clinicalName": "Aspirin Washout Period",
        "atomicIds": [
          "A0053"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.7",
        "criterionType": "exclusion",
        "criterionText": "The subject is currently receiving or requires anticoagulation therapy or any drugs or herbal supplements that affect platelet function, with the exception of low-dose anticoagulation medications that are used to maintain the patency of a central intravenous catheter.",
        "clinicalName": "Prohibition of Anticoagulants and Platelet Inhibitors",
        "atomicIds": [
          "A0054",
          "A0055",
          "A0056"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.8",
        "criterionType": "exclusion",
        "criterionText": "Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to the first dose of study drug with the exception of inhaled steroids for asthma, topical steroids, or replacement/stress corticosteroids.",
        "clinicalName": "Washout Period for Systemic Steroid Therapy",
        "atomicIds": [
          "A0057",
          "A0058",
          "A0059",
          "A0060"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "hybrid_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.9",
        "criterionType": "exclusion",
        "criterionText": "The subject has received any anti-cancer therapy including chemotherapy, immunotherapy, radiotherapy, hormonal (with the exception of hormones for thyroid conditions or estrogen replacement therapy [ERT]), or any investigational therapy within 14 days prior to the first dose of study drug, or has not recovered to less than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous therapy.",
        "clinicalName": "Washout Period for Prior Anti-Cancer Therapy",
        "atomicIds": [
          "A0061",
          "A0062",
          "A0063",
          "A0064",
          "A0065",
          "A0066",
          "A0067",
          "A0068"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.10",
        "criterionType": "exclusion",
        "criterionText": "The subject has received a biologic within 30 days prior to the first dose of study drug.",
        "clinicalName": "Washout Period for Prior Biologic Therapy",
        "atomicIds": [
          "A0069"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.11",
        "criterionType": "exclusion",
        "criterionText": "The subject has consumed grapefruit or grapefruit products within 3 days prior to the first dose of study drug.",
        "clinicalName": "Grapefruit and Grapefruit Product Restriction",
        "atomicIds": [
          "A0070",
          "A0071"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_EXC_5.2.2.12",
        "criterionType": "exclusion",
        "criterionText": "The subject has a significant history of cardiovascular disease (e.g., myocardial infarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, neurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic disease that in the opinion of the investigator would adversely affect his/her participating in this study.",
        "clinicalName": "Exclusion of Significant Uncontrolled Comorbidities",
        "atomicIds": [
          "A0072",
          "A0073",
          "A0074",
          "A0075",
          "A0076",
          "A0077",
          "A0078",
          "A0079",
          "A0080",
          "A0081",
          "A0082",
          "A0083"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.2.13",
        "criterionType": "exclusion",
        "criterionText": "A female subject is pregnant or breast-feeding.",
        "clinicalName": "Exclusion of Pregnant or Breast-Feeding Females",
        "atomicIds": [
          "A0084",
          "A0085",
          "A0086"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.3.1",
        "criterionType": "inclusion",
        "criterionText": "The subject must be \u2265 18 years of age.",
        "clinicalName": "Minimum Age of 18 Years",
        "atomicIds": [
          "A0087"
        ],
        "funnelStage": 2,
        "funnelStageName": "Demographics and Performance Status",
        "isKiller": false,
        "queryableStatus": "fully_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.3.2",
        "criterionType": "inclusion",
        "criterionText": "The subject must have CLL and require treatment in the opinion of the investigator.",
        "clinicalName": "Confirmed CLL Diagnosis Requiring Treatment",
        "atomicIds": [
          "A0088",
          "A0089"
        ],
        "funnelStage": 1,
        "funnelStageName": "CLL Diagnosis and Treatment Need",
        "isKiller": true,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.3.3",
        "criterionType": "inclusion",
        "criterionText": "The subject has relapsed disease and has received no more than 5 prior myelosuppressive/chemotherapy regimens.",
        "clinicalName": "Limited Prior Chemotherapy for Relapsed Disease",
        "atomicIds": [
          "A0090",
          "A0091"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_INC_5.2.3.4",
        "criterionType": "inclusion",
        "criterionText": "Subject has an Eastern Cooperative Oncology Group performance score of \u2264 1.",
        "clinicalName": "Good Performance Status (ECOG \u2264 1)",
        "atomicIds": [
          "A0092"
        ],
        "funnelStage": 2,
        "funnelStageName": "Demographics and Performance Status",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.3.5",
        "criterionType": "inclusion",
        "criterionText": "Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants (e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the first dose of study drug.",
        "clinicalName": "Stable Dose of SSRI Antidepressants",
        "atomicIds": [
          "A0093",
          "A0094"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_INC_5.2.3.6",
        "criterionType": "inclusion",
        "criterionText": "The subject must have adequate bone marrow independent of growth factor support (with the exception of subjects with ANC < 1000/\u03bcL and bone marrow heavily infiltrated with underlying disease [80% or more]), renal and hepatic function, per local laboratory reference range at Screening as follows:\n\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\u03bcL; Platelets \u2265 75,000/mm3 (entry platelet count must be independent of transfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;\n\u25cf Renal fun",
        "clinicalName": "Adequate Organ and Bone Marrow Function",
        "atomicIds": [
          "A0095",
          "A0096",
          "A0097",
          "A0098",
          "A0099",
          "A0100",
          "A0101",
          "A0102",
          "A0103",
          "A0104",
          "A0105",
          "A0106",
          "A0107",
          "A0108",
          "A0109"
        ],
        "funnelStage": 6,
        "funnelStageName": "Screening Laboratory and Organ Function",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.3.7",
        "criterionType": "inclusion",
        "criterionText": "Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or have negative results for a pregnancy test performed as follows:\n\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study drug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been > 7 days since obtaining the serum pregnancy test results.",
        "clinicalName": "Negative Pregnancy Status for Female Patients",
        "atomicIds": [
          "A0110",
          "A0111",
          "A0112",
          "A0113",
          "A0114",
          "A0115"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_INC_5.2.3.8",
        "criterionType": "inclusion",
        "criterionText": "All female subjects not surgically sterile or postmenopausal (for at least 1 year) and non-vasectomized male subjects must practice at least one of the following methods of birth control:\n\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual cycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive sponge, diaphragm or vagin",
        "clinicalName": "Contraception Requirement for Fertile Patients",
        "atomicIds": [
          "A0116",
          "A0117",
          "A0118",
          "A0119",
          "A0120",
          "A0121",
          "A0122",
          "A0123",
          "A0124"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_INC_5.2.3.9",
        "criterionType": "inclusion",
        "criterionText": "The subject must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
        "clinicalName": "Signed Informed Consent Form",
        "atomicIds": [
          "A0125"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_EXC_5.2.4.1",
        "criterionType": "exclusion",
        "criterionText": "The subject has a history or is clinically suspicious for cancer-related Central Nervous System (CNS) disease.",
        "clinicalName": "Exclusion of CNS Malignancy",
        "atomicIds": [
          "A0126",
          "A0127"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.2",
        "criterionType": "exclusion",
        "criterionText": "The subject has a recent history (within 1 year prior to first dose of study drug) of an underlying, predisposing condition of bleeding or currently exhibits signs of bleeding.",
        "clinicalName": "No Recent History of Bleeding",
        "atomicIds": [
          "A0128",
          "A0129"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.3",
        "criterionType": "exclusion",
        "criterionText": "The subject has undergone an allogeneic or autologous stem cell transplant.",
        "clinicalName": "No Prior Stem Cell Transplant",
        "atomicIds": [
          "A0130",
          "A0131"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "fully_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.4",
        "criterionType": "exclusion",
        "criterionText": "The subject has active peptic ulcer disease or other potentially hemorrhagic esophagitis/gastritis.",
        "clinicalName": "No Active Peptic Ulcer or Gastritis",
        "atomicIds": [
          "A0132",
          "A0133",
          "A0134"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.5",
        "criterionType": "exclusion",
        "criterionText": "The subject has active immune thrombocytopenic purpura or a history of being refractory to platelet transfusions (within 1 year prior to the first dose of study drug).",
        "clinicalName": "No Active ITP or Platelet Refractoriness",
        "atomicIds": [
          "A0135",
          "A0136"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.6",
        "criterionType": "exclusion",
        "criterionText": "The subject is currently receiving or requires anticoagulation therapy or any drugs or herbal supplements that affect platelet function, with the exception of low-dose anticoagulation medications that are used to maintain the patency of a central intravenous catheter.",
        "clinicalName": "Prohibition of Anticoagulants and Platelet Inhibitors",
        "atomicIds": [
          "A0137",
          "A0138",
          "A0139"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.7",
        "criterionType": "exclusion",
        "criterionText": "The subject has received steroid therapy for anti-neoplastic intent within 7 days prior to the first dose of study drug with the exception of inhaled steroids for asthma, topical steroids or replacement/stress corticosteroids.",
        "clinicalName": "Washout Period for Systemic Steroid Therapy",
        "atomicIds": [
          "A0140",
          "A0141",
          "A0142",
          "A0143"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "hybrid_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.8",
        "criterionType": "exclusion",
        "criterionText": "The subject has received aspirin within 7 days prior to the first dose of study drug.",
        "clinicalName": "Aspirin Washout Period",
        "atomicIds": [
          "A0144"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.9",
        "criterionType": "exclusion",
        "criterionText": "The subject has received any anti-cancer therapy including chemotherapy, immunotherapy, radiotherapy, hormonal (with the exception of hormones for thyroid conditions or estrogen replacement therapy [ERT]), or any investigational therapy within 14 days prior to the first dose of study drug, or has not recovered to less than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous therapy.",
        "clinicalName": "Washout Period for Prior Anti-Cancer Therapy",
        "atomicIds": [
          "A0145",
          "A0146",
          "A0147",
          "A0148",
          "A0149",
          "A0150",
          "A0151",
          "A0152"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.10",
        "criterionType": "exclusion",
        "criterionText": "The subject has received a biologic within 30 days prior to the first dose of study drug.",
        "clinicalName": "Washout Period for Prior Biologic Therapy",
        "atomicIds": [
          "A0153"
        ],
        "funnelStage": 3,
        "funnelStageName": "Prior Anti-Cancer Therapy Review",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.11",
        "criterionType": "exclusion",
        "criterionText": "The subject has consumed grapefruit or grapefruit products within 3 days prior to the first dose of study drug.",
        "clinicalName": "Grapefruit and Grapefruit Product Restriction",
        "atomicIds": [
          "A0154",
          "A0155"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_EXC_5.2.4.12",
        "criterionType": "exclusion",
        "criterionText": "The subject has a significant history of cardiovascular disease (e.g., myocardial infarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, neurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic disease that in the opinion of the investigator would adversely affect his/her participating in this study.",
        "clinicalName": "Exclusion of Significant Uncontrolled Comorbidities",
        "atomicIds": [
          "A0156",
          "A0157",
          "A0158",
          "A0159",
          "A0160",
          "A0161",
          "A0162",
          "A0163",
          "A0164",
          "A0165",
          "A0166",
          "A0167"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.13",
        "criterionType": "exclusion",
        "criterionText": "A female subject is pregnant or breast-feeding.",
        "clinicalName": "Exclusion of Pregnant or Breast-Feeding Females",
        "atomicIds": [
          "A0168",
          "A0169",
          "A0170"
        ],
        "funnelStage": 7,
        "funnelStageName": "Informed Consent and Reproductive Safety",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.14",
        "criterionType": "exclusion",
        "criterionText": "The subject has tested positive for HIV (due to potential drug-drug interactions between anti-retroviral medications and ABT-263, as well as anticipated ABT-263 mechanism based lymphopenia that may potentially increase the risk of opportunistic infections and potential drug-drug interactions with certain anti-infective agents).",
        "clinicalName": "Exclusion of HIV-Positive Patients",
        "atomicIds": [
          "A0171"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "fully_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.15",
        "criterionType": "exclusion",
        "criterionText": "The subject has a history of other active malignancies within the past 3 years prior to study entry, with the exception of:\n\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "clinicalName": "Exclusion of Other Recent Active Malignancies",
        "atomicIds": [
          "A0172",
          "A0173",
          "A0174",
          "A0175",
          "A0176",
          "A0177",
          "A0178"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.16",
        "criterionType": "exclusion",
        "criterionText": "The subject exhibits evidence of other clinically significant uncontrolled condition(s) including, but not limited to:\n\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug administration.",
        "clinicalName": "Exclusion of Uncontrolled Systemic Infections",
        "atomicIds": [
          "A0179",
          "A0180",
          "A0181"
        ],
        "funnelStage": 4,
        "funnelStageName": "Significant Medical History and Comorbidities",
        "isKiller": false,
        "queryableStatus": "partially_queryable"
      },
      {
        "qebId": "QEB_EXC_5.2.4.17",
        "criterionType": "exclusion",
        "criterionText": "The subject has received known CYP3A inhibitors (e.g., ketoconazole) within 7 days prior to first dose of study drug.",
        "clinicalName": "Washout for Strong CYP3A Inhibitors",
        "atomicIds": [
          "A0182"
        ],
        "funnelStage": 5,
        "funnelStageName": "Bleeding Risk and Prohibited Medications",
        "isKiller": false,
        "queryableStatus": "llm_extractable"
      },
      {
        "qebId": "QEB_INC_5.2.5.1",
        "criterionType": "inclusion",
        "criterionText": "Subjects who enter the Extension Study must continue to meet all Inclusion and Exclusion criteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. Subjects entering the Extension Study must also have stable lab values per applicable laboratory reference ranges.",
        "clinicalName": "Continued Eligibility for Extension Study",
        "atomicIds": [
          "A0183",
          "A0184",
          "A0185",
          "A0186",
          "A0187"
        ],
        "funnelStage": 0,
        "funnelStageName": "",
        "isKiller": false,
        "queryableStatus": "requires_manual"
      },
      {
        "qebId": "QEB_INC_5.2.5.2",
        "criterionType": "inclusion",
        "criterionText": "Subjects must meet the following hematology and coagulation lab criteria:\n\n\u25cb Platelet counts must be \u2265 25,000/mm3 (untransfused). Platelet counts \u2264 50,000/mm3 must be stable and monitored at an increased frequency at the discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\u03bcL. ANC \u2265 500/\u03bcL and < 1,000/\u03bcL should be monitored at an increased frequency at the discretion of the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exceed 1.2 \u00d7 ULN.",
        "clinicalName": "Hematology and Coagulation Criteria for Extension",
        "atomicIds": [
          "A0188",
          "A0189",
          "A0190",
          "A0191",
          "A0192",
          "A0193",
          "A0194",
          "A0195",
          "A0196",
          "A0197"
        ],
        "funnelStage": 0,
        "funnelStageName": "",
        "isKiller": false,
        "queryableStatus": "fully_queryable"
      },
      {
        "qebId": "QEB_INC_5.2.5.3",
        "criterionType": "inclusion",
        "criterionText": "Subjects must meet the following chemistry criteria:\n\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry labs should be monitored at an increased frequency at the discretion of the investigator.\n\u25cb Serum creatinine \u2264 3.0 \u00d7 the upper normal limit (ULN) of institution's normal range.\n\u25cb AST and ALT \u2264 5.0 \u00d7 the upper normal limit (ULN) of institution's normal range.\n\u25cb Bilirubin \u2264 3.0 \u00d7 ULN. Subjects with Gilbert's Syndrome may be allowed to have a Bilirubin > 3.0 \u00d7 ULN based on a",
        "clinicalName": "Chemistry Criteria for Extension Study",
        "atomicIds": [
          "A0198",
          "A0199",
          "A0200",
          "A0201",
          "A0202",
          "A0203",
          "A0204"
        ],
        "funnelStage": 0,
        "funnelStageName": "",
        "isKiller": false,
        "queryableStatus": "fully_queryable"
      }
    ],
    "processingMetadata": {
      "processingTimeSeconds": 584.1921029090881,
      "llmModelUsed": "gemini-2.5-pro",
      "stageInputsUsed": [
        "stage2",
        "stage11_eligibility_funnel"
      ],
      "llmWarnings": []
    }
  },
  "summary": {
    "totalQEBs": 50,
    "inclusionQEBs": 20,
    "exclusionQEBs": 30,
    "fullyQueryable": 6,
    "llmExtractable": 17,
    "hybridQueryable": 3,
    "screeningOnly": 0,
    "notApplicable": 0,
    "partiallyQueryable": 17,
    "requiresManualReview": 7,
    "totalAtomicsConsolidated": 204,
    "uniqueOmopConcepts": 21,
    "deduplicationRate": 0.8970588235294118,
    "killerCriteriaCount": 2,
    "funnelStagesCount": 7,
    "eligibilitySectionPages": {
      "start": 28,
      "end": 30
    }
  },
  "llm_warnings": [],
  "atomic_validation": {
    "is_valid": true,
    "mismatches": [],
    "warnings": [],
    "total_stage2_atomics": 204,
    "total_funnel_atomics": 204,
    "criteria_with_mismatches": 0,
    "validation_timestamp": "2026-02-13T14:31:58.305449"
  },
  "atomic_validation_passed": true
}